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Integrins are one of the major proteins that cells utilise to adhere to their extracellular 
matrix (ECM). Although integrins do not possess any catalytic capacity themselves, they 
facilitate and orchestrate the assembly of mechanically sensitive signalling hubs which 
provide essential cues to guide and inform cell behaviour. Within the heart, integrins are 
found in specialised adhesion structures called costameres which provide a physical link 
between the contractile sarcomere and the ECM. Via proteins such as vinculin and talin, 
integrin signalling has been reported to play a key role in developmental and diseased 
processes such as rigidity sensing and hypertrophy. Importantly, cardiomyocyte integrin 
expression is tightly regulated  during development and diseased states where fibronectin 
binding integrin subtypes become dominant, whereas laminin binding subtypes are 
predominant in the healthy adult heart. Currently, the implications of this dynamic 
integrin expression profile for integrin signalling and cardiomyocyte behaviour is not well 
understood. Thus the aim of this thesis was to conduct a comparative investigation of 
cardiomyocyte spreading, morphology and contractility when cultured on fibronectin or 
laminin ligands. Initial investigations utilising PDMS substrates, nanopillar arrays and 
ligand micropatterning revealed that cardiomyocyte cultured on fibronectin exhibit 
greater spreading, contractility and vinculin enrichment than cells cultured on laminin. 
From these results, it was hypothesised that changes in integrin subtype expression may 
result in differential integrin signalling pathways. To understand the underpinning 
molecular mechanisms of these observations, we sought to investigate integrin clustering 
via the implementation of a DNA origami ligand nanopatterning platform. The results 
revealed key differences in the integrin clustering dynamics of fibronectin and laminin 
binding subtypes. This data provide new insights into the molecular mechanisms of 
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1.1 The Heart 
The heart is the first functional organ to form in the developing embryo. As the size of 
the embryo increases, diffusion of oxygen to the cells at the centre becomes increasingly 
difficult and the heart is required to deliver oxygen. With continued development, the 
heart increases in size as cardiomyocytes proliferate and become increasingly organised 
to support oxygen demands. Throughout development, the cytoskeleton of 
cardiomyocytes becomes increasingly organised via cell-cell contacts, called intercalated 
discs (ICD), and cell-extracellular matrix (ECM) contacts at rib-like structures called 
costameres. These cell-cell and cell-ECM linkages play a major role in mechanically 
coupling cardiomyocytes with their environment as they respond to increases in 
haemodynamic load and changes in ECM composition during development and disease 
(Ward and Iskratsch, 2019). 
The study of how cells physically interact with their mechanical environment to direct 
and inform behaviour is called mechanobiology. Cells exert forces upon their 
environment via specialist adhesion structures which “sense” the compliance of the ECM. 
Mechanically sensitive proteins at adhesion sites translate the corresponding forces into 
chemical signals, in a process called mechanotransduction (Iskratsch et al., 2014). Owing 
to their contractile nature, cardiomyocytes have a unique mechanotransduction regime, 
whereby cells are exposed to the regular forces from cellular tractions, in addition to 
cyclical forces from muscle contraction and haemodynamic filling of the chambers 
(Pandey et al., 2018, Ward and Iskratsch, 2019).  
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The primary contractile unit of cardiomyocytes is the sarcomere. This highly organised 
structure is formed of parallel filamentous actin (F-actin) and actin associated proteins, 
anchored to the z-discs at the lateral aspect of the sarcomere, interdigitated by antiparallel 
myosin filaments and associated proteins, anchored at the centre of the sarcomere (M-
band). Upon electrical excitation and a corresponding release of calcium, myosin 
filaments engage with the actin and initiate a contraction, as described by the sliding 
filament theory  (Huxley and Niedergerke, 1954, Huxley and Hanson, 1954). The 
sarcomere is repeated in series throughout the length of cardiomyocytes to form 
myofibrils that contract together in unison. In addition to coupling between cells, the 
sarcomere is also coupled to the ECM at the z-discs via the costameres, where transverse 
forces regulate mechanotransduction (Pardo et al., 1983, Ervasti, 2003). 
 
1.2 Intercalated Discs, Costameres as Focal Adhesions 
Cardiomyocytes have physical links both to their ECM and the surrounding 
cardiomyocytes. These physical links provide cardiomyocytes to opportunity for 
registration and integration of their contractile sarcomeres with the sarcomeres of 
surrounding cells for improved contraction efficiency (Lyon et al., 2015). Furthermore, 
integration of the sarcomere with cell-ECM structures affords cardiomyocyte the ability 
to “sense” the biomechanical and biochemical properties of their micro- and nano- 
environment to inform cell behaviours such as hypertrophy and survival (Hawkes et al., 
Figure 1.1. A) Schematic representation of the cytoskeletal structure of cardiomyocytes. B) 
Integrin heterodimers (green and purple) represent a fundamental link between the ECM 
and sarcomere. ECM = extracellular matrix, F-actin = filamentous actin. Figure from 
Israeli-Rosenberg et al., 2014. 
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2019, Pandey et al., 2018, Israeli-Rosenberg et al., 2014). Intercellular binding is 
regulated by specialist cell-cell adhesion structures called intercalated discs, while bonds 
between the cell and the ECM are mediated via specialist cell-ECM adhesion structures 
called costameres (as depicted in Figure 1.1).  
The ICD is the primary structure that facilitates transmission of contractile forces, 
electrical conduction and sequential alignment of sarcomeres between connected 
cardiomyocytes. Primarily, the ICD is formed of three structures, each with highly 
specific roles: namely, Desmosomes, Gap Junctions and Fascia Adherens (Figure 1.2). 
Desmosomes are specially designed for resisting the shear forces associated with 
coordinated contraction of the heart during systole, as mediated by inter-cellular junctions 
by desmocollin/desmoglen, which integrate with the desmin cytoskeleton and non-
sarcomeric actin filaments (Estigoy et al., 2009, Garrod et al., 2005). Gap junctions are 
specialist electrical conduction sites due to the tightly packed intra-cellular connexin 
bonds and as such, play essential roles in conduction pathology such as atrial fibrillation 
(van der Velden and Jongsma, 2002). The fascia adherens are essential intra-cellular 
adhesion sites for cytoskeletal integration of adjoining cells, facilitating coordinated 
contraction and mechanotransduction and are thus, highly important in cardiomyocytes 
(Estigoy et al., 2009). Both N-Cadherins and E-cadherins are essential for myofibrillar 
organisation via integration with catenins and actin filaments. E-cadherins have also been 
suggested to stimulate the cell cycle pathway (Ferreira-Cornwell et al., 2002). More 
recent work has demonstrated that ICDs are involved in intra-cellular signalling and actin 
assembly/maintenance via associated with many proteins, such as vinculin, a-actinin and 





Figure 1.2. Schematic representation of the intercalated disc. The ICD is composed of 
three main structures, desmosomes, gap junctions and fascia adherens. In additional to 
providing structure support for cell-cell contacts, ICDs also facilitate the conduction of 
action potentials from one cell to another via the gap junction. Both muscle and non-
muscle forms of actin are associated with the ICD and as such, many actin associated 
proteins are found at these sites. Common proteins include desmin, a-actinin, vinculin, 
catenin and cadherin. Ifs = intermediate filaments. (Estigoy et al., 2009). 
Costameres are specialised structures that act to couple the sarcomere laterally, via the z-
disc, to the ECM (Figure 1.1B & Figure 1.3). The integrin adhesion complex and the 
dystrophin-associated glycoprotein complex (DGC) form the two major components of 
the costamere (Ward and Iskratsch, 2019) and have both been established as 
mechanosensitive (Engler et al., 2008, Hersch et al., 2013, Lyon et al., 2015, Morikawa 
et al., 2017, Pandey et al., 2018). Although the dystroglycan complex is important for 
cardiomyocyte function, the integrin adhesion complex has received far more attention 
due to its dynamic responses to changes in the composition and mechanical properties of 
the ECM(Israeli-Rosenberg et al., 2014, Ward and Iskratsch, 2019). 
The costameric integrin adhesion complex is often considered to be a specialised version 
of the focal adhesion (FA) found in adherent cells (Iskratsch et al., 2014, Israeli-
Rosenberg et al., 2014, Sit et al., 2019). Actin associated proteins such as talin (Manso et 
al., 2013, Bogatan et al., 2015, Manso et al., 2017, Pandey et al., 2018), vinculin (Pardo 
et al., 1983, Mondello et al., 1996, Zemljic-Harpf et al., 2007) and a-actinin  act to tether 
the sarcomere to the ECM by binding integrins to the z-disc (Figure 1.1C). Furthermore, 
many costameric proteins have been identified to activate signalling pathways associated 
with development and disease (Samarel, 2005, Israeli-Rosenberg et al., 2014, Sit et al., 




Figure 1.3. Key proteins found at the cardiomyocyte costamere. Transmembranous 
integrins (dark green) bind to the ECM and recruit key signalling proteins such as Src, 
GEF, RhoA in addition to structural protein such as talin and vinculin, which act as 
adaptors to facilitate integration of the actin cytoskeleton with cell-ECM binding sites. 
Src = Proto-oncogene tyrosine protein kinase, GEF = Guanine nucleotide exchange 
factor, RhoA = Ras homologue family member A.  Adapted from Ward & Iskratsch, 2019. 
 
1.3 Structure and Function of Integrins 
Integrins are transmembranous proteins, consisting of a and b subunits that non-
covalently associate with one another to form a heterodimer. There are 18 a and 8 b 
subunits, that combine to form 24 different subtypes that recognise specific components 
of the ECM, such as collagen, fibronectin and laminin. The majority of the integrin 
structure is situated outside of the cell membrane, where they bind ECM ligands. The 
extra-cellular components consist of the membrane-proximal calf domains, a flexible 
knee domain, the thigh domain and the head domain (Figure 1.4). Conformational 
changes occur at the knee and head domains to regulate the affinity for ECM ligands 
(Gahmberg et al., 2009). The relatively short cytoplasmic domain consists of 40-60 amino 
acids which contain binding sites for numerous proteins. 
The extra-cellular domain can exist in a number of conformations that regulate the 
binding affinity to ECM ligands (Figure 1.4). In their state of lowest affinity, integrins 
adopt a closed confirmation where the head domains are closely packed together and the 
knee domain is bent, positioning the heads close the membrane. In their state of medium 





domains remain closely packed and closed. Upon full activation, integrins are fully 
extended with the heads in an open confirmation where they are most likely to bind to 
ECM ligands. The activation of integrins from closed to open states can be regulated by 
intracellular signals  (termed inside-out signalling) and extracellular signals (termed 
outside-in signalling). The high affinity between a5b1 integrins and the RGD domain of 
fibronectin (Li and Springer, 2017) can result in integrin activation via proximity alone 
and is a good example of outside-in signalling. The binding of proteins such as talin to b-
integrin tails is a good example of inside-out signalling, where this interaction separates 
the a and b tails, causing the extracellular domain to extend into the open conformation 
(Calderwood et al., 2003, Kim et al., 2012). 
The b integrin subtype is considered to be responsible for providing bindings sites for 
proteins at the cytoplasmic tail (Legate and Fassler, 2009) although a number of protein 
binding sites have also been identified on the tail of a subunits (Bachmann et al., 2019). 
Integrins themselves do not have any intracellular signalling capacity but are able to 
recruit a number of proteins capable of initiating signalling cascades. The occurs 
Figure 1.4. Conformation and structure of integrin heterodimers. In the closed 
conformation, the head domain is closed and located close to the cell membrane. 
Conformational changes occur primarily around the knee joint between the thigh and 
calf domains. Integrin-ECM interactions occur at the head domain where protein 
interaction can occur on either of the head domains or via  combination of the two. 
Taken from Ghamberg et al., 2009. 
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primarily via two highly conserved domains on the integrin tails, the NPxY and NxxY 
domains (Humphries et al., 2006, Gahmberg et al., 2009, Legate and Fassler, 2009). As a 
result, many proteins compete for a limited number of binding sites on integrin tails. The 
regulation of adaptor binding to integrin tails occurs via changes in integrin confirmation 
and affinity modification of proteins, via phosphorylation of the serine threonine rich tail 
domain (Calderwood et al., 2003, Bachmann et al., 2019). 
Proteins that bind integrin tails are often termed adaptor proteins due to the way in which 
they recruit and bind to other proteins. Adaptors can be classified into three groups 
depending on their major functions; 1) structural adaptors bind directly to integrin tails 
and provide a physical link to the actin cytoskeleton, 2) scaffolding proteins recruit other 
proteins for structural or signalling roles and 3) catalytic proteins regulate signalling 
pathways from the site of the integrin adhesion. The clustering of integrins at adhesion 
sites acts to assemble of a complex array of adaptor proteins to form FAs, which then 
participate in mechanotransduction (Iskratsch et al., 2014).  
Costameric integrin adhesion sites represent a structural link to the ECM for essential 
functions that regulate cardiomyocyte behaviour. In-vivo studies have identified a clear 
role of costameric proteins such as talin (Manso et al., 2013, Manso et al., 2017), vinculin 
(Vasile et al., 2006, Zemljic-Harpf et al., 2007), focal adhesion kinase (FAK, (Peng et al., 
2006)), paxillin (Hirth et al., 2016) and Kindlin (Dowling et al., 2008) in regulating the 
physiological and pathological behaviours. Furthermore, in-vitro studies have begun to 
unravel the costameric mechanisms of integrin mediated mechanotransduction, and their 
importance in normal cardiomyocyte function (Torsoni et al., 2003, Engler et al., 2008, 
Tangney et al., 2013, Pandey et al., 2018).  Thus, the following section will discuss the 
field of cell spreading and its importance in understanding the role of integrin adhesion 
at the costamere. 
1.4 The Cardiomyocyte Focal Adhesion In-Vitro vs the 
Costamere In-Vivo 
The field of in-vitro cell spreading and integrin mediated mechanotransduction is vast 
and has been seminal in understanding how cell-ECM interactions are fundamental to cell 
behaviour and survival (Iskratsch et al., 2014, Wolfenson et al., 2019). Research on the 
role of costameric integrin adhesion is no exception and in-vitro studies have become 
increasingly prevalent since the discovery that integrin adhesions in culture contain many 
of the same components found in the costamere in-vivo (Ervasti, 2003, Samarel, 2005). 
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Furthermore, technological development in the field of induced pluripotent stem cell 
derived cardiomyocytes has led to a surge in in-vitro cardiomyocyte research (Mummery, 
2018).  
In culture, neonatal cardiomyocytes (particularly neonatal rat cardiomyocytes (Samarel, 
2005)) disassemble their cytoskeleton, including IDC and costameric structures, to 
remodel their adhesive structures and adapt to the two dimension culture environment. In 
order to achieve this, cardiomyocytes adhere and spread over their environment via the 
assembly of adhesive structure that resemble those found in the traditional FA (Samarel, 
2014, Sit et al., 2019, Ward and Iskratsch, 2019).  Isolated neonatal cardiomyocytes also 
form mechanically sensitive costamere-like structures that resemble the lateral 
transmission of force from the z-disc to the ECM (Danowski et al., 1992). However, 
cardiomyocyte spreading in-vitro is highly reliant upon integrin adhesion structures for 
cell morphology and cytoskeletal organisation. The resulting dominance of integrin 
mediated mechanotransduction and resulting cell behaviour is likely to differ to that 
observed in-vivo where the role of ICDs is highly important. 
In light of the dominant nature of integrin adhesions in-vitro, it is highly important that 
the structure and function of adhesion plaques resemble their costameric counterparts. 
Indeed, many of the important structural and signalling costameric proteins such as talin 
(Manso et al., 2013, Pandey et al., 2018), vinculin (Rudiger et al., 1998), focal adhesion 
kinase (Torsoni et al., 2003, Lal et al., 2007), kindlin (Qi et al., 2015), protocol-oncogene 
tyrosine-protein kinase Src (Src, (Pandey et al., 2018)) are found at cardiomyocyte FAs. 
Consequently, important costameric signalling cascades such as the hypertrophic 
pathways can be easily recapitulated in vitro (Johnston et al., 2009, Pandey et al., 2018, 
Manso et al., 2013, Ogawa et al., 2000). As a result, in-vitro cardiomyocyte research has 
led to a wealth of research in the role of the costamere/integrin adhesion complex in 
cardiomyopathy. In particular, in-vitro culturing of cardiomyocytes benefits from the 
ability to engineer the chemical and mechanical properties of culture surfaces and mimic 
the highly dynamic nature of the cardiac ECM. 
1.5 The Changing Cardiac ECM: Dynamic Chemical and 
Mechanical Properties of the Heart 
The cardiac ECM is composed of a complex meshwork of proteoglycans, 
glycosaminoglycans and glycoproteins which primarily contains collagens, fibronectin 
and laminin (Lockhart et al., 2011, Rienks et al., 2014, Hughes and Jacobs, 2017). While 
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providing a scaffold, it also functions to deliver extra-cellular chemical cues to inform 
cell behaviour. During development, the fibrillar collagens (types I, III, IV & VI) are 
highly expressed and are essential for embryonic development (Lockhart et al., 2011, 
Williams et al., 2014). Fibronectin (especially EIIIA and EIIIB splice variants)  is also 
highly expressed during development up until birth, when expression steadily declines 
during postnatal development and into adulthood (Kim et al., 1999, Lockhart et al., 2011). 
Laminin (with alpha chains 1-5) is expressed at low levels during embryonic development 
and becomes upregulated during post-natal development, in an opposite trend to 
fibronectin (Kim et al., 1999, Ringelmann et al., 1999, Oliviéro et al., 2000). During 
ageing and in diseased states, the cardiac ECM undergoes a transition back to a more a 
developmental ECM phenotype, where fibronectin becomes upregulated (Mamuya and 
Brecher, 1992, Burgess et al., 2001).  
In parallel with changes to ECM  composition and deposition, cardiomyocytes alter their 
integrin expression to match the major ECM components. Cardiomyocytes 
predominantly express a1b1, a3b1, a5b1, a6b1  and a7b1 integrins (Figure 1.5) which 
preferentially bind to collagen (a1b1), fibronectin (a5b1, a6b) and laminin (a3b1, 
a7b1).  Expression of different integrin subtypes mirrors the expression of ECM proteins. 
Collagen is upregulated during development where it provides a key structural role and a 
network of highways for migration of cardiac fibroblasts as the heart develops. Collagen 
expression also remains relatively stable into adulthood and becomes upregulated at sites 
of cardiac damage when cardiac fibroblasts increase collagen deposition during fibrosis 
and scar formation (Rog-Zielinska et al., 2016). Fibronectin and laminin ligands, 
however, exhibit more dynamic expression during development and disease, suggesting 
a more active role  in cardiomyocyte outside-in signalling (Ward and Iskratsch, 2019). As 
a result, cardiomyocytes predominantly express the fibronectin binding avb1 and a5b1 
integrin subtypes during development which become downregulated after birth, when the 
laminin binding a7b1 subtype becomes the predominant subtype (Brancaccio et al., 
1998). Likewise, during disease, cardiomyocyte integrin expression switches back to the 
developmental phenotype where fibronectin binding integrin subtypes become dominant 
(Babbitt et al., 2002, Balasubramanian and Kuppuswamy, 2003, Johnston et al., 2009, 
Suryakumar et al., 2010). The b1 integrin is the dominant beta-subtype in the heart 
throughout the lifespan (Israeli-Rosenberg et al., 2014, Ward and Iskratsch, 2019).  
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Variations in both the ligand and integrin subtype via alternative splicing further 
complicate matters, providing cardiomyocytes with an additional means to distinguish 
different ligands within the ECM. Numerous fibronectin splice variants are known to 
exist, of which, the EIIIA and EIIIB alternative splice variants play essential roles in 
development of the heart (Lockhart et al., 2011). During adulthood, alternative splicing 
of fibronectin is less frequent, but is associated with injury and pathology (White et al., 
2008). However, little is known about the affinity of a5b1 for fibronectin variants. 
Laminins are comprised of a, b and g chains which form numerous combinations. 
Integrins bind directly to the a chain, which has 5 different isoforms (a1-5). During 
development, the a1 and a2 isoforms are predominantly expressed which switches to a5 
in the adult heart (Miner et al., 1997, Ringelmann et al., 1999, Oliviéro et al., 2000). The 
laminin binding a7X2b1 integrin (an alternative splice variant of a7b1) bind most 
strongly to the a1 laminin chain, while the a7Xb1 integrin splice variant binds most 
strongly to a5 laminin chains. The laminin binding a6b1 and a3b1integrins bind a1, 3 
and 5 chains and a2, 3 and 5 chains, respectively  (Nishiuchi et al., 2006). Finally, 
although the b1 integrin is stably expressed in cardiomyocytes, splice variants exists and 
Figure 1.5. Cardiomyocyte integrin subtype expression during development and into 
adulthood in the mouse heart. Samples were collected at embryonic day 16 (E16), post-
natal day 1(P1) and in adult (Ad) mice. Data indicates that the fibronectin binding av 
and  a5 and a6 subtypes are dominant during development. During post-natal 
development, fibronectin binding subtypes become down regulated and replaced by 
dominant expression of the laminin binding a7 subtypes. The b1 subtypes is dominant 
in the heart but exhibits dynamic expression of the b1A and b1D splice variants. Figure 
adapted from Brancaccio et al., 1998. 
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differ during development. The b1A splice variant is strongly expressed during 
development and plays a key role in early myogenesis and maturation. The b1D splice 
variant then becomes expressed in late development and is the dominant isoform in adult 
cardiomyocytes (Brancaccio et al., 1998, Maitra et al., 2000). Importantly, these b1 
variants have non-interchangeable roles and their coordinated expression is essential for 
myogenesis (Cachaco et al., 2003). Therefore, via different integrin subtypes and splice 
variants, cardiomyocytes have an extensive repertoire of tools to detect changes in ECM 
composition that occur during development and disease.  
In addition to recognising specific chemical components, cells also utilise integrin 
adhesions to test the mechanical properties of the ECM, via rigidity sensing (Iskratsch et 
al., 2014, Wolfenson et al., 2019). The dynamic nature of the cardiac ECM during 
development and disease also results in changes to its mechanical properties  and 
therefore, rigidity sensing dynamics. During development, the stiffness of the heart is 
thought to range between 1-10 kPa, which increases to 10-20 kPa in the adult left 
ventricle, which further increases in excess of 50 kPa during diseased fibrotic states 
(Ward and Iskratsch, 2019). While, the range of measurements was shown by Ward & 
Iskratsch (2019) to vary significantly by method and model organism, all studies are in 
agreement that the heart undergoes gradual stiffening during development, with further 
stiffening during diseased states such as hypertrophic cardiomyopathy (HCM) and 
fibrosis. Thus, via a dynamic physical, chemical and mechanical environment, the cardiac 
ECM stimulates significant changes to integrin mediated mechanotransduction during 
development and disease. 
Being positioned at the cell membrane-ECM interface makes integrins one of the first 
responders to chemical and mechanical cues. Furthermore, by providing a physical link 
between the ECM, mechanosensitive proteins and the contractile sarcomere, 
cardiomyocytes have the ability to detect and respond to chemical and mechanical signals 
in a highly complex manner. The following section with focus on this link at the 
costamere and aims to discuss what is known about key mechanosensitive proteins.   
 
1.6 Mechanotransduction at the Costamere 
Mechanotransduction in cardiomyocytes is a unique and complex process, owing to the 
combination of passive (ECM remodelling, stiffness and haemodynamic loading) and 
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active (myofibrillar and non-myofibrillar contractility) forces/stimuli present within the 
heart. Costameres have been regarded as important mechanotransducers since 
observations that they directly transmit contractile forces to the surrounding ECM 
(Danowski et al., 1992). Others have also demonstrated that via the mechanical linkage 
of myofibrils to the ECM, stretching (e.g. stretching of the ventricle during 
haemodynamic loading) is detected across the entire cell, resulting in a highly complex 
mechanotransduction response (Mansour et al., 2004). Integrins play an essential role in 
mediating this response. For example, b1 integrins are required to activate the 
hypertrophic response after both pharmacological treatment (Ross et al., 1998) and 
mechanical stretching (Lal et al., 2007), via phosphorylation of mitogen-activated protein 
kinases (MAPK) p38, protein kinase 2(AKT) and Extra-cellular signal Related Kinase 
1/2 (ERK ½) and c-Jun N-terminal Kinase (JNK), as seen in Figure 1.6. Many 
downstream consequences of cardiomyocyte mechanotransduction have been well 
defined and strong links have been reported with gene expression and cardiomyocyte 
behaviours such as hypertrophy (Samarel, 2005, Buyandelger et al., 2011, Samarel, 2014, 
Israeli-Rosenberg et al., 2014, Jaka et al., 2015, Sit et al., 2019, Ward and Iskratsch, 
2019). However, the molecular mechanisms (i.e. mechanical stretching/unfolding, ligand 
affinity/avidity, molecular clutches, protein binding partners) that regulate integrin 
mediated signalling responses at the costamere are less well understood. The following 
section will present and discuss the major costameric players in mechanotransduction.  
 
Figure 1.6. Schematic depiction of known adaptor proteins present at the intercalated 
disc. A) Many scaffolding proteins such as paxillin, kindlin, talin and a-actinin have 
essential structural roles in bridging the connection between the cytoskeleton and the 
ECM bound integrins. B) Stimulation of the costameric structure,s and associated 
signalling proteins, with mechanical stress initiates signalling pathways important for 




oncogene tyrosine protein kinase, ERK – Extracellular signal related kinase, Akt – 
Protein kinase 2, NFkB - nuclear factor kappa-light-chain-enhancer of activated B cells, 
PP1a – Protein phosphatase 1a, Pyk2 – Protein tyrosine kinase 2beta, Vcl – Vinculin, 
MtVcl – Metavinculin, IQGAP1 - IQ Motif Containing GTPase Activating Protein 1, 
Hsp90 - heat shock protein 90, ILK – Integrin linked kinase, PINCH - particularly 
interesting new cysteine-histidine–rich protein. 
1.6.1 Talin 
The large protein talin is ubiquitously expressed in cells and has received a lot of attention 
for its essential role in FA dynamics (Klapholz and Brown, 2017). Within the 
cardiomyocyte, talin is strongly enriched at the costameres and intercalated discs (Manso 
et al., 2013, Wu et al., 2015, Manso et al., 2017) where it is known to provide a structural 
role by providing a biomechanical link between integrins and F-actin (Samarel, 2005, del 
Rio et al., 2009, Manso et al., 2017). Consistent with its structural role in adhesion 
reinforcement, talin unfolds under tension to reveal cryptic binding sites that act to 
reinforce the talin-actin bond via the recruitment of additional vinculin (del Rio et al., 
2009). Talin is also a potent activator of integrins: via disruption of the bond between the 
a and b integrin tails, they can switch integrins to their high affinity conformation 
(Calderwood et al., 1999, Kim et al., 2012, Klapholz and Brown, 2017), thereby 
regulating integrin adhesion dynamics. 
Talin is a 260 kDa protein consisting of an N-terminal head domain and a C-terminal rod 
domain (Figure 1.7). The N-terminal region contains ~ 400 amino acids that form the 
FERM (protein 4.1, ezrin, radixin, moesin) domain which contains the F1, F2, F3 and F0 
subdomains. The F3 subdomain bind b integrin tails with high affinity, which can be 
traced to a single residue depending on the talin isoform (Elliott et al., 2010, Qi et al., 
2016). Talin contains binding sites for many other proteins, as shown in Figure 1.7. 
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Vertebrates have two talin isoforms, talin 1 and 2, which exhibit differential expression 
during cardiac development and disease. Talin 1 is strongly expressed during embryonic 
development, which becomes down regulated after birth, when talin 2 is upregulated 
(Manso et al., 2013). This likely reflects the change in integrin expression due to stronger 
affinity of talin 1 and 2 for b1A and b1D integrins, respectively (Anthis et al., 2010). The 
binding affinity of talin 2 for b1D is highly important for mediating cellular traction 
forces (Anthis et al., 2010, Qi et al., 2016, Pandey et al., 2018). However, talin 1 is able 
to compensate for loss of talin 2 in cardiomyocytes during normal development and basal 
functioning, suggesting a level of redundancy between the two isoforms (Manso et al., 
2017).   
 Talin also plays a key role in development and basal functioning of the heart. Loss of 
talin is embryonic lethal in drosophila (Bogatan et al., 2015) and zebra fish (Wu et al., 
2015), with cardiomyocytes exhibiting severe structural deformities and failure to 
proliferate. Cre mediated Talin 1 and 2 knock out (KO) mice are born with 
Figure 1.7. Talin as a complex adapter protein. The N-terminal head (FERM) domain 
contains four subdomains (F0-3) which contains actin binding cites on F2 & F3 and an 
integrin binding site on F3. The integrin binding site on F3 competes with other adaptor 
proteins such as FAK (focal adhesion kinase), laylin, TIAM1 (T-lymphoma invasion and 
metastasis-inducing protein 1), RIAM (Rap1-GTP-interactin adapter molecule) and 
PIPKIg (Type I gamma phosphatidylinositol phosphate kinase). The rod domain is 
connected to the head domain via an ~80 amino acid linker between F3 and R1. The 
rod domain contains 61 a-helices, organised into 13 bundles (R1-13). Cryptic vinculin 
binding sites are also indicated for R2, R3 & R4. The numerous actin binding sites on 
the rod domain are also indicated for R4-R8 and R13-DH. Protein binding sites are 
indicated. IBS – Integrin binding site, ABS – actin binding site. Domain numbering is 
consistent with Talin 1. Image from Klapholz & Brown, 2017. 
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morphologically normal hearts, suggesting that talin could be essential during early 
developmental stages (in this study, Cre is only expressed from E10.5). However, these 
mice develop severe dilated cardiomyopathy 4 weeks post birth, with 0% survival after 8 
weeks (Manso et al., 2017). Evaluation of cardiomyocyte structural integrity revealed 
severely disorganised costameric and sarcomeric structures, due to downregulation of b1 
integrins (Manso et al., 2017).  
Recent work from the Iskratsch lab has revealed an important role for talin in 
cardiomyocyte rigidity sensing (Pandey et al., 2018). The use of FRET tension sensors 
revealed that talin undergoes specific stretching regimes depending on substrate rigidity; 
with no stretching on soft, cyclic stretching at physiological and constant stretching on 
stiff substrates. Furthermore, activation of the non-receptor tyrosine kinase Src was also 
upregulated according to substrate stiffness. From this finding, it was hypothesised that 
talin signalling may form a feedback loop, via Src and the actin assembly protein FHOD1, 
to facilitate rigidity sensing (Figure 1.8). Others have also demonstrated that talin 1 is 
responsible for mediation of a hypertrophic response in cardiomyocytes, via b-adrenergic 
signalling, which talin 2 cannot do on its own (Manso et al., 2013). Recent observations 
Figure 1.8. Talin participates in in a rigidity sensing feedback loop in cardiomyocytes. 
Talin stretching and mechanotransduction on different stiffnesses occurs alongside 
stiffness dependent feedback loop. The proposed feedback loop starts with talin 
stretching, resulting in activation of Src and downstream activation of the actin 
assembly protein FHOD1 and non-muscle myosin 2B (p-nmM2B) which in turn 
increases cytoskeletal contractility, stimulating/maintaining talin stretching, restarting 
the feedback loop. Model presented by Pandey et al., 2018. 
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have also revealed that complete unfolding of talin may facilitate the recruitment of other 
proteins, such as Deleted in Liver Cancer 1 (DLC1), that play a key role in heart 
development and disease (Ward and Iskratsch, 2019). The findings discussed above 
present talin as a key hub of mechanotransduction in cardiomyocytes. Thus, talin 
represents an exciting target for future investigations to further understand the molecular 
regulation of mechanotransduction. 
 
1.6.2 Vinculin 
Vinculin is a 116 kDa adaptor protein that localises to FAs, costameres and the ICDs. At 
the costamere, vinculin primarily acts as a structural adapter protein by reinforcing the 
talin-actin bond. Vinculin possesses a number of binding sites for costameric adaptors, 
including a-actinin, vasodilator-stimulated phosphoprotein (VASP), paxillin and protein 
kinase C a (PKCa), demonstrating its role as a structural adaptor (Ziegler et al., 2006). 
Figure 1.9 displays the structure of vinculin and illustrates the multiple protein binding 
sites. Vinculin exists in a closed, auto-inhibited state which can be released via binding 
Figure 1.9. Structure of vinculin as a scaffolding adaptor protein. Vinculin exists in an 
auto-inhibited state which is released upon talin binding to the N terminal domain. 
Numerous protein binding sites are located along the protein, including talin, a-actinin, 
a-catenin, Ponsin, Vinexin, VASP (vasodilator stimulated phosphoprotein), Mena, 
Arp2/3 (actin related proteins2/3), paxillin, actin and PIP2 (Phosphatidylinositol 4,5-
bisphosphate). Source: MBInfo, mechanobio.info. 
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to talin in the cytosol, or upon recruitment to talin when under tension (del Rio et al., 
2009, Austen et al., 2015, Atherton et al., Preprint). Upon recruitment to FAs, vinculin 
mediates the transmission of forces between the contractile cytoskeleton and the ECM by 
reinforcing the talin-actin bond (del Rio et al., 2009, Pasapera et al., 2010, Yao et al., 
2016), framing vinculin as a key mechanotransducer. However, recent observations that 
vinculin forms a complex with talin within the cytosol, which then goes on to promote 
FA assembly in a force independent process, suggest that vinculin may play a more 
complex and activate role in FA mechanotransduction than previously thought (Atherton 
et al., Preprint). 
Skeletal and cardiac muscle expresses an alternative spliced variant of vinculin, called 
metavinculin, which contains a 68-amino acid insert within the vinculin tail domain 
(Belkin et al., 1988, Rudiger et al., 1998). The metavinculin insert domain contains a 
unique  a-helix insert which causes a differential actin bundling phenotype, resulting in 
thinner F-actin structures (Rudiger et al., 1998, Rangarajan et al., 2010). Within the 
metavinculin insert, three point mutations have been associated with cardiomyopathy 
through disruption to actin bundling, disorganisation of IDC structure and loss of 
costameric localisation (Olson et al., 2002, Vasile et al., 2006). 
Within the heart, loss of function and knockout studies have begun to highlight the role 
of vinculin in cardiomyocytes. Cre recombinase ablation of vinculin in mouse 
cardiomyocytes (homozygous KO from E10.5 onwards), resulted in phenotypically 
normal mice being born with preserved cardiac function. From 6 weeks of age, ventricular 
tachycardia resulted in sudden death due to poor electrical conduction and severe 
disruption to ICD structure (Zemljic-Harpf et al., 2007). Disruption to the costameric and 
z-disc structure was observed but the authors were unable to differentiate between the 
role of vinculin at the ICD or costamere. This was later achieved using atomic force 
microscopy (AFM) to evaluate the membrane stiffness and costamere mechanics of 
isolated vinculin-null cardiomyocytes (Tangney et al., 2013). Compared to wild type 
controls, vinculin-null hearts had 55% lower transverse cortical stiffness, which was 
hypothesised to be the result of decreased cytoskeletal tension between neighbouring 
costameres. Furthermore, vinculin null cardiomyocytes were 40% less likely to bind to 
fibronectin coated AFM probes, which was likely due to decreased integrin expression in 
these cardiomyocytes (Zemljic-Harpf et al., 2007). These results suggest that vinculin has 
a key role in regulating the structural integrity of cardiomyocytes, via maintenance of the 
mechanical link between the z-disc and the ECM. Thus, via its interaction with talin, 
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vinculin represents a core component of the costamere as a structural adaptor and would 
thus participate strongly in mechanotransduction. 
 
1.6.3 Focal Adhesion Kinase (FAK) 
FAK is a nonreceptor tyrosine kinase that localises to the costamere and plays a key role 
in regulating hypertrophic signalling pathways (Israeli-Rosenberg et al., 2014, Samarel, 
2014). Localisation of FAK to costameres occurs via coordinated interactions with 
paxillin, talin and Src (Frame et al., 2010, Israeli-Rosenberg et al., 2014). FAK also has 
an alternative splice variant, FAK-related nonkinase (FRNK) which acts as a dominant 
negative mutant of FAK activity (DiMichele et al., 2009). Similar to talin, FAK contains 
a FERM domain, which can release other FAK molecules from their autoinhibited state, 
resulting in auto-phosphorylation of Y397, enabling binding to the non-receptor tyrosine 
kinase Src (Frame et al., 2010).  
Genetic ablation studies have demonstrated a clear role for FAK in development and 
disease. Embryonic deletion of FAK in mice is lethal by E18.5, with hearts exhibiting 
ventricular wall defects (Peng et al., 2006). However, perinatal deletion of heart specific 
FAK in mice and investigation of heart development in their offspring, resulted in 
phenotypically normal mice, suggesting that FAK is not required for basal heart function 
(DiMichele et al., 2006). A much stronger role for FAK is established upon exposure of 
FAK KO hearts to pressure overload (PO) via aortic constriction. Compared to control 
littermates, FAK-KO mouse hearts exhibited a blunted hypertrophic response, suggesting 
that FAK plays a key role in the compensatory response to hypertrophic stimuli (Peng et 
al., 2006, DiMichele et al., 2006, Peng et al., 2008). 
In cardiomyocytes, mechanical stretching of cells cultured on flexible polymer substrates, 
results in rapid phosphorylation of FAK Y-397, Y-681 and Y-295 in a b1D integrin 
dependent manner (Torsoni et al., 2003, Lal et al., 2007). Furthermore,  b1D integrin 
dependent FAK phosphorylation was found to cooperate with angiotensin II receptor 
activity, another regulator of hypertrophic signalling (Kagiyama et al., 2002, Zhou et al., 
2016). Furthermore, FAK/angiontensin II hypertrophy was also strongly affected by the 
presence of FRNK (Lal et al., 2007), suggesting a complex mechanosignalling network. 
Upon stretch induced activation, FAK translocates from the perinuclear region to the 
costameres, where it participates in hypertrophic signalling via activation of the MAPKs 
ERK, p38 and JNK (Torsoni et al., 2003, Lal et al., 2007). Additional studies in non-
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cardiomyocytes have also revealed a role for FAK in activation of Rho-family GTPases, 
suggesting a potential additional role in regulation of cytoskeletal dynamics (Mitra et al., 
2005). The key to the underlying regulation and activity of FAK may be due to an 
important interaction with Src (Frame et al., 2010). Upon release from its auto-inhibited 
state, FAK is able to phosphorylate itself at Y-397, permitting Src bidning which activates 
FAK to its fully catalytic state via phosphorylation of Y-576 and Y-577, which cannot 
then be deactivated (Mitra et al., 2005, Frame et al., 2010). Consequent formation of a 
complex with Src may play an important role in costamere localisation and activation of 
Src mediated signalling cascades.  
A more recent study in zebra fish embryos has further demonstrated the complexity of 
FAK activity and regulation at the costamere. The results reported that paxillin acts to 
stabilise FAK activity and that together, the two proteins are required for vinculin 
activation and costameric localisation (Hirth et al., 2016). While the mechanism of how 
FAK and paxillin regulate vinculin recruitment is unknown, it is intriguing to hypothesise 
that by acting as a scaffolding adaptor for Src, FAK may facilitate rigidity sensing via a 
recently proposed Src feedback loop (Pandey et al., 2018).  
 
1.6.4 Other Integrin Associated Proteins in Cardiomyocytes. 
Although talin, vinculin and FAK have received much attention as costameric 
mechanosensors, there are a number of other, less well understood, proteins that also 
localise to the costamere. Among these is the IPP complex, containing the proteins 
integrin-linked kinase (ILK), PINCH and PARVIN , which assemble within the cytosol 
before binding to  b1 integrin tails. Although initially thought to possess a catalytic 
capacity, ILK is a pseudo kinase, which primarily functions as a scaffolding adaptor 
protein (Legate et al., 2006, Wickstrom et al., 2010). In this effect, the IPP complex has 
been identified to bind a number of costameric proteins, such as vinculin and paxillin in 
addition to F-actin (Legate et al., 2006, Israeli-Rosenberg et al., 2014). Furthermore, 
knock out of ILK or PINCH results in postnatal lethality and cardiomyopathy due to the 
induction of dilated cardiomyopathy (DCM) and reduced contractility, establishing the 
role of the IPP complex as an important structural adaptor (Liang et al., 2009, Meder et 
al., 2011). Outside of the heart, the IPP complex has been shown to provide structural 
stability to integrin adhesion sites in a force-dependent manner, by decreasing integrin 
turnover and permitting mechanotransduction (Vakaloglou et al., 2016). However, the 
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mechanosensitive role of the IPP within muscle is not so clear and further research is 
required (Vakaloglou et al., 2012). 
Kindlin is another scaffolding adaptor protein which can activate b1 integrin via 
localisation to costameres and direct binding to the integrin cytoplasmic tail (Israeli-
Rosenberg et al., 2014, Li et al., 2017). Similar to vinculin, genetic ablation studies have 
revealed significant disruption of the sarcomeric-costamere interaction and highly 
irregular IDC structures, with difficulty in differentiating the two effects. Importantly, 
Kindlin negative mice died during early embryogenesis suggesting a key role for Kindlin 
in heart development (Dowling et al., 2008). Uncovering the crystal structure of Kindlin-
2 (expressed within the heart) revealed that Kindlins control integrin activation by 
switching from a monomeric to dimeric state, in a manner different to that of talin (Li et 
al., 2017). Furthermore, Kindlin mediated integrin activation has also been found to 
enhance integrin-talin interactions, and may function as a synergistic adaptor protein 
within the mechanotransduction process (Montanez et al., 2008). However, knowledge 
and understanding of Kindlin protein binding partners remains elusive and the exact role 
of Kindlin as a costameric structural adaptor is not well understood. More recent work in 
immortalised kidney fibroblasts negative for Kindlin-2, demonstrated that during nascent 
adhesion formation, Kindlin-2 recruits paxillin which together forms a complex with 
FAK, activating signalling pathways involved in rigidity sensing (Theodosiou et al., 
2016). However, this was not the case in mature focal adhesions and it is, therefore, 
difficult to relate these findings to the potential function of Kindlin-2 at the costamere. 
 
1.7 Regulation of the Actin Cytoskeleton 
The assembly of a contractile cytoskeleton is essential for the function of cardiomyocytes 
and, as a result, proteins that regulate polymerisation and maintenance of actin filaments 
are highly important for heart function. The nucleation and polymerisation of actin 
filaments is an energetically unfavourable process that requires actin assembly proteins. 
These can be  classified into three groups;  (1) The Arp2/3 complex which promoted the 
formation of branched actin filaments, (2) WH2 domain containing proteins such as spire 
and leiomodin and (3) the formin family of proteins which both nucleate actin to form 
linear actin filaments (Randall and Ehler, 2014). The WH2 containing protein leiomodin 
binds actin filament at the slow growing, pointed end and play an essential role in 
myofibrillogenesis (Chereau et al., 2008). Formins bind to the fast growing, barbed end 
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of actin filaments, where they work in a processive way by moving along filaments as 
they grow (Randall and Ehler, 2014). Recent data in cardiomyocytes demonstrates that 
the formin FHOD1 can be recruited and activated downstream of integrin signalling 
(Pandey et al., 2018). Furthermore, additional studies in non-muscle cells have also 
identified FHOD1 as an important member of the integrin mechanosensing machinery 
(Iskratsch et al., 2013, Changede et al., 2015). Therefore, formins represent an exciting 
area for future research into cardiomyocyte rigidity sensing. 
The formin family of proteins are characterised by the presence of formin-homology 
domains 1 and 2, which recruit and nucleate actin, respectively. Inactive formins adopt 
an auto-inhibited state which is released upon binding of a Rho GTPase to the N-terminal 
GTPase binding domain (GBD). This enables dimerisation of the FH2 domain with other 
formins, resulting in the formation of a donut shaped heterodimer (Figure 1.10). There 
are several members of the formin family that have been divided into serval classes; 
mouse diaphanous related formins (mDia), formin like proteins  (FRL), formin homology 
2 domain containing proteins (FHOD), dishevelled-associated activator of 
Figure 1.10. Schematic of key components of the formin family of proteins and their 
association with actin filaments. A) Domain structure of single formins. GBD, GTPase 
Binding Domain, DID, Diaphanous Inhibitory Domain, FH1, Formin Homology Domain 
1, FH2, Formin Homology Domain 2, DAD, Diaphanous Autoregulatory Domain. B) 
Active formins dimerise and nucleate actin into linear filaments. Figure adapted from 
Randall & Ehler, 2014. 
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morphogenesis (DAAM), inverted formins (INF), formin 1 (FMN1) and formin 2 
(FMN2). Within the heart, several formins have been found to play important roles in 
regulation of the actin cytoskeleton; Daam1, Daam2, FHOD3 and FHOD1. 
FHOD1 is a prominent formin in cardiomyocytes which, unlike other formins (e.g. 
FHOD3), does not act at the sarcomere. FHOD1 is not capable of nucleating cardiac actin 
and instead, participates in the polymerisation of cytoplasmic actin filaments, which are 
present at the ICDs and costameres (Schonichen and Geyer, 2010, Patel et al., 2018, 
Grimes et al., 2019). Consistent with this hypothesised role for polymerising cytoplasmic 
actin, FHOD1 localisation is prominent at the ICD and FA/costamere  in healthy and 
diseased models (Ehler et al., 2004, Dwyer et al., 2014, Al Haj et al., 2015, Pandey et al., 
2018). Furthermore, a recent study by the Iskratsch lab demonstrated that FHOD1 plays 
a critical role in non-myofibrillar force generation in neonatal rat cardiomyocytes, which 
is activated downstream of PKC and Src activation during hypertrophic signalling 
(Pandey et al., 2018). These results are also in agreement with observations that FHOD1 
is a potent regulator of directed traction forces at integrin mediated adhesions (Iskratsch 
et al., 2013). However, a recent study has reported that FHOD1 knock out mice are born 
with phenotypically normal hearts, proposing that FHOD1 is dispensable for cardiac 
development. Furthermore, the same study also investigated FHOD1 activity in a dilated 
cardiomyopathy (DCM) mouse model (Myosin binding protein C3 null mice) and 
reported no change in FHOD1 expression or subcellular enrichment (Sanematsu et al., 
2019). The reason for these inconsistent results has been suggested due to the use of 
different FHOD1 antibodies (Sanematsu et al., 2019) but clearly, further work is required 
to understand the role of FHOD1 in cardiomyocytes. 
 
1.8 Integrins as Mechanoreceptors: Ahead of the Focal Adhesion 
From a broad range of experiments carried out in vitro and in vivo, the importance of the 
costamere for development, basal functioning and responses to pathology in 
cardiomyocytes is well established, as discussed above. However, the way in which 
integrin mediated signalling at the costamere changes in response to dynamic integrin 
expression and cardiac tissue stiffness is less well understood. The majority of 
cytoplasmic integrin-protein interactions occur via the b1 integrin tail, although the 
number of interactions identified at a integrin tails are increasing (Legate and Fassler, 
2009, Morse et al., 2014, Bachmann et al., 2019). As expression of the b1 integrin subunit 
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is stable, it could be hypothesised that protein interactions at the costamere may also 
remain relatively consistent. However, integrin subtypes differ dramatically in their bond 
kinetics and cells exploit this to fine tune their rigidity sensing behaviours (Elosegui-
Artola et al., 2014, Bharadwaj et al., 2017, Lerche et al., Preprint). At the level of the 
integrin-ligand bond, vast differences in activation energy (Li and Springer, 2017), 
clustering (Elosegui-Artola et al., 2014, Schaufler et al., 2016, Lerche et al., Preprint) 
have been reported between different integrin subtypes. Furthermore, tissue stiffness is a 
central factor in determining the integrin-ligand bond dynamics (Elosegui-Artola et al., 
2014, Oria et al., 2017, Lerche et al., Preprint). It is therefore important to understand 
how changes in the integrin-ECM interface (such as tissue stiffness and integrin 
expression) alter mechanotransduction. Investigations within cardiomyocytes have 
remained limited to date, so the following section will present recent insights on the role 
of integrins in mechanotransduction from cell lines and computational models. 
 
1.8.1 The Molecular Clutch Model 
The molecular clutch model has been developed to understand the intra-molecular 
interactions that occur within adhesion structures and has provided experimental evidence 
that cells utilise integrins to modulate rigidity sensing. The model consists of four basic 
elements that form the adhesion structure: 1) Cytoskeletal tractions from myosin motors 
pulling on actin filaments as well as actin retrograde flow from the assembly of actin 
filaments, 2) Adaptor proteins connecting actin to integrins (talin, vinculin, paxillin, FAK, 
kindlin etc.), 3) Integrins connecting actin to the ECM and 4) ECM ligands. The resulting 
model describes three basic regimes of rigidity sensing by predicting the 
association/dissociation rates of intramolecular bonds during loading: 1) The application 
of optimal force, maintains bond lifetimes to balance association/disassociation rates, 
permitting force transmission long enough to enable a mechanotransduction event, such 
as talin unfolding and vinculin reinforcement. 2) Excessive force or rapid loading above 
bond thresholds results in excessive dissociation (dissociation > association) and an 
unstable adhesion. 3) Sub-optimal loading reduces bond dissociation (dissociation < 














Figure 1.11. Integrin mediated mechanotransduction, as described by the molecular 
clutch model. A) The effect of force and loading rate on mechanotransduction events 
(protein unfolding or unbinding). Typical bond/unfolding lifetimes are shown for catch 
and slip bonds . Below an optimum force threshold, proteins such as integrins unbind 
before mechanotransduction can occur. At an optimum force and loading threshold, 
lifetimes of integrin catch bonds are prolonged long enough for protein unfolding to 
occur (such as talin unfolding), initiating a mechanotransduction event. B) Load-fail 
cycles predicted by the molecular clutch model. Top to bottom: Top frame illustrates the 
components of the molecular clutch model. Second frame shows engagement of integrins 
with ligands prior to loading, only a subset of integrins engage. Third frame shows that 
upon loading from cytoskeletal contraction, integrin adaptors experience loading. The 
stress felt by adaptors is dependent upon ECM stiffness, ligand density and protein bond 
types. Adaptors experience sufficient force to surpass the mechanotransduction 
threshold, resulting in prolonged bond lifetime, a mechanotransduction event such as 
protein unfolding and adhesion reinforcement via increased integrin recruitment (frame 
4). The bottom frame demonstrate disassembly of the adhesion after a sufficient time or 







and its effect on cell tractions, actin flow and integrin density. Reinforcement of the 
adhesion (via integrin clustering) prevents a decline in cell tractions and actin flow. 
 pathways (Elosegui-Artola et al., 2018). 
 
Figure 1.11 describes the components of the molecular clutch model. Upon the 
application of force to the adhesion, the model utilises known data of adhesion bond 
lifetimes to predict the loading regime as a function of loading rate, the magnitude of 
force and substrate rigidity. Importantly, intramolecular bond lifetimes of different 
elements within the model are dependent on the types of bond: Slip bonds decrease their 
lifetime with increasing force, while catch bonds increase their lifetime with increasing 
force, up to a certain point. Thus, loading of catch bonds can act to stabilise the adhesome 
by decreasing protein dissociation, while loading of slip bonds results in a more dynamic 
system by increasing the dissociation rate (Elosegui-Artola et al., 2018). Catch bond 
behaviour has been described for integrin-ECM interactions for both a5b1 and avb3 
integrins (Kong et al., 2009), suggesting that loading certain integrin adhesions acts to 
stabilise the adhesome (e.g. providing sufficient time for additional integrins to bind). On 
the other hand, slip bond behaviour has been described for talin1-avb3 integrin bonds 
(Jiang et al., 2003), suggesting that stabilisation of integrins can facilitate more dynamic 
talin-integrin interactions. A recent study has identified that adhesion loading and 
dynamic bond lifetimes can be regulated by integrin clustering, which is essential  for 
controlling mechanotransduction in response to changing substrate rigidity and traction 
forces (Oria et al., 2017).  
 
1.8.2 The Nanoarchetecture of Integrin Adhesions- The Importance of 
Integrin Clustering 
The importance of integrin clustering in cell spreading and adhesion has been well known 
since the discovery that fibroblasts will only form adhesions and stress fibres when 3 or 
more integrins are clustered < ~60 nm of each other (Arnold et al., 2004, Schvartzman et 
al., 2011). Follow up investigations also revealed that above this 60 nm threshold, 
turnover of FA proteins such as zyxin, paxillin and vinculin is greatly increased, and cells 
were unable to form stable adhesions that permit spreading (Cavalcanti-Adam et al., 
2007). Furthermore, this clustering requirement was found to be highly sensitive to 
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changes in ligand positioning of just a few tens of nanometres, suggesting that integrin 
clustering may be a specific mechanism to sense the geometry of the ECM (Huang et al., 
2009, Schvartzman et al., 2011). By combining ligand nanopatterning techniques with 
molecular force probes, it was revealed that cells were only able to generate traction 
forces upon their environment, when inter-ligand spacing was < 60 nm (Liu et al., 2014). 
Thus, integrin clustering was found to directly regulate spreading through the stabilisation 
of adhesions to facilitate mechanotransduction. However, the underlying mechanisms 
that make integrin clustering such an important element for mechanotransduction 
remained unclear.  
The result that integrin clustering stabilises adhesions for force transmission, suggests 
that the requirement for clustering may depend upon the forces that adhesions experience. 
To provide further clarity on this question, Oria and colleagues (2017) evaluated cell 
adhesion formation, using ligand nanopatterning experiments at different substrate 
rigidities. Firstly, the results demonstrated that the requirement for integrin clustering is 
dependent upon substrate rigidity. On softer substrate stiffnesses of 1 – 30 kPa, cells 
required integrin spacing of  200 - 100 nm and the 60 nm threshold was only observed on 
stiff substrates of >150 kPa. Importantly, integrin spacing of 60 nm on soft substrates, 
prevented adhesion formation and cell spreading. These results were fed into the 
molecular clutch model which was able to predict cellular traction forces with remarkable 
accuracy, when compared to experimental results. In line with previous predictions from 
the model (Elosegui-Artola et al., 2014), these results suggest that integrin clustering acts 
to stabilise adhesions by modulating molecular tension experienced within the adhesion. 
This was further verified by the observation that increasing cytoskeletal contractility (i.e. 
increasing molecular tension within adhesions) at lower rigidities resulted in a decrease 
in the clustering requirement (i.e. more force requires more integrins) and vice versa. 
Thus, on stiff substrates, the ECM doesn’t yield, resulting in adhesion proteins bearing 
the majority of the traction forces and a high degree of clustering is required to distribute 
the load and prevent overloading. At low rigidities, the ECM yields and bears the majority 
of the traction forces and fewer integrins are required to ensure adhesion proteins are 
subject to sufficient loading to facilitate mechanotransduction. 
These findings demonstrate that changes and cellular contractility and in tissue stiffness 
can result in dramatic changes in the composition of adhesion structures. This has 
important implications for the heart which undergoes dynamic changes in stiffness during 
development and disease. Importantly, whether the integrin clustering requirement 
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changes between different integrin subtypes, is not well understood, especially in the case 
of cardiomyocytes. We therefore look to work carried out in other systems. 
 
1.8.3 Is there Evidence For Differential Mechanotransduction Between 
Integrin Subtypes? 
The expression of different integrin subtypes within the same cell provides a mechanism 
to recognise different components of the ECM. In binding to the ECM, integrin subtypes 
demonstrate a large degree of overlap in their ligand affinities, such as the binding of 
a5b1 and avb3 integrins to the RGD motif (Humphries et al., 2006, Bharadwaj et al., 
2017, Schaufler et al., 2016). However, little evidence exists of overlapping or redundant 
functions of different integrin subtypes from a signalling perspective. Different subtypes 
have been reported to exhibit unique spatial and mechanical properties during adhesion 
assembly and maturation. Upon initial adhesion, a3-class integrins outcompete a5b1 by 
forming stronger adhesions, more rapidly, which has a knock-on effect for the spatial 
distribution of subtypes within (Bharadwaj et al., 2017) and between individual adhesions 
(Schaufler et al., 2016). In cancer cells, avb6 integrins also outcompete a5b1 to favour 
stronger traction forces in response to increasing substrate stiffness (Elosegui-Artola et 
al., 2014). Furthermore, recent work has also reported preferential integrin subtype 
expresion for adhesion formation on very soft surfcaes (Lerche et al., Preprint). Therefore, 
this data suggest that the expression different integrin subtypes may function, in part, to 
adapt to changes in substrate rigidity. However, these experiments did not control for the 
spatial distribution of integrin clustering, which is key for mediating rigidity sensing (Oria 
et al., 2017). Under comparable integrin clustering and substrate rigidity conditions, a5b1 
integrins promote greater cell spreading while avb3 subtypes form larger adhesions and 
are essential for adhesion maturation (Schaufler et al., 2016). These findings suggest that 
the underlying clustering properties of different integrin subtypes may direct the rigidity 
sensing of cells. In contrast to the cell lines used to investigate the molecular clutch model, 
cardiomyocytes have a unique rigidity sensing mechanism that utilises a combination of 
muscle and non-muscle myosin contractility (Pandey et al., 2018). It is therefore 
important to investigate the integrin clustering properties of different integrin subtypes in 
cardiomyocytes to understand how integrin signalling changes during development, 




The cardiac extracellular matrix undergoes dramatic changes in tissue composition and 
stiffness during development and disease. Fibronectin and laminin ligands exhibit a 
dynamic expression profile during development and disease, suggesting that they have 
important, yet independent roles and consequences for cardiomyocytes behaviour. The 
costamere represents an important mechanosignalling hub for detection of dynamic 
extracellular cues, via the assembly of highly complex adhesome structures. Costameric 
mechanosignalling is well known to detect and respond to mechanical changes in the 
ECM. However, little is known about how integrin mechanosignalling is altered upon the 
expression of different integrin isoforms. Recent work has identified key differences in 
the ligation and clustering dynamics of different integrin subtypes in non-cardiac cells 
and highlights a large gap in the literature on cardiac integrin signalling. From these 
findings, the aim of the current thesis was to further investigate cardiomyocyte integrin 
signalling dynamics when adhering to fibronectin and laminin.  
 
1.10 Hypothesis 
Recent developments have outlined the importance of integrin clustering in the 
facilitating mechanotransduction. Furthermore,  important differences have been 
discovered in the rigidity sensing properties of different integrin subtypes. Therefore, it 
is hypothesised that within cardiomyocytes, a change in the integrin expression observed 
during development and disease will result in a corresponding change in the rigidity 
sensing behaviours such as cell spreading, traction forces and adhesion formation. 
Furthermore, it is also hypothesised that differences in rigidity sensing behaviour will 
also manifest as differences in the integrin clustering properties of fibronectin and laminin 
binding subtypes. 
 
1.11 Aims and Objectives 
Integrin mediated mechanotransduction plays a kay role in the basal and pathological 
functioning of cardiomyocytes. Recent findings in other cell types has demonstrated that 
integrin expression can be utilised to exploit a range of subtypes with unique rigidity 
sensing properties, depending on the required cellular function. Cardiomyocytes utilise 
integrins to respond to changes in the chemical and mechanical landscape of their 
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environment but how different integrin subtypes differ in their mechanosignalling 
properties, in this cellular context, is not well understood. In light of this knowledge, 
further research into the consequences of culturing cardiomyocytes on engineered 
surfaces, with tuneable chemical and mechanical properties, would be of great interest 
and benefit in understanding cardiomyocyte behaviours during development and disease. 
Thus, the central question of this project was “how do the physical, chemical and 
geometric properties of the ECM affect cell spreading, integrin signalling and rigidity 
sensing behaviours of cardiomyocytes?”. The role of collagen will not be addressed in 
the current investigation. Specifically, this investigation will focus on the role of 
fibronectin or laminin ligands on cardiomyocyte behaviours, due to their dynamic 
expression during development and disease. To answer this research question, this thesis 
will present novel data on cardiomyocyte spreading and rigidity sensing on fibronectin 
and laminin substrates. Furthermore, novel data will also be presented on the development 
and implementation of a ligand nanopatterning platform to begin to investigate the 
differences or similarities of ligand dependent, cardiomyocyte adhesion nanoarchitecture. 
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2 MATERIALS & MATERIALS 
2.1 Materials 
2.1.1 DNA Origami Materials 
ssDNA: 
M13mp18 ssDNA   Tilibit 
DNA backbone and strands   Integrated DNA Technology (IDT) 
Acrydite ssDNA  IDT 
Amino Anchors  IDT 
Alexa 647 labelled ssDNA  IDT 
 
Peptides: 
RGDfC – Cyclo( - Arg - Gly - Asp - D - 
Phe - Cys) 
Anaspec 







TAE Buffer 40 mM Tris, 20 mM Acetic Acid, 1 mM 
EDTA, 12.5 mM MgCl 
Tris buffer 5 mM Tris, 30 mM MgCl, pH 8.3 
MOPS buffer 10 mM MOPS, 30 mM MgCl, pH 8.1 
TEAA Buffer 100 mM Triethyl amine, 100 mM Acetic 










CTES  (Carboxyethylsilantriol) Gelest 
 
AFM tips: 
Scan Assyst Air (silicon tip on Nitride 
lever, f0: 70 kHz, k: 0.4 N/m) 
Bruker 
Scan Assyst Fluid + (silicon tip on Nitride 




100 kDa Spin Column Amicon 
3 kDa Spin Column Amicon 
 
HPLC Column: 
C18 column, 2.5 µm, 4.6 mm x 50 mm Xbridge, Waters 
2.1.2 Substrate nanofabrication 
Chemicals: 
99% Ethanol Sigma 
Propanol-2 VWR 
Acetone (HPLC Grade) VWR 
NMP (1-Methyl-2-pyrrolidinone) VWR 
MFCD26   Microposit 
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HMDS (Hexamethyldisilazane) Sigma 
 
2.1.3 Tissue culture 
Buffers: 
ADS Buffer 116mM NaCl, 20mM Hepes, 0.8mM 
NaH2PO4, 5.6mM Glucose, 5.4 mM 
KCL, 0.8 mM MgSO4 at pH 7.4 
Enzyme solution 246U Collagenase and 0.6 mg Pancreatin 
/ ml at pH 7.4 
Immunostaining Buffer 20 mM Tris, 155 mM NaCl, 2 mM EGTA, 
2mM MgCl2, 1% BSA at pH 7.4 
Phosphate Buffered Saline Sigma 
 
Tissue Culture Media: 
NRC Plating Media 65% DMEM, 17% M199, 10% Horse 
Serum, 5% FCS, 2% Glutamax, 1% 
Penecillin/Streptamycin 
NRC Maintenance Media 77% DMEM, 18% M199, 2% Horse 
Serum, 2% Glutamax, 1% 
Penecillin/Streptamycin 












PP2 (10 µM) Cambridge Bioscience 
smiFH2 (5 µM) Sigma 
Verapamil Hydrochloride (10 µM) Santa Cruz Biotechnology 
Omecamtiv Mercabil (500 nM) AdooQ Bioscience 
Y27632 (10 µM) Tocris 
Blebbistatin (50 µM) Calbiochem 
Calyculin A (100 nM) Sigma 
 
Ligands: 
Fibronectin  (Human) Roche 
Laminin (Engelbreth-Holm-Swarm, 
Murine) 
Sigma – L2020 
 
2.1.4 PDMS 
Sylgard 184 Dow Corning 
Sylgard 527 Dow Corning 




















Anti-a– actinin (Mouse, IF: 1:500) Sigma (#A7811) 
Anti-Vinculin (Mouse, IF: 1:200) Sigma (#V9131) 
Anti-phospho-Src Family (Tyr416, 
Rabbit, 1:200) 
Cell Signalling Technology (#2101) 
Anti-phospho FHOD1 (Thr1141, Rabbit, 
1:200) 
ECM Biosciences (#FP3481) 
 
Secondary Antibodies: 
Cy2 Goat anti-mouse (1:200) Jackson Immuno Research (#115-225-
146) 
Cy3 Goat anti-mouse (1:200) Jackson Immuno Research (#115-165-
146) 
Cy5 Goat anti-mouse (1:200) Jackson Immuno Research (#115-175-
146) 
Cy2 Goat anti-Rabbit (1:200) Jackson Immuno Research (#111-165-
144) 








2.2.1 DNA Origami and Nanopatterning 
2.2.1.1 Synthesis of DNA Origami.  
DNA origami designs and protocols were initially implemented from the protocols 
developed and published by Paul Rothemund and Ashwin Gopinath (Gopinath and 
Rothemund, 2014, Gopinath et al., 2016, Rothemund, 2006, Woo and Rothemund, 2014) 
DNA origami was assembled by combining M13mp18 (40 nM) and staple strands (200 
nM) in 50 µL of 10 mM TAE buffer with 12.5 mM Mg2+. M13mp18 is a bacteria phage 
vector strand 7249 bases in length. An appropriate quantity of ions, such as magnesium 
(here), or sodium, are required for efficient DNA hybridization. This acts to equilibrate 
electrostatic repulsion between highly negatively charged DNA molecules. A 
concentration of 12.5 mM Mg2+ was sufficient to achieve a high yield of DNA origami 
and limit any aggregation effects. DNA origami are synthesised by annealing from an 
initial temperature of 94 °C to completely melt all dsDNA. Temperature step-controlled 
annealing was carried out in a PCR machine. Samples were cooled from 94 to 65 °C at a 
rate of ~0.3 °C per minute. A cooling rate of 0.1 °C per minute is employed from 65 °C 
to room temperature. The self-assembled DNA origami were then purified using 
Millipore Amicon Ultra 100 kDa spin columns in a centrifuge at 2000 rcf for 6 min, three 
times, removing excess staple strands. DNA origami were adjusted to a concentration ~40 
nM and stored in Lo-Bind Eppendorf tubes at 4 oC. A NanoDrop spectrophotometer was 
used to detect the approximate concentration of DNA origami products based on the 
constant of a molecular weight of 330 g/mol per base and an extinction coefficient = 33 
mg/mL for A260 = the actual result is close to the estimated numbers. To ensure efficient 
assembly and labelling of DNA origami with peptide conjugates, unmodified staple 
strands and amino anchors were added at a 5 X excess to the M13mp18 backbone and 
peptide conjugates were added at a 10 X excess to amount of available sticky-ends, as 
validated in chapter 4.5.2. Full sequences of all modified oligonucleotides utilised in the 
design of the functionalised DNA origami can be found in the appendix. 
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2.2.1.2 AFM Characterisation of DNA Origami 
Initial AFM parameters were guided by protocol published by Ashwin Gopinath 
(Gopinath and Rothemund, 2014) and were adapted as necessary to achieve high image 
quality. AFM (Bruker, Dimension Icon) was used to image the DNA origami structures. 
DNA origami were cast on either glass, or mica surfaces for imaging. The DNA origami 
solution is diluted by TAE buffer with 30 mM MgCl2 to around 1 nM in order to get a 
good separation of the DNA nanostructures once immobilized on surface. Magnesium is 
required in the procedure as an ion charged bridge, immobilizing DNA origami to the 
substrate surfaces. Mica samples were cleaved twice by solid scotch tape immediately 
prior to casting. 5 µL of diluted DNA origami solution was directly deposited on freshly 
cleaved mica and left to adsorb on the surface for 2 min. Subsequently, the substrate was 
washed by distilled water to remove non-adsorbed DNA origami and then blown dry with 
compressed air. Silicon nitride ScanAsyst-Air tips with 0.4 N/m spring constant were 
used to scan the sample by AFM under ScanAsyst Mode. A resolution of 512 pixels per 
line (for scan sizes of 1-5µm) with 1 Hz scan rate was chosen for appropriate imaging of 
the DNA nanostructure.  
For DNA origami cast randomly on glass substrates. All AFM imaging was carried out 
in air using peak force quantitative nanomechanical mapping (QNM) mode. The 
advantages of this mode is that by measuring the mechanical features of the sample, it 
permits the user more methods by which to view and analyse the sample. This is 
particularly important after extensive treatment of the substrate to help identify what is 
present on the substrate and to help verify the success of the experiment. Every scan was 
optimised in live scanning mode by altering the amplitude set point (how hard the tip 
presses against the surface) and gain levels. After identifying the best settings for each 
scan, a full scan was repeated. 
For the nanopatterned substrates, imaging the PMMA layer (during development and 
etching experiments) was carried out in air using peak force QNM mode. After lift-off, 
however, the highly hydrophobic hexamethyldisilazane (HMDS) layer on EBL patterned 
surfaces made it very difficult to accurately track the surface when scanning in air. 
Therefore, to characterise DNA origami on the EBL nanopattern, AFM characterisation 
was carried out in fluid soft tapping mode. All samples were imaged in imaging buffer 
(5mM Tris, pH 8.3, 40mM MgCl2). This buffer was used to ensure that DNA origami 
were strongly bound, flat against the surface by the elevated pH and magnesium 
concentration, facilitating a clearer image acquisition. Silicon nitride ScanAsyst-Fluid+ 
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with 0.7 N/m spring constant were used at a resolution of 512 pixels per line and a 1Hz 
scan rate. Amplitude setpoint and gain were optimised for each sample and tip. Further 
difficulties were experienced when imaging e-Beam patterned DNA origami after an 
overnight incubation in PBS. Mild hydrolysis of the HMDS background resulted in 
physisorption of salts to the background which resulted in frequent contamination of the 
AFM tip and imaging artefacts such as shadows and feature duplication. As a result, 
samples were washed in 0.1% Tween 20 in 10 mM Tris pH 8.3 40 mM MgCl2 (v/v) for 
20 minutes and before being switched back to imaging buffer. This improved the 
cleanliness of the surface, although image acquisition remained problematic. 
2.2.1.3 Peptide-DNA Conjugation 
For cRGDfC and IKVAV peptides, conjugation to ssDNA was performed through a UV 
mediated thiol-ene reaction, via a sulfhydryl (thiol) group on the peptides and a ene-group 
on acrydite modified ssDNA (Integrated DNA Technologies). Peptides were diluted to 
100 µM in H2O containing 100 X TCEP, to reduce any disulfide bonds and present the 
cysteine groups for conjugation. 8µl of peptides were then mixed with 8 µl of acrydite 
modified ssDNA at a final concentration of 20 µM and 200 µM, respectively. A reaction 
buffer was made containing 120 mM Tris (pH 6.8) and 35 mM of the photoinitiator 2- 
hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone. 2.5 µl  of the reaction buffer 
then was added to the peptide/ssDNA mix. When exposed to UV light, the photoinitiator 
is degraded, releasing free radicals which catalyse the reaction between the sulfhydryl 
group on the peptide and the ene residue on the acrydite, completing the conjugation 
(Torres-Kolbus et al., 2014). Samples were exposed to 260 nm UV light for 1 hour and 
purified using Amicon ultra 3kDa spin columns (Merck Millipore) to remove any 
unconjugated peptides and the photoinitiator, and samples were resuspended in 0.1 M 
TEAA buffer (0.1 M Triethyl Amine, 0.1 M Acetic Acid, pH 7.0).  
2.2.1.4 Conjugate Verification and Purification: Reversed Phase High Performance 
Liquid Chromatography  (HPLC) 
After spin filtration, samples were resuspended in 0.1 M TEAA buffer and samples were 
injected into a c18 column (XBridge, 2.5 µm, 4.6 mm x 50 mm) in a 95:5 solution of 
TEAA:acetonitrile (ACN), as published by (Huang et al., 2019). Between 0 and 28 
minutes, the proportion of TEAA:ACN was changed, in a linear manner, to 50:50. This 
gradient time was chosen to achieve a sufficient gap between elution time of the conjugate 
and the unconjugated DNA. Unconjugated peptides were removed in the spin filtration 
stage. The conjugated products were obtained by collecting the eluted product between 
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3.4 and 4.6 minutes, before the unconjugated ssDNA eluted at 5.6 minutes. Conjugates 
were then frozen in liquid nitrogen and freeze dried overnight to remove the solvent. 
Successful purification was confirmed using RP-HPLC, by observing the absence of the 
ssDNA peak, and samples were stored in H2O at -20 oC. 
2.2.2 Fabrication of Nanopatterned Substrates with Electron Beam 
Lithography (EBL). 
All work in this section was carried out by Paul Reynolds (Nikolaj Gaadegard Lab, 
University of Glasgow) in the James Watt NanoFab Centre. Substrates were produced by 
direct write EBL on coverslips. Coverslips were solvent cleaned in an ultrasonic bath 
(acetone followed by methanol, IPA, and water) and dehydrated in a 180 oC oven 
overnight. Design and fabrication of EBL patterned substrates was based on protocols 
published by Gopinath and Rothemund (2014). An oxygen plasma treatment for 60s at 
100W power prepared the surface for silane deposition, which was done from HMDS 
vapour in a closed container at 150 oC. A 950k molecular weight poly(methyl 
methacrylate) (PMMA) film was spin coated on the coverslips at 5k rpm, followed by a 
short solvent bake on a 180 oC hotplate for 30s. A 10 nm aluminium charge conduction 
layer was evaporated on the coverslips, and they were mounted on a 4-inch silicon wafer 
for EBL processing using crystalbond 555 adhesive. Samples were loaded into the EBL 
chamber (Vistec VB6 2006) to define arrays of 200 nm and 300 nm pitch holes, 150 nm 
in diameter in the PMMA layer. After exposure, the aluminium charge conduction layer 
was removed in a 2.6% TMAH solution (MF-CD26) for 60s followed by water rinse. The 
surface roughness for both kind of patterned surfaces was calculated from AFM 





2.2.3 Positioning and Cross-linking of DNA Origami to E-Beam Patterned 
Substrates 
The following protocol for the positioning and washing of substrates during the 
positioning of DNA origami was adapted from Gopinath and Rothemund (2014). 
Substrates were first developed in a 2:1 solution of propanol-2:methyl isobutyl ketone for 
60 seconds at 23 °C, followed by a 30 seconds wash in 100 % propanol-2. DNA origami 
binding sites were then etched using oxygen plasma treatment (100W, 70 seconds, room 
air) followed by silanisation with 0.1% CTES in Tris buffer (5 mM, pH 8.0) for 30 
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minutes at room temperature. The PMMA resist was then removed by immersion in NMP 
at 50 °C for 2 minutes followed by sonication for 10 minutes. DNA Origami were 
incubated for 1 hour at room temperature at a concentration of 500 pM in placement 
buffer (5 mM Tris, pH 8.3, 50 mM MgCl2). Due to the hydrophobic nature of the HMDS 
layer and the size of the patterned area, 100 µL of DNA origami solution was required to 
cover the surface sufficiently. The tris buffer was then exchanged with MOPS buffer (10 
mM, pH 8.1, 50 mM MgCl2) to remove primary amines, followed by an additional wash 
with MOPS buffer (10 mM, pH 8.1, 50 mM MgCl2) containing 100 mM EDC and 50 
mM sulfo-NHS. Finally, samples were then washed with the MOPS buffer (10mM, pH 
8.1) containing 50 mM NaCl and incubated in DPBS containing 50 mM NaCl. Before 
AFM characterisation, samples were placed into placement buffer. A pH of 8.1 or higher 
has been demonstrated to increase the changes of DNA origami binding to the silanised 
surface (Gopinath & Rothemund, 2014). This is due to the elevated ionisation state of the 
silane at higher pH, generating more [-OH] groups at the binding sites, thus increasing 
the chances the DNA origami binding. However, long durations at elevated pH result in 
hydrolysis of the HMDS background and loss of the passivation layer essential to reduce 
nonspecific adhesion between cells and the substrate. The buffer pH chosen here reflects 
what has been reported to be effective within the literature (Gopinath and Rothemund, 
2014, Gopinath et al., 2016, Shen et al., 2018b). 
2.2.4 Photobleaching Assays 
To evaluate the efficiency of DNA origami labelling and functionalised via the sticky-
end strands, photobleaching assays were employed. DNA origami were fabricated with 
6, 12 or 18 Alexa-647 fluorophores. 35mm glass bottomed dishes were plasma treated for 
5 minutes at 18W to generate surface silanols for the physisorption or DNA origami. 
DNA origami were cast into the dish at a concentration of 200pM (200 µl) in 10mM Tris 
buffer (pH 8.3) containing 20mM MgCl and were incubated at room temperature for 1 
hour. The substrate was very gently washed with tris buffer once to reduce the background 
noise from DNA origami still in solution and the dish was loaded into a confocal 
microscope (Zeiss LSM710 Confocal). Samples were imaged at a sampling rate of 143Hz 
with a 100X objective. This frame rate was chosen to detect rapid single bleaching events, 
which has also been demonstrated to be sufficient in previous work (Cox et al., 2011).  
Upon image acquisition, the focus was adjusted and the stage moved to an adjacent area 
to ensure all bleaching events were captured. A total of 10,000 frames (70 seconds) were 
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acquired which was sufficient to totally bleach the sample and obtain a good signal from 
the background. The magnitude of a single bleaching event was quantified by manually 
calculating the average drop in signal from 50 individual bleaching events. Individual 
signalling events were counted manually (as can be seen in Figure 4.17) by observing the 
number of “stepping events” and the number of observed bleaching events were divided 
by the total signal drop from the start to the end of photobleaching (Chen et al., 2014). To 
calculate the total number of fluorophores on a single DNA origami, the absolute 
difference between the starting signal intensity and the final signal intensity (the 
background signal)  after the sample had been fully photobleached was divided by the 
average magnitude of a single bleaching or “stepping event” (Chen et al., 2014). 
2.2.5 Cell Isolation and Tissue Culture 
2.2.5.1 Cardiomyocyte Isolation and Culture  
Neonatal rat cardiomyocytes were isolated and harvested as published in (Pandey et al., 
2018) New born (Postnatal day 0-3) rat hearts were dissected into ice-cold ADS buffer 
(116 mM NaCl, 20mM Hepes, 0.8 mM NaH2PO4, 5.6 mM glucose, 5.4 mM KCL, 0.8 
mM MgSO4) and washed  again with ADS buffer. The ADS buffer was then removed 
and hearts were incubated with of 5ml enzyme solution in ADS buffer (ES, 246U 
collagenase and 0.6 mg pancreatin/mL), for 5 min, at 37 °C under vigorous shaking (Ehler 
et al., 2013). Tissues were then triturated by pipetting up and down 30 times and the 
supernatant was discarded. This step was followed by 6 digests further digests. After each 
digest and trituration, the supernatant was collected and transferred into plating medium 
(65 % DMEM, 17 % M199, 10 % Horse Serum, 5 % FCS, 2 % Glutamax, 1 % 
Penecillin/Streptamycin (P/S)) and 5 ml of fresh enzyme solution was added to the hearts. 
Every two digests, the supernatant was  combined in one tube with 20 ml plating medium, 
then passed through a 100 µm cell strainer, spun down at 1200 rpm for 5 min at room 
temperature, resuspended in 10 ml plating medium and pre-plated in 10 cm tissues culture 
dishes for a minimum of 90 minutes to allow the cardiac fibroblasts the adhere to the dish 
(Ehler et al., 2013). After all digests had been completed, and the final dish had at least 
90 minutes pre-plating, the media was collected and the dishes were washed down once 
to collect the cardiomyocytes, leaving behind many of the fibroblasts. Cardiomyocytes 
were then plated onto the respective substrates either in plating medium or serum free 
medium (70 % DMEM, 22 % M199, 2 % Glutamax, 1 % Penicillin/ Streptamycin (P/S)). 
The medium was changed the next day to serum containing maintenance medium (78 % 
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DMEM, 17 % M199, 2 % horse serum, 2  % Glutamax, 1 % P/S) or serum free 
maintenance medium (78 % DMEM, 19 % M199, 2  % Glutamax, 1 % P/S). 
2.2.5.2 Immortalised Mouse Embryonic Fibroblasts (MEFs) 
Immortalised MEFs were chosen as a control cell line for carrying out validation 
experiments on DNA origami and optimisation experiments on the micropattern. These 
cells were cultured in a high glucose maintenance medium and incubated at 37 oC with 5 
% CO2. Cells became 70 – 80 % confluent every 2 – 3 days and were then passaged. After 
the cells had been passaged 20 times, the culture was discarded and a fresh batch of cells 
were thawed from liquid nitrogen. 
2.2.6 Fabrication of PDMS Coated Coverslips and Ligand Micropatterning 
2.2.6.1 PDMS Coated Glass Coverslips 
PDMS coverslips were prepared as described in (Pandey et al., 2018). Sylgard 184 (1:10, 
base : cross-linker) and Sylgard 527 (1:1, parts A:B) were mixed at a ratio of  1:19,  1:9 
and 1:4. Soft PDMS gels were pre-cured in 50 ml falcon tubes on a roller for 2 hours at 
room temperature until they had a similar viscosity as PDMS 184. Then, 150 ul of the 
PDMS mix was placed on plasma cleaned (5 minutes, 18W, ozone oxygen plasma, PDC-
32G-2, Harrick Plasma) 22x22 glass coverslips (size no.1.5) and spin coated at 1000 rpm 
for 100 seconds and baked at 80 °C for 2 hours.  Sample mechanisms of PDMS substrates 
were calculated using oscillatory using a TA Discovery HR-3 hybrid rheometer. The 
samples were cured in situ at 80°C for 2hrs and the gelation was monitored by an 
oscillating time sweep, with an oscillating frequency of 1Hz and an oscillating 
displacement of 1e-4rads. Once cured the samples were then kept at room temperature 
for 5 minutes to cool and were then characterised using an oscillating frequency and stress 
sweep, and by transient stress relaxation. The frequency sweeps were performed from 
0.1-100Hz at an oscillating displacement of 1e-4rads and the stress sweeps were 
performed from 0.1-100Pa at a frequency of 1Hz. Finally stress relaxation was performed 
using a shear strain of 2%and a hold time of 300s. Rheology measurements (kindly carried 
out by Will Megone, QMUL) calculated the final stiffness of 1:19, 1:9 and 1:4 gels to be 
6 kPa 20 kPa and 130 kPa (respectively). 
2.2.6.2 Fabrication	of	Micropatterned	Lines. 
Ligands were micropatterned using PDMS stamps created via soft lithography, largely as 
described by (Qin et al., 2010). The micropattern consisted of parallel lines 1 µm in width 
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and a 5 µm centre-to-centre distance. To make the PDMS stamps, 3.4 g of VDT-731 
(Gelest Inc.) was mixed with 1 g of HMS-301 before mixing 4 drops of modulator (Sigma, 
2,4,6,8-Tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane) and then mixing in 4 droplets 
of a platinum catalyst (Platinum(0)-2,4,6,8-tetramethyl-2,4,6,8-
tetravinylcyclotetrasiloxane complex solution). The hPDMS mixture was degassed by 
centrifugation and spread over a silicon wafer with the negative micropattern and cured 
at 60 oC for 40 minutes. 40 ml of PDMS (Sylgard 184) was poured over the cured hPDMS 
and backed for 2 hours at 80 oC. Micropattern stamps were cut into ~1 cm2 cubes, washed 
with H2O, to remove any PDMS dust and blow dried.   
Fibronectin (Human, Roche #11051407001) or laminin (Engelbreth-Holm-Swarm, 
Murine, Sigma #L2020) were labelled (if required) at 100 mg / ml in bicarbonate buffer 
(10 mM, pH 8.3) with amine reactive Atto-405, Atto-488 and Atto-546 NHS-esters 
(Sigma – 10 µl per 100 µg of ligand). Labelling was carried out for 1 hour at room 
temperature with gentle agitation before dialysis against PBS to remove unconjugated 
fluorescent NHS-esters. For labelling the micropattern, labelled ligands were diluted 3x 
with unlabelled ligands. 
Micropattern stamping surfaces were coated with 15 µ l of the desired ligands and 
incubated at room temperature for 45 minutes. Even coating of the stamping surface was 
achieved by placing a 22 x 22 mm glass coverslip over each 15 µ l droplet. Glass 
coverslips were prepared for stamping by plasma treatment for 5 minutes (Harrick 
Plasma, room air, 18 W) to generate charged surface silanols groups and facilitate transfer 
of the ligands from the micropattern to the culture surface. Exposure of PDMS to oxygen 
plasma can increase the surface stiffness of the gel (Glatz and Fery, 2019). Therefore, 
PDMS coated coverslips were plasma treated for 1 minute. 
Ligand coated PDMS stamps were dipped in diH2O 5 times, blow dried with N2, inverted 
and placed on the plasma treated coverslips with light pressure for 10 seconds. 
Micropatterned surfaces were immediately placed in PBS containing 5% BSA (Cell 
Signalling Technology) for 1 hour to minimise nonspecific cell adhesion (Sweryda-
Krawiec et al., 2004). 
2.2.6.3 Tissue Culture on the Micropatterned Lines 
Prior to any tissue culture, micropatterned ligands were blocked against nonspecific 
adhesion with 5 % BSA for 30 minutes. Blood serum products contain large amounts of 
fibronectin and other ECM components that could be laid down by the cells and skew the 
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results of the experiments. Therefore, all cells were plated and cultured in serum-free 
media for the duration of the experiment. RPTP cells were cultured for 1 hour and NRCs 
were cultured for 24 hours before fixation with 4 % PFA. 
2.2.6.4 Image Analysis of Micropattern Data 
All images were processed in ImageJ (Schneider et al., 2012). Images underwent a 
background subtraction (radius = 20 pixels), to minimise background noise. The filter 
parameters were optimised to achieve the highest signal to noise ratio while maintaining 
fine detail in the images. 
Cell morphology and quantification of whole cell protein intensity were calculated by 
firstly outlining the cell by thresholding and measuring cell area, length and the integrated 
density of the fluorescent signal using ImageJ. 
Adhesion density along the lines were calculated by measuring the pixel intensity along 
the length of the line for the desired channels. Enrichment of adhesion proteins was 
evaluated by calculating the signal intensity of the object channel over the lines only, 
relative to the signal intensity from the whole cell. ROI’s for the whole cell were 
generated using thresholding. ROIs for the adaptor proteins along the lines were generated 
by the overlap between the ROI for the whole cell and ROIs for each line (generated from 
the lines image).  Signal intensities were calculated using the integrated density feature 
of ImageJ and then normalised to the area of each ROI to obtain a measure of enrichment 
per unit area. 
 
2.2.6.5 Drug Treatments of Cardiomyocytes on Randomly Positioned IKVAV and 
RGDfC DNA Origami Arrays 
Randomly positioned DNA Origami arrays were fabricated as described above and NRCs 




spreading. The following morning, cells were given fresh serum free maintenance media. 
After 21 hours in culture, culture media was exchanged to serum free maintenance media 
containing Blebbistatin (50 µM), PP2 (10 µM), Y- Y27632 (10 µM), smiFH2 (5 µM), 
Verapamil Hydrochloride (10 µM), Calyculin A (100 nM) or  Omecamtiv Mercabil (500 
nM). Cells were fixed with 4% PFA after 3 hours of treatment. 
 
2.2.7 Immunostaining 
Immunostaining was performed as presented by Pandey et al. (2018). Cells were firstly 
fixed by removing culture media, washing with PBS and incubating cell in a solution of 
4% paraformaldehyde for 10 minutes at room temperature (RT). Cells were washed with 
PBS and then permeabilised by incubation with a 0.2% solution of Triton-x (Sigma) for 
5 minutes at RT. Samples were then briefly washed with PBS before being incubated with 
immunostaining buffer (20 mM Tris, 155 mM NaCl, 2 mM EGTA, 2 mM MgCl2 at pH 
7.4) containing 1% BSA (CST) for blocking of non-specific binding of antibodies. Cells 
were then incubated with primary antibodies (see 2.1.5 for antibodies and concentrations) 
in immunostaining buffer at 4°C overnight. The following day, samples were washed at 
least 3 times with PBS (5 minute incubation at RT on a rocker) to remove primary 
antibodies that remained in solution. Samples were then incubated in secondary 
antibodies (see 2.1.5 for concentrations) in immunostaining buffer for 1 hour at room 
temperature. Samples were then washed 3 times with PBS (5 minute incubation at RT on 
a rocker) before being mounted on a coverslips with a drop of Mowiol (MOWIOL 4-88) 
to prevent fading of fluorophores. The antibodies used in this thesis are presented in 
section 2.1.5. However, a number of antibodies were also tested for use in this thesis but 
were not of sufficient quality to be included. These antibodies can be found in 
appendicies. 
2.2.8 Nano-Pillar Arrays 
2.2.8.1 Fabrication of the Nano-Pillars 
Micro-Pillar arrays (1.7 µm height (Pandey et al., 2018), 500 nm diameter, 1 µm centre 
to centre, k=3.75nN / µm) were created by soft lithography from a negative master, using 
PDMS (Sylgard 184). The negative master chips were first spin coated with 10 µl of 
CdSeS/ZnS alloyed quantum dots (488 nm, Aldrich) at 500 rpm for 10 seconds clockwise 
then counter clockwise, followed by 30 seconds at 10,000 rpm both clockwise and counter 
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clockwise. ~80 µl of mixed Slygard 184 was then spin coated onto the master chip at 1500 
rpm for 60 seconds. Coated chips were then degassed in a vacuum chamber for 5 minutes 
and glass bottomed 35mm dishes (No.0, Ibidi) were plasma treated (as above). Degassed 
coated master chips were placed face down in the treated dishes and cured in the oven for 
2 hours at 80 °C or overnight at 60 °C. Pillars were coated with fibronectin (50 µg / ml) 
or laminin (50 µg / ml) in PBS for 1 hour at 37 °C. Cells were plated on pillars in serum 
free plating medium. 
2.2.8.2 Live Cell Imaging of NRCs on the Nano-Pillars 
NRCs were cultured on nano-pillar arrays for 24-48 hours prior to imaging to provide 
sufficient time for the cell to recover and begin spontaneous contraction. Prior to imaging, 
cells were given fresh media. Samples were loaded into a live cell imaging chamber and 
mounted on a Zeiss LSM710 Confocal microscope in widefield mode.  
Cells were firstly imaged in their normal condition for a few contraction cycles (typically 
a 30 second window recorded 2-10 contractions).  Without pacing, the number of 
contractions varied from cell to cell. Brightfield movies provided the outline of the cell 
and confirmed that the cell was spontaneously contracting. Movies were then taken of the 
pillars by exciting the 575 quantum dots using a 547 laser line to detect pillar 
displacements. Following this, cells were trypsinised with TryplE for 20 minutes to 
detach the cells form the pillars and obtain a reference of the pillars under zero stress. 
This final stage was essential to accurately calculate the pillar displacements in the 
proceeding data analysis step (see the following section). 
2.2.8.3 Calculation of the Pillar Stiffness 
Pillar stiffness was calculated as reported in Ghibaudo et al., 2008). Furthermore, the 
effects of substrate warping, as described by Schoen et al. (Schoen et al., 2010) was also 
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2.2.8.4 Analysis of Pillar Displacements to Calculate Traction Forces 
ImageJ was used to process the pillar movie files and prepare them for analysis. This was 
necessary to increase the signal to noise ratio of the data from the quantum dots after 
photobleaching. Furthermore, it was necessary to align movies taken from the reference 
image and experimental images.  
Data were first imported into ImageJ and processed with a bandpass filter to remove 
signals greater than 30 pixels (the size of the pillars) and less than 0 pixels. Images then 
underwent a background subtraction (radius = 20 pixels), Gaussian blur (radius = 1 pixels) 
and a Kalman stack filter. Regions of interest were defined and analysed using the Nano 
Tracking Plugin (MBI, Singapore). This plugin tracks the displacement of the pillars 
throughout the movie, relative to the reference frame, recoding the position of every pillar 
in each frame.  
This data was then analysed using custom Matlab scripts to calculate the displacement of 
each pillar as a vector (magnitude and direction) and plots these vectors on the movie 
files. The level of noise was calculated by tracking any recorded displacements of pillars 
outside the cell. This was calculated for every cell analysed and an average noise level 
was calculated and pillar displacements greater than this level of noise were then included 
in the analysis. The data used for the statistical analysis was taken from whole cells and 
not individual pillars. 
2.3 Statistical Analysis 
All statistical calculations were carried out using Graphpad Prism (v 8.0). Analysis of 
differences between cardiomyocyte morphology on different stiffnesses and ligands were 
conducted using a two-way ANOVA to evaluate differences within and between 
conditions. To limit the degree of freedom, ANOVA calculations were restricted to 
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evaluate only the relevant conditions (i.e. differences between stiffnesses on the same 
ligand and not differences between ligands on different stiffnesses). Where appropriate, 
students t-tests were used to evaluate significant differences between two conditions. N 
numbers are given in figure legends. A single biological repeat is presented as 
observations from a single preparation and isolation of a litter of neonatal rats. 
Independent repeats/experiments refers to observations from different biological repeats 
using cells from different litters. The minimum N number of independent repeats used in 
this thesis is two. In cases where n numbers indicate single cells, data will have been 
pooled from 2 or more biological repeats and will be indicated where relevant. Technical 




3 CARDIOMYOCYTE RIGIDITY 
SENSING ON FIBRONECTIN 
& LAMININ 
3.1 Integrin Expression in Neonatal Rat Cardiomyocytes 
To investigate the different integrin signalling regimes occurring within cardiomyocytes, 
it was important to work with a model system which expresses the relevant integrin 
subtypes. Neonatal rat cardiomyocytes (NRCs) have been used extensively as an in-vitro 
model system within cardiac mechanobiology due to their ability to disassemble their 
myofibrils, spread on tissue culture surfaces and then reassemble their myofibrils in the 
presence of experimental stimuli. The ECM of the neonatal rat heart contains significant 
amounts of both fibronectin and laminin and, as a result, NRCs express integrin subtypes 
that bind to both fibronectin (predominantly  a5b1) and laminin (predominantly a7b1) 
(Brancaccio et al., 1998, Maitra et al., 2000, Williams et al., 2014). Furthermore, in-vitro 
culture of NRCs has been routinely carried out on substrates coated with fibronectin or 
laminin, with studies reporting similar levels of cell attachment on both ligands (Borg et 
al., 1984, Taylor et al., 2000, Boateng et al., 2005, Williams et al., 2014). To compare 
and contrast the rigidity sensing behaviours of NRCs cultured on fibronectin or laminin, 
it was firstly important to verify that NRC express similar levels of a5b1 and a7b1 
integrin subtypes.  
To provide further verification of integrin expression in NRCs, a mini meta-analysis of 
integrin gene expression was carried out from online data repositories. Data was collected 
using Genevestigator, which collates data from numerous online microarray and mRNA-
Sequence datasets. Genevestigator standardises all data in the database to the log2 format 
for comparison between different probes. An advantage of Genevestigator is the 
standardisation of expression data from thousands of experiments, enabling easy meta-
analysis. For comparison, genevestigator to characterises expression data into three 
categories, low (0 – 7.5), medium (7.5 – 11.5) and high (> 11.5).  
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Inclusion criteria for the meta-analysis were as follows: 1) Whole heart lysates, 2) Cells 
were cultured in-vitro for 24-48 hours prior to lysis, 3) Cells were isolated from either 
Sprague Dawley or Wistar rats from P1 – 3) Studies must report data from at least three 
independent repeats. Data from control experiments such as treatment with DMSO were 
also included within the analysis. Searching the Genevestigator database returned 4 
studies that met the inclusion criteria, reporting a total of 17 independent experiments. 
Within these 4 studies, the expression of a3, a5, a6, a7, a8, av, b1 and b3 integrin 
subtypes, which have all been studies in cardiomyocytes, were analysed.  In general, the 
level of mRNA expression for all subtypes was medium to high (Figure 3.1).  Importantly, 
this data demonstrates that, at the level of transcription, NRCs express a range of 
fibronectin and laminin binding integrins at a medium to high level. This finding suggests 
Figure 3.1. Summary of the mini-meta analysis of microarray and mRNA expression 
data from the Genevestigator database for the alpha subunits for the fibronectin/RGD 
binding ITGA5 (a5), ITGA8 (a8), ITGAV (av) and laminin binding ITGA7 (a7), 
ITGA3 (a3) and ITGA6 (a6) subtypes. Expression also shown for the beta subtypes 
ITGB1 (b1) and ITGB3 (b3). All data has been normalised to the Log2 expression, 
which can be classified to three classes of expression; High (>11.5), Medium (8.5 – 
11.5) and Low (<8.5). Bars indicate mean ± SD. 






















that NRCs represent a suitable model for investigating the integrin rigidity sensing 
behaviours of different integrin isoforms in cardiomyocytes. 
 
3.2 Spreading and Rigidity Sensing of NRCs on Fibronectin and 
Laminin Coated Substrates 
3.2.1 NRC Spreading on PDMS Substrates 
During development and disease, cardiomyocytes are subject to dynamic changes in ECM 
composition and stiffness. Previous work has demonstrated a relationship between ECM 
stiffness and cell area, contractility, cytoskeletal architecture and morphology (Engler et 
al., 2008, Hersch et al., 2013, McCain et al., 2014, Pandey et al., 2018). Furthermore, 
recent work from the Iskratsch lab (Pandey et al., 2018) has demonstrated that 
cardiomyocytes sense changes in matrix rigidity via a combination of myofibrillar and 
non-myofibrillar contractions and that the costameric protein talin plays a key role in 
mediating the mechanotransduction response. While the effect and mechanisms by which 
cardiomyocytes detect changes in ECM rigidity are beginning to unfold, it is not clear 
whether these rigidity sensing strategies are consistent when occurring via different 
integrin isoforms. 
PDMS substrates offer a highly tuneable platform for controlling substrate rigidity and 
therefore, provide a strong platform for investigating the rigidity sensing behaviours of 
NRCs. By mixing PDMS 184 and PDMS 527 at different ratios, we are able to produce 
substrates of different stiffnesses, representing Embroynic/neonatal (PDMS 184 : PDMS 
527, 1:19), adult (1:9) and fibrotic (1:4) conditions of the heart. The stiffness of the 
different PDMS conditions was confirmed using oscillatory rheology, the results of which 
demonstrated the PDMS stiffness to be 6 kPa for neonatal, 20 kPa for adult and 130 kPa 
for fibrotic conditions (Figure 3.2). All rheology work was carried out together with 
William Valentine-Megone from the Gautrot group at Queen Mary University of London.  
Previous work has shown that contractility is highly sensitive to substrate stiffness and 
that cardiomyocytes fine tune their contractile properties to match ECM elasticity (Engler 
et al., 2008, Hersch et al., 2013). To verify that PDMS substrates of various stiffness 
produce similar contractile responses to those observed on other polyacrylamide or other 
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silicone based substrates, NRCs were plated on 1kPa, 6kPa, 20kPa and 130kPa substrates 
and visualised GFP a-actinin to measure sarcomeric shortening at the z-disc. This work 
was collected in collaboration with Liisa Hirvonen (Cox Lab, KCL). Consistent with the 
work of others, sarcomeric shortening and velocity was greater on soft compared to rigid 
substrates and confirms the suitability of PDMS substrates for investigating NRC rigidity 
sensing (Figure 3.3).  
Cell spreading and morphology provide useful measures of the overarching 
mechanotransduction occurring within cells (Wolfenson et al., 2019). Therefore, NRCs 
were isolated and cultured for 24 – 72 hours on 6 kPa, 20kPa and 130kPa PDMS 
substrates coated with fibronectin or laminin. Cells were cultured in serum free media to 
remove any effect of serum components on NRC spreading. Cell area, morphology, was 
evaluated by visualising F-actin and a-actinin (Figure 3.4). After 24 hours, NRCs 
cultured on fibronectin had significantly greater cell area in 20kPa and 130 kPa conditions 
while cells in the 6kPa condition were spread to a similar extent. After 48 hours spreading, 
cells in all conditions had significantly increased in cell area compared to 24 hours. NRCs 
spreading on fibronectin again exhibited a larger cell area compared to those on laminin 
on the 6kPa and 20 kPa condition only. After 72 hours in culture, no significant 
differences in cell area were observed between fibronectin and laminin although there 
was a trend toward NRCs on fibronectin having greater cell area at 6 kPa. These results 
Figure 3.2. Rheometric measurements of PDMS stiffness by mixing 185 PDMS and 527 
PDMS at different ratios. Data was collected in collaboration with William Valentine 
Megone (Galtrot lab, QMUL).  



























demonstrate unique differences in the spreading of cardiomyocytes and that substrate 
rigidity and composition play in important roles in NRC rigidity sensing. Differences 
were ameliorated with increasing time in culture which could, in part, be due to 
cardiomyocyte depositing their own matrix over time. Therefore, to reduce the impact of 
Figure 3.3. Sarcomeric contraction velocity of NRCs on PDMS substrates of different 
stiffness. NRCs were infected with a GFP a-actinin adenovirus and sarcomeric 
contractions were recorded with high speed movies (209 fps). This data was collected 
in collaboration with Liisa Hirvonon (Cox lab, QMUL). A,D) Representative images of 
infected NRCs on soft (1 kPa) and stiff (20 kPa) PDMS. Yellow lines indicate areas of 
analysis with kymographs (B & E). Kymographs were used to monitor z-disc position 
during contraction on 1 kPa (C) and 130 kPa (D) PDMS. G, H) Quantification of 
sarcomere length change and shortening velocity in the four PDMS conditions.  n = 11, 
12, 11 & 13 cells for 1, 6, 20 & 130 kPa. * = p < 0.05, **  p < 0.01, *** = p < 0.001, 
p < 0.0001. P values from ANOVA and Tukey correction for multiple comparisons. 
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endogenous matrix deposition, and ensure confidence in our observations between 
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fibronectin and laminin, the rest of our analysis focussed on the 24 hour time point only.  
At the 24 hour time point, significant differences in cell area were observed between 
stiffnesses, suggesting that NRCs are able to actively detect differences in substrate 
rigidity, even at this early time point. Analysis of cell morphology also provided further 
validation of the use of this early time point. Quantifying cell circularity revealed that 79 
% of 1,741 cells could be characterised by an index of <0.4 and that NRCs adopt a more 
polygonal, rather than circular, shape (Figure 3.5C). Significant differences were also 
observed in cell morphology between cells spreading on fibronectin or laminin. At 6 kPa, 
NRCs on fibronectin were significantly more circular than cells on laminin. At 20 kPa, 
the opposite trend was observed where NRCs on laminin were significantly more circular 
than those on fibronectin.  
To evaluate whether the differences in spreading observed between fibronectin and 
laminin could be attributed to differences in cytoskeletal assembly, the fluorescent 
intensity of F-actin and a-actinin was quantified (Figure 3.5 D & E). This measure is 
frequently utilised as an indication of cytoskeletal content. To ensure reliability, all 
samples were immunostained at the same time, from the same antibody solutions. NRCs 
cultured on fibronectin had significantly greater F-actin intensity in 6kPa and 20kPa 
conditions only. Interestingly, NRCs on laminin at 130 kPa had significantly greater F-
actin intensity than those on fibronectin. For a-actinin content, only NRCs on 20kPa 
fibronectin substrates had significantly greater intensity compared to laminin. Between 
stiffnesses, subtle but significant differences were observed. On fibronectin, cells in the 
20kPa condition had significantly greater F-actin and a-actinin intensity. Whereas on 
laminin, NRCs had significantly greater F-actin intensity in 130kPa conditions and 
significantly lower a-actinin in 20kPa conditions. These results suggests that NRC 
Figure 3.4. NRC spreading on embryonic, adult and fibrotic PDMS substrates coated 
with Fibronectin (A) or Laminin (B). Quantified Cell Area after 24, 48 and 72 hours in 
culture. n = 3 independent experiments, > 400 cells per condition. * = p < 0.05, **  p 
< 0.01, *** = p < 0.001, p < 0.0001. P values from one-way (fibronectin vs laminin for 









3.2.2 Cardiomyocyte Traction Forces: Differences between Fibronectin & 
Laminin 
Previous work has demonstrated that cardiomyocytes employ a combination of 
myofibrillar and non-myofibrillar contractions for rigidity sensing (Pandey et al., 2018). 
Furthermore, cardiomyocyte contractility is closely related to sarcomeric content and cell 
morphology (Engler et al., 2008, Rodriguez et al., 2011, Hersch et al., 2013, McCain et 
al., 2014, Oyunbaatar et al., 2016). The differences observed between NRC spreading and 
morphology on fibronectin and laminin may be indicative of differences in the underlying 
traction forces.  
In order to quantify fibronectin and laminin mediated traction forces, NRCs were cultured 
on nanopillar arrays. This platform has previously been successfully employed to measure 
the rigidity sensing behaviours of cardiomyocytes (Rodriguez et al., 2011, Hersch et al., 
2013, Oyunbaatar et al., 2016, Pandey et al., 2018) and other non-muscle cells (Ghassemi 
et al., 2012, Iskratsch et al., 2013, Yang et al., 2016) . Furthermore, in collaboration with 
the Lappalainen lab (University of Helsinki), I have also demonstrated that nanopillars 
can be employed with high precision and sensitivity to detect cytoskeletal events such as 
stress fibre breakage(Ciuba et al., 2018). Therefore, nanopillar arrays (pillar diameter = 
500 nm, spacing = 1000 nm, Stiffness = 3 pN / nm, calculated moduli of individual pillars 
= 10 kPa) were employed to compare the traction forces of NRCs cultured on fibronectin 
of laminin. This pillar dimension was chosen as previous work has identified cyclical 
stretching of the mechanosensitive protein Talin, within this stiffness range (Pandey et 
al., 2018). Pillar tops were firstly coated with quantum dots to enable accurate 
visualisation of pillar positions. Pillar displacements were measured with the cell in situ 
Figure 3.5. Cytoskeletal morphology of NRCs cultured on fibronectin of laminin for 24 
hours. Cells on fibronectin (A) and laminin (B) coated substrates were stained for F-
actin and a-actinin and cell morphology (C), F-actin intensity (D) and a-actinin 
intensity were quantified. n = 2 independent experiments, > 300 cells per condition. * 
= p < 0.05, **  p < 0.01, *** = p < 0.001, p < 0.0001. P values from one-way 





and then compared to the position of the pillars after the cells had been removed by 
trypsinisation. 
Freshly isolated NRCs were cultured for 24 hours before observing pillar displacements 
with live cell experiments. NRCs cast onto pillars without a fibronectin or laminin coating 
did not adhere and died before the start of experiments. After 24 hours, NRCs were spread 
on both fibronectin and laminin coated pillars but the extent of spreading was less (~50-
75%) than that observed on flat PDMS substrates, suggesting that the nanotopography of 
the pillars is a more challenging environment for the NRCs to attach and spread. At this 
time point, cell traction forces were slightly larger on fibronectin than on laminin but this 
did not approach statistical significance (Figure 3.6). Measured pillar displacements in 
either condition ranged between 20 – 40 nm. Background noise from pillar displacements 
outside of the cell was calculated at 27 nm and so the traction forces detected in NRCs 
after 24 hours, especially on laminin were not sufficient high enough above the level of 
background noise. Therefore, NRCs were cultured on the nanopillars for an additional 24 
hours to allow more time for cell adhesions and the cytoskeleton to mature. 
After 48 hours, NRCs began to spontaneously twitch, suggesting a more mature 
cytoskeletal phenotype. Significant pillar placements were observed during the resting 
state (hereby referred to as the diastolic phase) with additional displacements of a subset 
of pillars occurring during twitches (hereby referred to as the systolic phase). Diastolic 
traction forces were significantly greater than those measured at 24 hours, and pillar 
displacements ranged from 58 – 100 nm on laminin and 87 – 241 nm on fibronectin . 
Noise levels were measured at ~ 30 nm on both fibronectin and laminin. On average, 
diastolic traction forces were 78 ± 21 % (mean ± SD) greater on fibronectin compared to 
laminin, with displacements measured at 79 ± 15 nm and 140 ± 49 nm for laminin and 
fibronectin, respectively. Systolic contractility (net maximum pillar displacements 
measured during systolic phase) was 46 ± 13 % greater in NRCs cultured on fibronectin 
compared to laminin, with displacements measured at 87 ± 23 nm and 127 ± 28 nm on 
laminin and fibronectin, respectively. 
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To help characterise the contribution of myofibrillar (sarcomeric myosin) and non-
myofibrillar (non-muscle myosin) forces to the displacements observed during the 
diastolic phase, NRCs were treated with verapamil, which inhibits myofibrillar tension 
by blocking L-type and T-type calcium channels. Verapamil treatment (15 minutes) 
resulted in inhibition of the systolic phase and an average decrease in diastolic pillar 
displacements  of ~ 15% (Figure 3.7). Pillar by pillar analysis of displacements in the 
untreated diastolic phase relative to the displacements under verapamil treatment, 
revealed a log normal distribution, peaking at around 0.6 which suggests a 40 % reduction 
in tension in the absence of myofibrillar forces. However, the majority of the pillar 
Figure 3.6. A) NRC traction forces were analysed using PDMS nanopillars coated with 
quantum dots. B) Bright field images enabled confirmation of cell spreading and 
spontaneous twitching. C. Examples pillar displacements during diastole and systole. D) 
Analysis of pillar displacements after 24 hours in culture n = 7 & 9 cells for laminin and 
9 fibronectin, respectively . E) Analysis of diastolic and systolic pillar displacements 
after 48 hours in culture. n = 10 & 9 cells for laminin and fibronectin respectively. * = 
p < 0.05, **  p < 0.01. P values from students t-test (fibronectin vs laminin). Figure 
adapted from Iskratsch, Wolfenson & Sheetz, 2014. 
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displacements were insensitive to verapamil treatment, especially at the edges of cells 
(Figure 3.7A, blue circles) suggesting a strong contribution of non-myofibrillar forces 
during the diastolic phase. Therefore, this data suggests that NRCs on fibronectin are 
capable of generating significantly greater myofibrillar and non-myofibrillar traction 
forces when cultured on fibronectin. Furthermore, this finding suggests that 
mechanosensitive elements at fibronectin adhesions experience greater tension and may 
promote more mechanosignalling events than laminin adhesions. 
 
Figure 3.7. Verapamil treatment of NRCs on fibronectin coated pillars. A) Representative 
force maps during systole, diastole and after verapamil treatment. Blue circles highlight 
pillars which were insensitive to verapamil treatment. B) Quantification of pillar 
displacements during diastole before and after verapamil treatment. C) Pillar by pillar 
analysis of displacement in diastole relative to displacement after verapamil treatment 
demonstrated a log normal distribution, peaking around 0.4, suggesting a 40% loss of 
tension. * = p < 0.05. P value from students t- test. 
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3.3 Adhesion dependent Cardiomyocyte Rigidity Sensing Using 
Ligand Micropatterning 
3.3.1 Micropatterning of Fibronectin and Laminin Lines 
The data presented so far in this chapter has suggested that NRCs cultured on fibronectin 
and laminin have different rigidity sensing properties. On fibronectin, NRCs have 
significantly greater cell area, more cytoskeletal content and exhibit greater myofibrillar 
and non-myofibrillar traction forces. Furthermore, subtle rigidity dependent differences 
were observed in cytoskeletal content and spreading, suggesting an interplay between 
rigidity and composition of the ECM. It is therefore important to investigate these 
differences at the level of the focal adhesion, which appears to be mediating these 
observed differences. Ligand micropatterning offers a strong platform for controlling the 
composition and geometry of the ECM and has been utilised in previous work to 
investigate the effects of cardiomyocyte morphology on sarcomere assembly and 
contractility (Kuo et al., 2012, McCain et al., 2014, Yuan et al., 2017). Furthermore, 
micropatterning of fine features (1 – 4 µm in size) has been utilised by others to 
investigate focal adhesion and integrin signalling properties in other model systems such 
as T-cells and carcinoma cells (Tabdanov et al., 2015, Tabdanov et al., 2018, Rafiq et al., 
2019). We therefore sought to combine micropatterning techniques with PDMS 
substrates to compare adhesion properties of NRCs spreading on micropatterned 
fibronectin or laminin, at different rigidities.  
Micropatterned substrates were engineered by creating PDMS stamps presenting parallel 
lines, 1 µm thick at 5 µm spacings. To visualise the micropattern, fibronectin and laminin 
were labelled with a GFP NHS-ester. Stamps were coated with GFP-fibronectin or GFP-
Figure 3.8. Common stamping errors on 6 kPa PDMS substrates. Common errors include 
background stamping where the PDMS has come into contact with the areas between the lines 
(left), streaking (middle) where the stickiness of the soft PDMS caused pattern streaks, and 
substrate yielding or topographical deformation of the PDMS (right). Scale bar = 10 µm. 
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laminin and patterns were transferred to PDMS substrates via manual contact printing 
(Figure 3.9A). Analysis of the stamped line features verified that micropatterns could be 
stamped consistently, with an average line width of 1.1 µm (range = 0.9 – 1.3 µm) on 130 
kPa and 20 kPa and 6 kPa substrates.  
Culturing of mouse embryonic fibroblasts on micropatterned fibronectin lines for 1 hour 
demonstrated that FAs (as evidenced by paxillin immunofluorescence Figure 3.9B) only 
form on the lines and not on the background. Culturing of NRCs on the micropattern for 
24 hours also demonstrated strong paxillin staining to the micropatterned ligands (Figure 
3.9C). Because the micropattern is non-covalently adsorbed to the PDMS, the NRCs may 
be able to reorganise and/or degrade the micropattern. For this reason, culture duration of 
NRCs on the micropattern was limited to 24 hours. This time point was also chosen to 
minimise artefact from NRCs depositing their own matrix over time. Furthermore, the 
softness of the 6 kPa PDMS substrates resulted in considerable variability in the quality 
of the stamp and patterning errors such as background stamping (the compliant substrate 
allowed contact with the background of the stamp, streaking and topographical 
Figure 3.9. A) Schematic of stamping of atto 488-labelled fibronectin or laminin using 
PDMS stamps. B) MEFs were cultured on micropatterned atto 488 fibronectin for 1 
hour and cell exhibited strong localisation of paxillin to the lines which also results in 
alignment of the cytoskeleton with the micropattern. C) NRCs cultured on fibronectin 
and laminin lines also exhibited strong paxillin localisation to the micropatterned 
lines. Scale bars = 10 µm. 
 
 63 
deformation of the PDMS (Figure 3.8) were observed. Therefore, experiments were 
limited to 130 kPa and 20 kPa substrates. 
3.3.2 NRC Morphology on Fibronectin and Laminin Lines 
After 24 hours in culture, NRCs on 130 kPa and 20 kPa micropatterned substrates all 
cardiomyocytes adopted a rod like morphology, independent of stiffness and ligand type. 
Figure 3.10. Spreading of NRCs on micropatterned fibronectin or laminin lines. A) 
Representative images of typical cell morphology after 24 hours in culture on the 
micropatterned lines. B) Quantification of cell area, aspect ratio, cell spreading length 
along the lines and cell spreading width across the lines. n = 60, 41, 51 & 45 cells 
(from 3 biological repeats) for fibronectin 130 kPa, laminin 130 kPa, fibronectin 20 
kPa and laminin 20 kPa. Data points (grey dots) indicate values for individual cells, 
red lines indicate the mean and error bars indicate 25th to 75th percentiles. * = p < 
0.05, **  p < 0.01, *** = p < 0.001, p < 0.0001. P values from students t- test. Scale 
bar = 10 µm. 
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NRCs exhibited a range of morphologies by spreading across just 1 - 3 lines, resulting in 
cells exhibiting narrow widths of 5-15 µm and long cell lengths of 30 – 100 µm (Figure 
3.10) which appears to be consistent with previous observations on micropatterned line 
with similar dimensions (Clark et al., 1992). Statistical analysis revealed that at 130 kPa, 
NRCs on fibronectin had significantly greater adhesion area but similar cell length to 
NRCs cultured on laminin. At 20 kPa, NRCs on fibronectin had similar cell area but 
significantly greater cell length compared to laminin. Previous work has demonstrated 
that when NRCs adopt such a rod like morphology, subtle changes in cell aspect ratio 
(AR) can have significant effects on contractility, by modulating the stacking of 
myofibrils in serial (high AR) or in parallel (low AR) (Kuo et al., 2012, McCain et al., 
2014). NRC ARs were thus quantified, revealing that NRCs exhibited ARs ranging from 
1:3 – 1:9 (on average). At 130 kPa, cell ARs were similar between fibronectin (6.7 ± 2.8) 
and laminin (6.9 ± 3.2). At 20 kPa, NRCs on laminin micropatterns had significantly 
lower AR than those on fibronectin (6.9 ± 2.6 and 5.6 ± 2.2, respectively), suggesting 
possible differences in cytoskeletal arrangement.  
3.3.3 Enrichment of Cytoskeletal Proteins on Micropatterned Fibronectin 
and Laminin Lines 
Visualisation of the cytoskeleton (F-actin & a-actinin via immunofluorescence) and 
analysis of whole cell F-actin and a-actinin content (fluorescence intensity), revealed 
significantly greater F-actin enrichment and a trend towards greater a-actinin content on 
fibronectin at 130 kPa (Figure 3.11). At 20 kPa, no significant differences in whole-cell 
F-actin or a-actinin intensity were observed between the two ligands, although F-actin 
content demonstrated a trend towards being significantly lower on laminin. Finally, both 
F-actin and a-actinin appeared to be enriched at the cell edges, in proximity to the 
micropatterned lines. Analysis of F-actin or a-actinin enrichment to the lines compared 
to the whole cell, revealed that both F-actin and a-actinin were mildly enriched in 
proximity to the lines. Statistical analysis revealed significantly less F-actin on 20 kPa 
laminin lines compared to fibronectin, but not 130 kPa. a-actinin exhibited a trend 
towards significantly less enrichment on 20 kPa laminin lines. These results suggest a 
potential interplay between substrate rigidity and ECM composition, with NRCs 
exhibiting strong spreading phenotype with increased cytoskeletal content at fibrotic 
stiffnesses, with a more pronounced effect on fibronectin. However, analysis of 
cytoskeletal enrichment in proximity to integrin adhesions at the lines, revealed similar 
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behaviours between ligands at the fibrotic stiffness and significantly less activity on 
laminin at physiological stiffness, suggesting more pronounced differences in ECM 
sensing at 20 kPa. 
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3.3.4 Vinculin Enrichment to Fibronectin and Laminin Lines 
In light of morphological and cytoskeletal differences between NRCs spreading on 
fibronectin and laminin lines, it was necessary to evaluate the effects of the different 
pattern dimensions at the level of the focal adhesion. Vinculin is a prominent adapter 
protein in cardiomyocyte focal adhesions and plays a key role in integrin mediated force 
transmission (Zemljic-Harpf et al., 2007, Tangney et al., 2013, Yao et al., 2016). Recent 
work from the Iskratsch lab using NRCs, has also demonstrated the localisation of 
vinculin at sites of high force transmission (Pandey et al., 2018). Following the 
observation that NRCs on fibronectin exert greater traction forces than cells on laminin 
(Figure 3.6). It was hypothesised that vinculin may be differentially enriched at 
fibronectin and laminin adhesions.  
To test this hypothesis, the chosen vinculin antibody was validated by comparing its 
colocalization with transfected GFP-vinculin in MEFs (Figure 3.12A). After antibody 
validation, vinculin enrichment was quantified on the 130 kPa and 20 kPa micropatterns 
after 24 hours in culture (see Figure 3.12B for visual description of image segmentation). 
Enrichment was calculated by measuring the immunostaining density (total signal divided 
by area) from areas of the cell that overlapped with the lines, relative to the whole cell, 
minus the background (Tabdanov et al., 2015, Tabdanov et al., 2018). Therefore, a value 
of greater than 1 suggest enrichment to the lines, relative to the rest of the cell. Vinculin 
was enriched to adhesions along the micropatterned lines throughout the entire length of 
the cells. Analysis of vinculin enrichment on 130 kPa micropatterns revealed similar 
enrichment on both fibronectin and laminin (1.1 ± 0.12 and 1.08 ± 0.14, respectively). On 
20 kPa substrates, however, NRCs on fibronectin lines exhibited significantly more 
vinculin enrichment than cells on laminin (1.13 ± 0.11 and 0.84 ± 0.09, respectively). 
Figure 3.11. Cytoskeletal and sarcomeric content on the different micropatterns and 
enrichment to fibronectin and laminin lines. A) Representative images from each 
condition. B) Quantification of  Whole cell F- actin and a-actinin content. C) 
Quantification of F- actin and a-actinin enrichment to the lines relative to the whole 
cell. n = 14, 14, 22 & 15 cells (from 2 biological repeats) for fibronectin 130 kPa, 
laminin 130 kPa, fibronectin 20 kPa and laminin 20 kPa. * = p < 0.05, **  p < 0.01, 
*** = p < 0.001, p < 0.0001. for the Plots, data points (grey dots) indicate values for 
individual cells, red lines indicate the mean and error bars indicate 25th to 75th 
percentiles. P values from students t- test. Scale bar = 5 µm. 
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Coupled with the observation of reduced traction forces on nanopillars (10 kPa), reduced 
AR and cytoskeletal content, reduced vinculin enrichment to laminin lines at 20 kPa is 





3.3.5 FHOD1 Enrichment to Fibronectin and Laminin Lines 
So far, results from the micropatterned lines have suggested that NRCs cultured on 
laminin at physiological stiffness (20 kPa) have less vinculin and F-actin enrichment at 
adhesion sites, suggesting less tension through adhesions. To further investigate the 
different rigidity sensing regimes observed on fibronectin and laminin lines, it was 
important to evaluate the localisation of other proteins that participate in rigidity sensing. 
The actin polymerising protein Formin Homology Domain-containing protein 1 
(FHOD1) has been shown to be a key regulator of integrin mediated traction forces and 
participate in cardiomyocyte rigidity sensing at focal adhesions (Iskratsch et al., 2013, 
Pandey et al., 2018). Therefore, activity and localisation of FHOD1 was evaluated on the 
micropatterned lines using a phospho-specific FHOD1 antibody (active FHOD1, 
phosphorylated at Thr1141, pFHOD1). The antibody was first validated for 
immunostaining by comparing localisation with a transiently transfected GFP-FHOD1 
plasmid which exhibited colocalization at the cell edge, where FHOD1 is thought to be 
activated by ROCK (Hannemann et al., 2008). This observation is also in agreement with 
reports of this antibody localising close to sites of high traction forces at the cell edge 
Figure 3.12.  Vinculin enrichment to micropatterned fibronectin and laminin lines. A) 
Validation of a vinculin antibody for immunofluorescence studies was confirmed by 
visualising co-localisation between the antibody and a transiently transfected GFP-
vinculin plasmid in MEFs. B) Visual descriptions of analysis of vinculin enrichment to 
the lines. Regions of interest (ROI) are generated for the whole cell and the position of 
the lines. Then an ROI is generated of the overlapping area of the whole cell and lines 
ROI. Vinculin enrichment is calculated by dividing the signal intensity form the vinculin 
on the lines ROI by the signal intensity from the whole cell. Enrichment values greater 
than 1 = enrichment to the lines. C) Representative images and quantification of 
vinculin enrichment to fibronectin and laminin lines of fibrotic or physiological stiffness. 
n = 53, 29, 31 & 29 cells (from 2 biological repeats) for fibronectin 130 kPa, laminin 
130 kPa, fibronectin 20 kPa and laminin 20 kPa. Plots, data points (grey dots) indicate 
values for individual cells, red lines indicate the mean and error bars indicate 25th to 
75th percentiles. * = p < 0.05, **  p < 0.01, *** = p < 0.001, p < 0.0001. P values from 




(Pandey et al., 2018).  In NRCs cultured on micropattern, pFHOD1 exhibited a low level 
of localisation to the lines in addition to a diffuse cytoplasmic or cytoskeletal localisation 
(Figure 3.13). However, analysis of pFHOD1 enrichment to the lines vs the whole cell 
did not demonstrate significant enrichment to the lines (enrichment value < 1), due to 
moderate staining to cytoplasmic and cytoskeletal structures. While the conditions 
observed here may provide sufficient cues for cell spreading and morphology, the 
micropatterned lines do not appear to be a good platform to investigate enrichment of 
adhesion proteins in detail. The observed enrichment of vinculin and poor enrichment of 
pFHOD1 suggest that key adhesion proteins are not being recruited to adhesions using 
this platform. It was, therefore, necessary to continue investigations on substrates that are 
less restrictive to cell spreading and enable greater adaptor enrichment while also 
permitting comparison of adhesion to fibronectin and laminin. 
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3.3.6 Investigating Vinculin and pFHOD1 Enrichment Using 
Micropatterned Grids 
To further investigate the localisation of adaptor proteins to different ligands, 
micropatterned grids were engineered to present fibronectin and laminin lines in a 
perpendicular fashion, presenting a grid of ligands. Grids were produced in the same 
manner as the lines, with fibronectin lines being manually stamped on the PDMS 
followed immediately by manual perpendicular stamping of laminin lines. This approach 
offers the advantage of directly comparing fibronectin and laminin adhesion within the 
same cells. On micropatterned grids, cell area increased at both rigidities and cells still 
preferred to spread across 2-4 lines. Interestingly, NRC morphology and spreading along 
either ligand demonstrated rigidity dependent changes. At 130 kPa, NRCs invariably 
aligned their major axis along fibronectin lines, as demonstrated by dramatic differences 
in spreading length on fibronectin and laminin Figure 3.14. At 20 kPa, however, spreading 
along fibronectin or laminin lines was more variable, with decreased spreading along 
fibronectin and increased spreading along laminin, relative to 130 kPa. This stiffness 
dependent morphology change is further verified by the cell ARs which were significantly 
greater at 130 kPa (mean ± SD, 6.1 ± 2.9) compared to 20 kPa (4.2 ± 2.1). These results 
suggest that fibronectin adhesions may be stronger and more stable at fibrotic stiffnesses 
and that laminin adhesions may play a more important role in spreading and adhesion at 
physiological stiffnesses. To further investigate this, vinculin and pFHOD1 localisation 
were evaluated on the grids to evaluate how the morphological differences observed at 
each stiffness translate to the enrichment of adaptor proteins. 
Figure 3.13. Analysis of pFHOD1 enrichment to micropatterned fibronectin and 
laminin lines. A & C) Validation of pFHOD1 antibody for immunofluorescence studies 
was confirmed by visualising co-localisation between the antibody and a transiently 
transfected GFP-FHOD1 plasmid in MEFs. B) Representative images of diffuse (Left) 
or cytoskeletal (right) pFHOD1 localisation, note mild enrichment to the lines. E) 
Quantification of pFHOD1 enrichment to the lines demonstrated poor enrichment. n = 
33, 22, 32, 18 cells (from 2 biological repeats) for fibronectin 130 kPa, laminin 130 
kPa, fibronectin 20 kPa and laminin 20 kPa. Plots, data points (grey dots) indicate 
values for individual cells, red lines indicate the mean and error bars indicate 25th to 




 Vinculin enrichment on the grids demonstrated stark differences on fibronectin and 
laminin lines, which was also changed with substrate rigidity. At 130 kPa, vinculin was 
greatly enriched on fibronectin lines, with less enrichment on laminin lines. At 20 kPa, 
vinculin enrichment was still greater on fibronectin lines but, compared to 130 kPa, 
enrichment was generally lower on fibronectin and greater on laminin lines. To evaluate 
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whether vinculin enrichment was dependent upon the degree of spreading on either set of 
lines, vinculin enrichment against the spreading length. The results demonstrated a 
moderate positive correlation on fibronectin (r = 0.6, p < 0.0001) and no correlation on 
laminin (r = -0.13, p > 0.05), suggesting differential regulation of vinculin recruitment. 
On the micropatterned grids, pFHOD1 exhibited a more distinct localisation to F-actin or 
cytoskeletal structures, resulting in little enrichment to the line (enrichment value < 1, 
Figure 3.13D). However, subcellular enrichment of pFHOD1 to adhesions was still 
observed (Figure 3.13A) consistent with its hypothesised role in cardiomyocyte rigidity 
sensing (Pandey et al., 2018). Adhesion enrichment of pFHOD1 was mostly observed in 
small protrusions along lines at the cell edge. These findings suggest that pFHOD1 is 
present at fibronectin and laminin adhesions and may participate in actin polymerisation  
downstream of integrin signalling, as suggested by others (Iskratsch et al., 2013, Pandey 
et al., 2018).  However, this investigation was unable to further investigate this pathway 
due to the different subcellular localisations of pFHOD1. 
 
3.4 Discussion 
This investigation has shown that the spreading and adhesion behaviours of NRCs  differ 
when cultured on fibronectin and laminin. NRCs cultured on fibronectin spread further, 
exhibit more cytoskeletal content and have greater myofibrillar and non-myofibrillar 
contractility, which likely results in the greater enrichment of force sensitive integrin 
adaptor proteins such as vinculin. Ligand micropatterning also revealed an important 
differences between substrates with physiological or fibrotic stiffness. At high stiffness, 
Figure 3.14. Vinculin and pFHOD1 enrichment to fibronectin/laminin grids. A & B) 
Representative images on pFHOD1 (A) and vinculin (B) localisation to the grids. C) 
Quantification of cell morphology on the grids. n = 46 and 40 cells (from 2 biological 
repeats) for 130 kPa and 20 kPa conditions. D) Analysis of pFHOD1 enrichment to the 
grids. n = 13 cells (from 2 biological repeats) in each condition. E) Analysis of vinculin 
enrichment to the grids and Persons correlation coefficient of vinculin enrichment vs 
spreading length . n = 21 & 23 cells (from 2 biological repeats) at 130 kPa and 20 kPa 
conditions. Plots, data points (grey dots) indicate values for individual cells, red lines 
indicate the mean and error bars indicate 25th to 75th percentiles.* = p < 0.05, **  p < 




NRCs exhibit a preference for fibronectin adhesions, which promote greater spreading, 
vinculin enrichment and cytoskeletal assembly, resulting in preferential adhesion and 
alignment. At physiological stiffness, fibronectin adhesions are still dominant but NRCs 
demonstrate increased spreading along laminin ligands compared to fibrotic stiffnesses. 
However, increased spreading along laminin at physiological stiffness did not result in 
strong vinculin enrichment to laminin adhesions, suggesting the NRCs preferentially 
spread along fibronectin due to increased adhesion stability.  
Cardiomyocyte integrin expression is dynamic during development and disease. The 
fibronectin binding a5b1 integrins are upregulated when the heart is undergoing dynamic 
changes in ECM stiffness during embryonic development and disease states (Ward and 
Iskratsch, 2019). In the current investigation, NRCs cultured on fibronectin exhibited 
greater substrate interaction (cell area) as well as greater contractility (traction forces), 
cytoskeletal content (F-actin and a-actinin) and vinculin enrichment to adhesions. This 
phenotype could be more favourable for important behaviours during embryonic 
development (such as migration or proliferation) and disease (such cytoskeletal 
remodelling or rapid hypertrophy). Indeed, the fibronectin binding a5 integrin subtype is 
rapidly upregulated in cardiomyocytes during diseased states such as hypertension and 
ischaemia (Nawata et al., 1999, Babbitt et al., 2002). Furthermore, numerous studies have 
identified fibronectin binding integrins as key players in mediating cardiomyocyte 
hypertrophy (Ogawa et al., 2000, Babbitt et al., 2002, Balasubramanian and 
Kuppuswamy, 2003, Willey, 2003, Johnston et al., 2009). However, why fibronectin 
binding integrin subtypes play such a strong role in pathological hypertrophic signalling 
remains unclear. The results from the current investigation suggest that NRCs on 
fibronectin substrates have greater vinculin enrichment which suggest greater adhesion 
stability through reinforcement of the integrin/F-actin link (Humphries et al., 2007, del 
Rio et al., 2009). This would permit the greater spreading, cytoskeletal content and 
traction forces observed here.  
 This investigation directly compared the behaviour (morphology, forces) of 
cardiomyocytes cultured on fibronectin and laminin coated substrates. The nano-pillar 
arrays implemented here are advantageous for this approach as they permit the analysis 
of the traction forces occurring at multiple adhesion sites, providing superior resolution 
to micro-pillar arrays used by others (Rodriguez et al., 2011, Hersch et al., 2013, 
Oyunbaatar et al., 2016). Furthermore, the sub-micron dimensions of the pillars disrupt 
cell morphology less than micro-pillars by enabling cells to sit on top of, as opposed to 
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between, the pillars (Li et al., 2007). The results from the current investigation 
demonstrate that NRCs on fibronectin coated pillars produce greater traction forces 
during diastolic and systolic phases, than those on laminin coated pillars. The majority of 
diastolic pillar displacements at the cell edge were insensitive to muscle myosin 
inhibition, suggesting that both muscle and non-muscle myosin contribute towards the 
elevated traction forces on fibronectin. Recent work from the Iskratsch lab has 
demonstrated that both myofibrillar and non-myofibrillar contractility contribute towards 
rigidity sensing in NRCs (Pandey et al., 2018). Results from cell spreading and 
micropatterning suggest that differences in cytoskeletal content and adhesion stability 
may explain the observed differences in contractility. However, cytoskeletal content and 
vinculin enrichment was also found to vary dependent upon substrate rigidity. Previous 
work as demonstrated that cardiomyocyte contractility increases with substrate stiffness 
(Engler et al., 2008)}(Hersch et al., 2013, Pandey et al., 2018). Furthermore, how 
contractility changes between fibronectin and laminin remains unclear and further 
investigation with nanopillars of different stiffness will provide more information on the 
role of integrin signalling on cardiomyocyte traction forces. This is especially important 
in the light of previous work which clearly demonstrated a direct link between integrin 
subtype, adaptor protein enrichment and cellular contractility (Rahmouni et al., 2013). 
Implementation of PDMS substrates and ligand micropatterning has revealed unique 
spreading, morphology and adhesion enrichment properties of NRCs on fibronectin and 
laminin. Micropatterning has several advantages including, control the adhesion area, cell 
morphology, ECM geometry and ligand composition, while enabling analysis of adhesion 
properties relative to the micropattern. Previous work has demonstrated that NRCs will 
align their myofibrils along the axis of maximal stress, which can be modulated by 
controlling cell morphology (Yuan et al., 2017). Culturing of NRCs on micropatterned 
fibronectin rectangles with defined ARs demonstrated that cardiomyocytes generate 
maximum traction forces at 13 kPa when cell have an AR of 7:1. Furthermore, at 90 kPa, 
cell morphology required an AR of 2:1 for maximum traction force (Kuo et al., 2012, 
McCain et al., 2014). All NRCs observed in the current investigation adopted a highly 
polarised rod-shaped morphology along micropatterned lines with average ARs ranging 
from 4:1 – 7:1 on all stiffnesses, suggesting that NRCs are adopting spreading 
morphologies for optimal contractility. However, no differences in morphology were 
observed between fibronectin lines at 130 kPa and 20 kPa (AR = ~1:7), while cells on 
laminin exhibited a less extreme aspect ratio in softer conditions only (AR = ~ 1:5). These 
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results may reflect differences in maturity of the contractile cytoskeleton due to 
differences in the culture time (24 hours vs 72 hours) between this study and McCain et 
al. (2014). Therefore, the behaviours observed here may represent early rigidity sensing 
strategies and perhaps reflects how NRCs initially sense changes in ECM stiffness and 
composition.  
Rigidity sensing occurs via the coordinated assembly of contractile cytoskeletal elements 
at FAs (Iskratsch et al., 2014). Extensive data on the precise molecular regulation of 
rigidity sensing in cardiomyocytes is still missing from the literature, but recent work has 
identified protein kinase C (PKC) and Src as key regulators of non-myofibrillar rigidity 
sensing (Pandey et al., 2018). In non-myocytes, Src phosphorylation of FHOD1 results 
in localisation to the plasma membrane, where it is further activated by ROCK to direct 
rigidity sensing (Hannemann et al., 2008, Iskratsch et al., 2013). In cardiomyocytes, 
FHOD1 has been observed to localise to the intercalated disc (ICD) and the costamere 
where it is capable to nucleating the cytoplasmic actin found there (Al Haj et al., 2015, 
Patel et al., 2018). However, others have suggest that FHOD1 has more of an actin 
bundling and capping role and that it is disposable for heart development in mice 
(Schonichen et al., 2013, Sanematsu et al., 2019). The current investigation has observed 
localisation of active FHOD1 at both fibronectin and laminin adhesions. However, 
FHOD1 was also strongly localised to cytoplasmic or cytoskeletal structures. These 
findings are consistent with proposed roles of FHOD1 at integrin adhesions and at the 
cytoskeleton (Iskratsch et al., 2013, Schulze et al., 2014, Pandey et al., 2018). Future 
investigations could utilise the micropatterns to further investigate the mechanisms that 
regulate FHOD1 localisation and translocation to adhesions (such as PCK activation, Src 
activity or contractility). 
Micro array and published (Miner et al., 1997, Brancaccio et al., 1998, Maitra et al., 2000) 
data suggests that adhesion to fibronectin is mediated by a combination of a5b1, avb3  
and avb1 integrins and that adhesion of cardiomyocytes to laminin occurs via a 
combination of a3b1, a6b1  and a7b1 integrins. While different integrin subtypes have 
considerable overlap in their ligand affinity, little evidence exists of redundant sub-
cellular functions between different integrin subtypes. Cancer cells utilise a combination 
of fibronectin binding integrins for rigidity sensing depending on substrate stiffness 
(Elosegui-Artola et al., 2014).  It has been reported that carcinoma cells utilise a5b1 
integrins to exert greater traction forces on soft (~1 kPa) substrates, a combination of 
a5b1 and avb6 integrins to generate traction forces at moderate rigidities (5-10 kPa) and 
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mostly avb6 integrins at high rigidities (Elosegui-Artola et al., 2014). Furthermore, cells 
that express the fibronectin binding a5b1 and avb3 integrins utilise the capabilities of 
a5b1 subtypes to exert greater traction forces for rapid cell spreading and adhesion 
stability, while avb3 provide a greater capacity for the recruitment of adaptor proteins 
and the activation of integrin signalling pathways such as ROCK and Arp2/3 (Schaufler 
et al., 2016, Bharadwaj et al., 2017). Results from the current study demonstrate that 
fibronectin mediated adhesions promote a stronger spreading phenotype, presumably 
owing to greater adhesion stability/strength, as evidenced by higher vinculin enrichment 
and traction forces. Fibronectin binding integrins are specifically upregulated during 
compensatory events, such as post-MI, where elevated contractility may be beneficial to 
recovery of cardiac function (Nawata et al., 1999, Burgess et al., 2001). However, the 
roles of different fibronectin and laminin binding integrin subtypes within the behaviours 
observed here remain unclear. Furthermore, this investigation has not presented data on 
NRC integrin expression. Microarray data suggest that within the first 24 hours of culture, 
NRCs express both fibronectin and laminin subtypes. Furthermore, preliminary Western 
Blot data (not shown) appears to confirm this data. However, future work should go on 
to verify integrin expression in NRCs in culture. This will provide further validity to the 
results presented here. Furthermore, future studies could then go on to utilise integrin 
specific ligand nanopatterning, integrin specific blocking antibodies, siRNAs and integrin 
transfection constructs to elucidate the roles of specific integrin subtypes in 
cardiomyocyte integrin signalling. 
There are a number of limitations that should be taken into account when interpreting the 
results of the current investigation. Firstly, at the time of isolation (postnatal days 1-3) 
NRCs are not terminally differentiated and as a result, are able to disassemble their 
myofibrils, spread over tissue culture surface and reassemble their myofibrils de-novo. 
While this enables detailed investigation of the integrin mediated signalling properties of 
cardiomyocytes, the morphology and behaviours of integrin adhesions and myofibrils 
may not resemble those in-vivo. Finally, while the 24 hour culture duration time point 
used here was necessary to reduce the influence of endogenous matrix deposition, it 
should be noted that NRCs could still be adjusting to in-vitro culture conditions and 
results could be different with longer culture durations. Furthermore, cardiomyocyte 
cytoskeletal maturation has been reported to continue for at least 44 hours (Skwarek-
Maruszewska et al., 2009) and the results obtained here may reflect a more immature 
phenotype.    
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This investigation has demonstrated that NRCs exhibit different rigidity sensing 
behaviours on fibronectin and laminin ligands, during early spreading. Both fibronectin 
and laminin are key components within the basal lamina of the cardiac ECM. 
Cardiomyocytes alter their integrin expression to favour fibronectin or laminin ligands 
according to the developmental stage, or diseased state of the heart. Previous work has 
suggested that matrix rigidity can be a direct regulator of integrin expression, depending 
on the desired function (Schiller et al., 2013, Elosegui-Artola et al., 2014), and differential 
expression of integrin subtypes can work in a competitive (Guasch et al., 2015, Bharadwaj 
et al., 2017) or complementary fashion (Elosegui-Artola et al., 2014, Schaufler et al., 
2016). The findings from the current investigation suggest that laminin and fibronectin 
adhesion have different mechanical properties. Furthermore, results from micropatterned 
grids suggest that fibronectin and laminin integrins have mutually exclusive but 
complementary roles at physiological, but not at fibrotic stiffnesses. Recent work has 
demonstrated that the activity and function of different integrins is largely determined by 
their bond dynamics under force (Elosegui-Artola et al., 2014, Oria et al., 2017). 
Importantly, differential integrin bond dynamics and their functional implications for 
rigidity sensing, manifest at the FA through integrin clustering, which occurs at the 
nanoscale from a few tens to  hundreds of nanometres, depending on substrate rigidity 
(Cavalcanti-Adam et al., 2007, Huang et al., 2009, Schaufler et al., 2016).  Thus, to 
understand the functional roles of fibronectin and laminin binding integrins in 
cardiomyocytes, it is essential to understand the clustering of a5b1 and a7b1 integrin 
subtypes. The next chapter of this thesis will present the development and optimisation 
of a ligand nanopatterning platform for the investigation of integrin-ligand clustering 





4 IMPLEMENTATION AND 





The previous chapter has presented importance differences in the spreading, traction 
forces and adhesion assembly in cardiomyocytes cultured on fibronectin or laminin. We 
hypothesised that the underlying clustering and signalling behaviours of different integrin 
subtypes could be underpinning these behaviours. To investigate the integrin clustering 
behaviour of fibronectin (predominantly a5b1) or laminin (predominantly a7b1) binding 
integrin subtypes, it was necessary to implement a platform capable of precisely 
controlling the composition, concentration and geometry of integrin binding ligands in 
the ECM.  
Previous work to investigate integrin clustering in adherent cells has utilised micellular 
diblock copolymer self-assembly for single molecule nanopatterning of integrin ligands. 
This platform utilises gold nanoislands to tether single integrins at specific distances with 
a resolution of ~ 30 nm (Arnold et al., 2004). Notably, this approach offers the ability to 
control inter-ligand spacing, ligand geometry (hexagonal or triangular ligand clusters) 
and the global order/disorder of the nanopattern (Arnold et al., 2004, Cavalcanti-Adam et 
al., 2007, Huang et al., 2009, Schvartzman et al., 2011). However, recent developments 
in DNA nanotechnology have presented an additional ligand nanopatterning model in the 
form of DNA origami (Rothemund, 2006, Gopinath and Rothemund, 2014, Huang et al., 
2017, Huang et al., 2019). Specifically, DNA origami nanostructures ~ 100 nm in size 
can be functionalised with integrin binding peptides with high resolution. Lithographic 
nanopatterning is then used to selectively position functionalised DNA origami, in desired 
 
 79 
configurations, across tissue culture surfaces. While providing similar capabilities of 
micellular diblock copolymer self-assembly, DNA origami offers two key advantages. 
Firstly, the modifiable nature of DNA structures provides significant improvements in the 
resolution of single molecule positioning, with published designs offering 6 nm resolution 
(Rothemund, 2006). Furthermore, recent work from the Palma lab demonstrated the 
capacity of DNA origami for multivalent investigations, with the ability to control the 
positioning of 2 or more molecules with nanoscale resolution (Hawkes et al., 2019, Huang 
et al., 2019). Therefore, this investigation has sought to utilise the advantageous 
capabilities of DNA origami to investigate the integrin clustering and signalling 
behaviours of cardiomyocytes. While the multivalent capabilities of DNA origami are not 
explored in this thesis, this platform offers multiple meaningful options to build on the 
work presented. 
Initial attempts to implement DNA origami nanopatterning technology and replicate 
previously published work (Gopinath and Rothemund, 2014) were unsuccessful. 
Furthermore, compared to previous work, different equipment was used to fabricate 
nanopatterned substrates in the current investigation which resulted in significant changes 
in the characteristics of substrates produced. This meant that published protocols were 
unsuitable for this investigation and considerable efforts were thus required to optimise 
the methodology for the current investigation. Therefore, this chapter will present the 
implementation and optimisation of a DNA origami nanopatterning platform for the 
investigation of integrin clustering dynamics in cardiomyocytes.  
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4.2 Design and modification of DNA origami 
4.2.1 DNA Origami Design and Fabrication 
DNA origami are highly customisable, nanoscale structures consisting of a long single 
strand of DNA (ssDNA) (termed the backbone), folded into defined shapes by hundreds 
of short strands (called staple strands) of ssDNA that are complimentary to multiple sites 
along the backbone (Figure 4.1). The use of computer assisted design of DNA origami 
has resulted in the systematic production of DNA nanostructures with high efficiency and 
few errors (Rothemund, 2006). Furthermore, the production of structures with precisely 
known parameters also enables easy and efficient modification of DNA origami designs. 
Previous work has reported successful modification of DNA origami for covalent 
attachment to silica (Gopinath and Rothemund, 2014), attachment of single quantum dots 
to individual DNA origami (Huang et al., 2017) and to present ligands for cell adhesion 
(Huang et al., 2019). 
The pointed triangle DNA origami has proven to be one of the most reliable and 
repeatable designs for fabrication (Rothemund, 2006) and has been used successfully in 
Figure 4.1. Example design of DNA origami nanostructures. A) Colour coded design of 
DNA origami. The backbone (black/grey) is folded to design the shape of the structure 
by short staple stands (blue, orange, purple, red & green). B) Depicts how staples bind 




patterning platforms in the past (Gopinath and Rothemund, 2014, Huang et al., 2017, 
Brassat et al., 2018, Shen et al., 2018a, Huang et al., 2019). Therefore, the pointed triangle 
DNA origami design was chosen for the current investigation. The three pointed triangle 
design utilises backbone 7,249 nucleotides in length, which is derived from the 
bacteriophage m13mp18. The backbone is folded into the pointed triangle shape by 206 
staple strands with an average length of 35 nucleotides. This DNA origami design is 
particularly suitable for nanopatterning investigations due to the intrinsic design of the 
structure. DNA origami structures can aggregate at sites where folds in the backbone 
occur at the edge of the structure (Rothemund, 2006, Woo and Rothemund, 2014). The 
pointed triangle DNA origami is designed so that no folds in the backbone occur along 
the outer edges of the structure (Figure 4.2), preventing aggregation from blunt end 
Figure 4.2. Schematic design of the Pointed Triangle DNA Origami. Red x indicates 
locations where the backbone is folded. Note that backbone folds do not occur along 




stacking (Rothemund, 2006). The sequences for the backbone and all staple strands used 
in the current investigation are reported in the appendix.    
To verify the reliability of DNA origami assembly in our hands, triangular DNA origami 
were assembled and their physical dimensions were characterised using atomic force 
microscopy (AFM). Triangular DNA origami were fabricated by adding staple strands at 
a 5x excess to the backbone and then annealed from 90 °C to 20 °C over 3 hours, followed 
by spin column filtration to remove excess staples. Imaging was carried out in dry and 
fluidic conditions to verify DNA origami dimensions in different environments. High 
resolution scans confirmed that the triangular DNA origami were forming to the expected 
dimension of 127 ± 4 nm edge length in air and 128 ± 4 nm in fluid scanning (Figure 
4.3). Furthermore, cross sections of the DNA origami height demonstrate the DNA 
origami to be 1.5 – 2 nm in height. This corresponds to the diameter of a single DNA 
helix and confirm the DNA origami design. Higher scale AFM scans then confirmed that 
from 250 DNA origamis, ~95% of the structures were fully assembled. The other 5% 
Figure 4.3. AFM characterisation of sharp pointed triangle DNA origami structures 
deposited on mica. A) Schematic of the DNA origami with the predicted size of 128 
nm. DNA origami were characterised using AFM in air (B) and in liquid (D) which 
confirmed fabrication of DNA origami with the expected dimensions. Cross-sections 
also demonstrated the height of a single DNA origami to be ~1.5 nm, corresponding 




displayed strand breakages, presumably due to damage from shear forces during 
pipetting. This data is in lines with the reported performance of the pointed triangle DNA 
origami design (Rothemund, 2006) confirmed the reliable assembly of the triangular 
DNA origami for this investigation. 
4.2.2 Optimisation of DNA Origami Covalent Immobilisation: Amino 
Anchor Modification and Cross-Linking 
This investigation aims to utilise DNA origami as a functional platform to precisely 
control the properties of the ECM. Therefore, the DNA origami are required to remain 
bound to tissue culture surfaces in a range of buffers. The adsorption of DNA origami to 
silicon based surfaces is commonly achieved by divalent ions (such as MgCl) which form 
a bridge between a negatively charged surface (commonly mica or silicon) and the 
negatively charged DNA origami. This approach has been utilised for the successful 
positioning of single DNA origami in previous work (Gopinath and Rothemund, 2014, 
Brassat et al., 2018). However, washing of physiosorbed DNA origami with commonly 
used buffers, such as PBS, releases DNA origami from the surface (Gopinath and 
Rothemund, 2014). Furthermore, for use on tissue culture surfaces, DNA is required to 
remain stably bound to the surface, in solution, for long periods of time. It was therefore 
necessary to modify the DNA origami to facilitate covalent immobilisation to silicon 
surfaces such as glass. All experiments were performed on borosilicate glass coverslips 
to allow optical microscopy in later experiments. 
Covalent attachment of DNA origami to silicon substrates has previously been achieved 
through carbodiimide catalysis between amino residues on the DNA origami and a 
carboxyl silane (Gopinath and Rothemund, 2014). Therefore, DNA origami were 
modified to present 15 free adenine (poly-A) nucleotides at their 5’ ends, which were 
complementary to staple strands containing 15 thymine (poly-T) nucleotides with an 
additional amino residue at the 5’ end (hereby referred to as an amino anchor). This two-
step “sticky-end” design was chosen over a one-step (addition of an amino anchor directly 
to the original staple strand) amino modification for ease of use in future investigations 
where the amino anchor may be substituted for another functional group such as 
biotin/streptavidin.  
Modified strands were purchased from IDT and added to the backbone prior to annealing 
and the DNA origami were fabricated as described above. Glass coverslips were prepared 
by room air O2 plasma treatment (Harrick Plasma, 18W 10 minutes) and the surface was 
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silanised with 0.01% carboxyethylsilanetriol (CTES). CTES treatment forms carboxyl 
groups on the surface through which the DNA origami can be covalently cross-linked to 
the surface via EDC/NHS catalysis of the amino anchor and carboxyl silane (Figure 4.4) 
(Gopinath and Rothemund, 2014). This cross-linking reaction forms amide bonds 
between the DNA origami and the silane which remain stable in PBS (Gopinath & 
Rothemund, 2014). After silanisation, 1 nM of DNA origami was cast on the glass 
coverslips, which were then cross-linked to the surface via EDC/NHS catalysis. AFM 
characterisation of non-covalently adsorbed and covalently attached DNA origami 
confirmed that only the EDC/NHS treated DNA origami remained bound to the surface 
after overnight incubation in PBS, confirming stable cross-linking (Figure 4.4). 
The number of amino anchors required for efficient cross-linking to glass surfaces was 
initially unknown. Previous investigations have reported efficient cross-linking with 6 
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(Huang et al., 2017) and 15 amino anchors (Gopinath & Rothemund, 2014) but the effect 
of anchor number was not evaluated in either case. To test whether the number of amino 
anchors was important for cross-linking efficiency, DNA origami functionalised with 6 
or 15 amino anchors were covalently bound to glass coverslips. To remove non-
covalently attached DNA origami from the surface, samples were incubated in PBS 
overnight before being characterised with AFM. Increasing the number of amino anchors 
from 6 to 15 resulted in a significant increase in DNA origami density from 10 ± 3 / 𝜇m2 
to 16 ± 2 / 𝜇m2 Figure 4.5.  
Effective crosslinking of DNA origami to the glass surface would also be dependent upon 
the quality of surface silanisation with COOH groups, for strong adsorption to the surface 
followed by cross-linking. High quality silanisation could be achieved with longer plasma 
treatment, to generate more silanols for silanisation, of improved CTES silane treatment 
to generate sufficient COOH groups for cross-linking. The aim of this project is to 
combine DNA nanotechnology with surfaces patterned by e-beam lithography, which are 
sensitive to plasma treatment. Therefore, plasma treatment was kept the same (10 
minutes, 18W) and cross-linking of DNA origami (1 nM) with 6 or 15 amino anchors was 
compared between surfaces treated with 0.01% or 0.1% CTES. AFM characterisation 
revealed significant differences between 6 and 15 amino anchors at 0.01% CTES but not 
at 0.1% CTES. This results suggests that the quality of DNA origami cross-linking is 
improved by silanisation with 0.1% CTES treatment and that, under this condition, the 
number of amino anchors is not important for short term cross-linking. However, the 
stability of covalently attached DNA origami over long periods in solution was not tested. 
Therefore, 15 amino anchors were chosen for future investigations to maximise the 
number of anchors (there are a maximum of 15 modifications available along the inner 
Figure 4.4. Modification of DNA origami for covalent attachment to glass substrates 
and stability in tissue culture buffers (PBS). A) Schematic of amino anchor 
modifications along the inner edges. B) Schematic of covalent attachment approach. 
Surfaces are first silanised with CTES before casting DNA origami which are then 
incubated with EDC & NHS, resulting in covalent bonding of DNA origami to the 
glass. C) AFM DNA Origami adsorbed to the glass surface via MgCl are stable in 
PBS, resulting in detachment of DNA origami from the surface. D) After EDC/NHS 
mediated covalent attachment to glass, DNA origami are stable and remain bound to 
the surface after 24 hours in PBS. Scale bars in large images = 1𝜇m and 500 nm in 





edges of the DNA origami), under the assumption that more amide bonds to the surface 
results in more stable cross-linking. 
 
 
4.3 Nanoscale Patterning of DNA Origami for Large Scale 
Investigations 
For the investigation of integrin clustering on a biological level, the patterning of DNA 
origami was required on the scale of nanometres to micrometres which requires efficient 
placement of DNA origami. Lithographic techniques are often used for high precision 
patterning at the scale required for biological investigations. Here, electron-beam 
lithography (EBL) was employed to pattern silica surfaces of 1.5 mm x 1.5 mm in size to 
which the DNA origami were precisely immobilised in specific configurations.  
Figure 4.5. Optimisation of surface silanisation results in higher cross-linking yield, 
independent of the number of amino anchors. Glass surfaces were silanised with 
0.01% CTES or 0.1% CTES for 30 minutes. AFM was then used to image the DNA 
DNA origami presenting 6 or 15 amino anchors which had been cross-linked to the 
surface. The quantification displays mean ± SD DNA origami density per 𝜇m2 over 
three independent repeats. Student’s t-test, ** = p<0.01. 
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4.3.1 Fabrication of E-Beam Nanopatterned Substrates. 
To control the positioning of single DNA origami structures on tissue culture surfaces, 
EBL was employed due to its capacity for high precision surface patterning. All EBL 
work was carried out by Paul Reynolds (Gadegaard Lab, University of Glasgow). Circular 
holes (diameter = 150 nm) were patterned into a resist on a glass coverslip in 200 nm, 
300 nm or 300 ± 50 nm intervals across 1.5 mm x 1.5 mm areas, resulting in 126.56 
million or 56.25 million DNA origami bindings sites, respectively. These configurations 
were chosen to investigate the effect of ordered and disordered integrin cluster geometries 
in combination with the different peptide configurations discussed previously.  
Glass coverslips were cleaned before evaporation coating of an Hexamethyldisilazane 
(HMDS) resist followed by spin coating of a Poly(methyl methacrylate) (PMMA) resist 
and were then loaded into an EBL system (Vistec VB6 2006) for patterning. The three 
pattern configurations were each written into the resists and three, 1.5 x 1.5 mm areas 
were patterned for the 200 nm and 300 nm resists while three, 0.75 x 0.75 mm areas were 
written with the disorganised pattern (Figure 4.6). Scanning electron microscopy (SEM) 
was used to verify the EBL pattern which confirmed the size of the holes to be 150nm in 




Figure 4.6. Fabrication of the e-beam nanopatterned substrates. This work was 
carried out by Paul Reynolds (Gadegaard Lab) at the University of Glasgow. A) 
Schematic of the surface preparation and e-beam patterning process. Samples were 
shipped as seen in B, after e-beam writing. C & D) Characterisation of the surface 
features using scanning electron microscopy (SEM) of the pattern confirmed the 
holes of be 150nm in diameter at the desired spacing of 200 (SQ P200) or 300 (SQ 
P300) nm. E) Nanopatterned chips consisted of 9 patterned areas. 300 nm and 200 
nm arrays were patterned in 3 1.5 x 1.5 mm square (SQ) arrays and 300 ± 50 nm 
were patterned in  3 0.75 x 0.75 mm non-square (NSQ) arrays, as shown in SEM 





4.3.2 Optimisation Surface Activation Using O2 Plasma Etching 
To prepare the nanopatterned substrates for placement of DNA origami, the EBL pattern 
was developed using a 2:1 solution of propanol-2:methyl isobutyl ketone for 60 seconds 
at 23 °C (Gopinath and Rothemund, 2014). This removes un-crosslinked PMMA from 
the holes and exposes the underlying HMDS passivation layer. As previously stated, 
surface silanisation is critical for DNA origami cross-linking. The ideal tool for etching 
the HMDS from the bottom of the holes and generating silanol [OH-] groups for CTES 
silanisation would have been reactive ion etching (RIE) (Gopinath and Rothemund, 2014, 
Gopinath et al., 2016, Shen et al., 2018a). This generates a unidirectional flow of highly 
charged ions towards the surface of the pattern, at an angle perpendicular to the surface, 
etching the surface. Importantly, the HMDS would be etched from the bottom of the holes 
and silanols would be generated in a highly efficient way, without widening the holes 
themselves. However, RIE equipment was not available at King’s College or QMUL. The 
London Centre for Nanotechnology own an RIE chamber but the time of investigation, 
the centre were not allowing the use of glass substrates. Therefore, the etching procedure 
was optimised using an O2 plasma chamber (Henniker HPT-200). This generates an 
isotropic field of reactive ions which rapidly widens the holes while etching the surface 
at the bottom.  
At a power of 100 W, O2 plasma etching was optimised to achieve maximum etching of 
glass surfaces at the bottom of the nanopatterned holes without widening their diameter 
beyond 150nm. Etching time was critical to ensure sufficient silanol generation on the 
underlying  glass and the extent of etching was evaluated using AFM by monitoring the 
width of the patterned holes. The results from etching experiments can be seen in Figure 
4.7. As etching time increased, the bottom of the holes became flatter and wider and the 
three patterns were etched at different rates. After 70 seconds, the diameter of the holes 
on the 200 nm, 300 nm and 300 ± 50 nm configurations were (mean ±SD)  153 ± 6 nm, 
131 ± 7 nm and 70 ± 28 nm, respectively. On the ordered patterns, etching was faster 
and more homogenous compared to the disordered array where etching was highly 
variable, suggesting inconsistent silanol generation on the underlying glass.  
While feature width was limited to a maximum of 150 nm and under the optimised 
conditions, the HMDS was cleared from the holes, the quality of silanol generation or 
silanisation cannot be directly measured. The quality of silanisation is believed to be key 
to the quality of DNA origami positioning on the nanopattern and as such, it is also 
believed to be the reason for differences in the DNA origami placement conditions 
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4.3.3 Optimisation of Resist Lift-Off 
To ensure a flat surface with no topological effects of the surface on cell adhesion, it was 
important to achieve sufficient lift-off of the PMMA resist, without damaging the 
underlying pattern in the HMDS passivation layer. The first approach to be tested was an 
overnight incubation in acetone at room temperature (Palma et al., 2011). Surface 
characterisation with AFM demonstrated that only a partial lift-off was achieved. 
Residues of PMMA and aluminium remained on the surface of the pattern, as shown by 
the large white (high) features in Figure 4.8. Lift-off was then attempted by a 20 minute 
soak in N-Methyl-2-pyrrolidone (NMP) at 50 oC (Gopinath and Rothemund, 2014) but 
again large residues of PMMA and aluminium remained on the surface. The best results 
were observed by soaking coverslips in NMP at 50 oC for 10 minutes followed by 10 
minutes of sonication in NMP at 50 oC . The PMMA resist was fully removed while 
maintaining the HMDS pattern for DNA origami placement (Figure 4.8). 
 
4.3.4 Optimisation of DNA Origami Placement on EBL Nanopatterns 
This platform was implemented to fabricate ECM mimicking cell culture surfaces with 
precise ligand concentration, spacing and stoichiometry. To stably cross-link DNA 
origami to the surface, a two-step approach was used. Firstly, DNA origami were cast 
Figure 4.7. Optimisation of nanopattern O2 plasma etching to achieve sufficient 
clearing of residual PMMA and HMDS form the bottom of the holes. 300 nm (A), 200 
nm (B) and 300 ± 50 nm nanopatterns were etched with O2 plasma from room air (21 
%) for 30 – 70 seconds. AFM characterisation of the nanopattern with progressive 
etching revealed that the PMMA was being etched in both the x, y and z directions as 
demonstrated by widening of features and decreasing thickness of the PMMA resist. 
Etching time was optimised to achieve maximum clearing of the holes to allow 
maximum silanol generation within. The maximum hole diameter was set at 150nm to 
ensure each hole could only fit a single DNA origami. After 70s etching time, the mean 
±	SD hole diameter was 153 ± 6 nm, 131 ± 7 nm and 70 ± 28 nm for 200 nm, 300 nm 
and 300 ± 50 nm arrays, respectively. Grey bars indicate the trace for the cross-





onto the surface which was subsequently washed to remove excess DNA origami. 
Secondly, the DNA origami were incubated with EDC and NHS to form amide bonds 
between the amino anchors and the carboxyl silane (Gopinath and Rothemund, 2014). It 
was therefore essential to validate the casting conditions to the nanopattern. Substrates 
with 200nm and 300nm nanopatterns were fabricated, developed and etched via the 
optimised approach, described above, and DNA origami were cast onto the silinised 
surface. Previous reports (Gopinath and Rothemund, 2014) have reported the optimum 
placement conditions to be 110 pM DNA origami in 5 mM Tris and 12.5 mM MgCl at 
pH 8.3 and an incubation of 1 hour at room temperature, which was used as a starting 
point for comparative analysis. Results from the optimisation of placement conditions can 
be seen in Figure 4.9. 
The initial placement conditions resulted in a yield of 15 % and 28 % for the 200 nm and 
300 nm patterns (respectively) and therefore placement conditions were optimised for the 
current investigation. Both the DNA origami and MgCl concentration were optimised to 
achieve high pattern occupancy. Increasing DNA origami concentration results in an 
increased probability of DNA origami binding events while increased MgCl results in 
stronger binding of DNA origami to the pattern. Keeping the MgCl concentration at 12.5 
mM but increasing the DNA origami concentration to 250 pM and 500 pM results in 
small increases in placement yield to 39 % and 44 % for 200 nm and 300 nm arrays, 
respectively. This data confirms that isotropic O2 plasma etching results in poor surface 
activation and while DNA origami are binding to the pattern, higher concentration of 
Figure 4.8. Examples of the poor  resist lift-off achieved via an overnight soak in 
acetone compared to a good lift-off achieved by a 10 minutes soak in NMP followed 
by 10 minutes sonication in NMP at 50°C. 
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Mg2+ ions are required to prevent unbinding. Increases in both DNA origami and MgCl 
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concentration were required to achieve 100% binding site occupancy on both nanopattern 
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configurations and optimum conditions were confirmed to be 500 pM DNA origami and 
50 mM MgCl in 5 mM Tris at pH 8.3. 
 
4.3.5 Covalent Cross-linking of DNA Origami to EBL Nanopatterns 
The placement of DNA origami to the nanopatterned holes is dependent upon the 
presence of magnesium ions in the solution to provide a divalent bridge between the 
negatively charged silane and the negatively charged DNA. In the presence of many 
buffers used for tissue culture, such as PBS, DNA origami will detach form the pattern 
(Gopinath and Rothemund, 2014). Covalently cross-linking the patterned DNA origami 
to the substrate was essential to ensure the stability and reliability through several buffer 
washes and long term incubation and culture. After placement in optimised conditions, 
DNA origami were cross-linked to the glass surface via the amino modification and the 
carboxyl silane using an EDC/NHS reaction under the previously described optimum 
reaction conditions. Following overnight incubation in PBS to remove non-covalently 
bound DNA origami, AFM characterisation confirmed a high yield of cross-linking of 
without the loss of DNA origami from the nanopattern (Figure 4.10). Furthermore, this 
data confirms the stability of the nanopatterned DNA origami independent of Mg ion 
binding.  
AFM characterisation of nanopatterned DNA origami revealed a discontinuous 
background coating of HMDS consisting of tightly packed dots, suggesting that the 
HMDS deposition was insufficient to achieve a smooth monolayer. Features were often 
higher than the DNA origami and the surface roughness (Rq) was, therefore, calculated 
to see if this could induce artefacts in in the cell culture assay. The EBL substrates 
Figure 4.9. AFM characterisation of DNA origami adsorption to the nanopattern 
for optimisation of DNA origami placement conditions on 200 nm (A) and 300 nm 
(B) patterns. After optimum etching, DNA origami were incubated on the pattern for 
1 hour at room temperature at three different concentrations in Tris buffer with 
different MgCl concentration. Both DNA origami and MgCl concentration was 
important for achieving a 100% placement efficiency and the optimum conditions 
were identified to be 500 pM DNA origami in 5 mM Tris buffer containing 50 mM 
MgCl. Scale bars = 200 nm. 
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exhibited Rq values of 0.7 ± 0.1 nm  which is not deemed sufficient to affect cell adhesion 
via topological effects. 
4.3.6 Drying of DNA Origami Nanopatterned Arrays for Long Term 
Storage 
The successful fabrication of the pattern and covalent immobilisation of DNA origami is 
a complex and time consuming procedure. It would have, therefore, been advantageous 
to prepare the patterns in advance of the experiment and store them in a stable condition, 
ready for future use. Others (Gopinath and Rothemund, 2014, Gopinath et al., 2016, Shen 
et al., 2018b) have shown washing the substrates with ethanol solutions of increasing 
concentration and air drying enables stable storage at room temperature for up to 12 
months.  
Figure 4.10. Verification of covalent bonding of DNA origami to the 
nanopattern and stability of patterned DNA origami in PBS. DNA origami 
were cast in the optimised conditions (500 pM DNA origami, 5 mM Tris, 50 
mM MgCl) and bound to the surface via EDC/NHS catalysis of amino 
anchors and incubated in PBS overnight. AFM was used to characterise the 
patterned DNA origami and confirm successful patterning of DNA origami 
in 200 nm and 300 nm square arrays. Modified from Hawkes et al. (2019) 
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Nanopatterned DNA origami arrays were sequentially submerged in solutions containing 
50 %, 75 %, 85 % and 95 % ethanol for 10, 15, 30 and 60 seconds respectively before 
blow drying. AFM was used to characterise the quality of the drying. Although many 
good quality DNA origami were observed, a large number of DNA origami were 
deformed and exhibited streaking and aggregation of (presumably) salts (Figure 4.11). To 
avoid streaking, samples were left to air dry and while no streaks were observed, a large 
aggregation of salts to the holes were observed and DNA origami appeared highly 
distorted. Different washing steps and ethanol drying times were attempted with the same 
result. As the quality of the DNA origami in the dried arrays is not guaranteed, it was 
decided that the nanopatterned arrays would have to be made fresh for each experiment 
and used immediately to ensure reliability of the platform.  
 
Figure 4.11. Drying of nanopatterned DNA origami covalently bound to the pattern. 
Samples were serially dipped in ethanol solutions of increasing strength before being  
blow dried (A) or air dried (B). Blow drying resulted in streaking of DNA origami 
while air drying resulted in aggregation of salts to the patterned features and balling 
up of DNA origami. Both phenomena are thought to occur due to capillary action 




4.4 Peptide Modification of DNA Origami 
This chapter has so far demonstrated that DNA origami can be selectively patterned and 
cross-linked to a substrate in stable configurations, with a precision of ~200 nm. In order 
to achieve control of integrin clustering with the required  resolution of  < 60 nm (Arnold 
et al., 2004), the DNA origami design was modified to present integrin selective peptides 
at intervals of 20 – 60 nm. In order to achieve this, specific staple strands along the outer 
edge of the DNA origami design were extended to present a “sticky end” sequence 
(AGTTGTGGATCCTACT). Sticky ends were designed to be complimentary to a single 
strand of ssDNA conjugated to a peptide of choice Figure 4.12.  
4.5 Peptides 
A primary aim of the current investigation was to analyse the integrin clustering and 
signalling properties of fibronectin and laminin binding integrins in cardiomyocytes. It 
was therefore necessary to choose peptides that possess a high affinity towards the 
fibronectin and laminin binding integrins expressed in cardiomyocytes, which are 
predominantly a5b1 and a7b1 subtypes, respectively. The primary adhesion site for 
integrins on fibronectin is the tripeptide sequences, RGD. This sequence is located on the 
10th repeat of FN-III domain. The cyclic RGD peptide (cRGD) has been reported to bind 
a5b1 integrins with high affinity (Pfaff et al., 1994, Kapp et al., 2017). Furthermore, 
cRGD peptides have been extensively utilised in previous nanopatterning work to 
investigate the integrin clustering dynamics of cells, such as fibroblasts, that express the 
fibronectin binding avb3 and a5b1 subtypes (Arnold et al., 2004, Cavalcanti-Adam et 
al., 2007, Schvartzman et al., 2011). Within cardiomyocytes, RGD peptides have been 
utilised with varying degrees of success and certain linear RGD have exhibited poor cell 
Figure 4.12. Sticky end modification for DNA origami for peptide functionalisation. 
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adhesion and spreading (Boateng et al., 2005, LaNasa and Bryant, 2009).  For this reason, 
we also sought to utilise cRGD peptides to recruit the fibronectin binding integrins 
expressed in cardiomyocytes. For conjugation to ssDNA, we also required our peptide of 
choice to contain a cysteine residue to permit thiol-ene reactions have which been highly 
successful in mediating conjugated products in previous work (Lowe, 2010). Therefore, 
we utilised the cyclic RDGfC (cRGDfC) peptide for this investigation (cyclo [Arg-Gly-
Asp-D-Phe-Lys(Cys)]. 
Neonatal cardiomyocytes express the a7X2b1 and a6b1integrin subtypes which strongly 
bind to the laminin a1 chain (Nishiuchi et al., 2006, Brancaccio et al., 1998, Maitra et al., 
2000). The primary integrin binding motif on the laminin a1 chain is the sequence 
IKVAV, which is located at the C-terminal end of the chain (Patel et al., 2019). 
Investigations using IKVAV peptides has been primarily focussed on neuron tissue and 
investigations in cardiomyocytes have not yet been carried out. Therefore, information 
on the affinity for laminin binding integrins for IKVAV peptides is currently unavailable. 
Therefore, we utilised an 18 amino acid laminin A chain peptide with a cysteine residue 
at the N-terminal (Cys-Ser-Arg-Ala-Arg-Lys-Gln-Ala-Ala-Ser-Ile-Lys-Val-Ala-Val-
Ser-Ala-Asp-Arg), hereby referred to as the IKVAV peptide. This sequence has been 
previously reported to support cell adhesion and migration of neuronal cells in addition 
to promoting malignant behaviours in cancer cells (Sephel et al., 1989, Tashiro et al., 
1989, Kikkawa et al., 2013). 
4.5.1 Peptide conjugation 
A significant challenge during this project has been to produce peptide conjugates in a 
sufficient quantity for addition to the annealing mixture, at an excess necessary to achieve 
efficient labelling of DNA origami structures. For example, Rothemund (2006) 
demonstrated that staples need to be added at a 5x excess concentration to that of the 
backbone. Therefore, peptide-ssDNA conjugates are required to added at a 5x excess to 
the concentration of sticky ends. For example, using the backbone at 40 nM requires 200 
nM of  staple strands /sticky ends, which 1 µM of peptide-ssDNA conjugates per each 
sticky end included within the design. Therefore, it was necessary to implement a 




4.5.1.1 Maleimide Conjugation 
Previous work from the Palma lab has demonstrated that a thiol-ene reaction between 
ssDNA modified with a maleimide and a thiol group (cysteine) on a peptide (Figure 4.13), 
can be achieved with yields of 63% (Huang et al., 2019). Thiol-ene reactions occur via 
hydrothiolation of carbon-carbon (ene) bonds and have been recognised for their “click” 
like properties, in enabling modular reaction with many reagents, under mild conditions 
(Lowe, 2010). We therefore sought to replicate this reaction chemistry with the RGDfC 
and IKVAV peptides and ssDNA modified with a maleimide group (Figure 10A). The 
maleimide-ssDNA was deprotected using toluene washing and evaporation and then 
incubated with the peptide for 30-60 minutes (Huang et al., 2019). However, Reverse-
Phase High Performance Liquid Chromatography (RP-HPLC) was unable to observe an 
emergence of a second peak, or a change in the column retention time was the 
unconjugated ssDNA  (Figure 4.13). Therefore, it appeared that in this case, the 
maleimide-ssDNA reaction was unsuccessful. The reason for this is currently unclear but 
it may be, in part, due to low reactivity of the maleimide ene group compared to other 
Figure 4.13. Maleimide Conjugation. A) Schematic of the maleimide-thiol 
conjugation. Peptides and maleimide-ssDNA are incubated together for 60 
minutes in PBS. B) RP-HPLC validation of unsuccessful conjugation showing no 
change in unconjugated DNA peak and no emergence of a new conjugate peak. 
Modified from Hawkes et al. (2019). 
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ene-presenting molecules and the absence of a radical catalyst in the reaction which is 
often used for thiol-ene reactions (Lowe, 2010). 
 
4.5.1.2 Acrydite Conjugation 
The second conjugation approach utilised a UV mediated thiol-ene reaction (Figure 10C) 
between the peptides and acrydite modified ssDNA (Torres-Kolbus et al., 2014). The 
reaction occurs via an alkene group on the acrydite which demonstrates greater reactivity 
with thiols compared to maleimide. RGDfC peptide were firstly incubated with TCEP to 
reduce disulphide bonds and make the thiol groups available for conjugation. RGDfC 
peptides were then incubated with the acrydite modified ssDNA in the presence of the 
photoinitiator 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (which acts as a 
radical catalyst for the reaction) and exposed to 260 nm UV light for 5-20 minutes. RP-
HPLC (260 nm absorption spectra) verified successful conjugation between cRGDfC and 
the ssDNA via the emergence of a new peak, which increased in magnitude with 
increasing reaction time, and a decrease in the intensity of the unconjugated ssDNA peak 
(Figure 4.14). Neither the RGD or IKVAV peptides had a specific absorption peak at 260 
nm and therefore only the DNA would be detected. Furthermore, samples were filtered 
with a 3 kDa spin column to remove unconjugated peptides and the photoinitiator, leaving 
only the conjugated and unconjugated DNA products. Control experiments of the reaction 
mix without UV exposure, the reaction mix without the peptides but with UV exposure 
or the reaction mix without the ssDNA did not show the emergence of any additional 
peaks, suggesting that this emerging peak is the conjugated product. The successful 
conjugation was then confirmed for the IKVAV peptide (Figure 4.14). Peptide-ssDNA 
conjugates were purified using HPLC to collect only the conjugate peak and remove 
unconjugated ssDNA from the solution. Purified samples were freeze dried to remove 
solvents used in HPLC and samples were resuspended in H2O. Additional validation of 
the experiment and quantification of the yield was obtained using a microvolume 
spectrophotometer (see methods). 
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4.5.2 Verifying the Efficient Functionalisation of DNA origami via Sticky-
End Strands 
Before annealing, peptide conjugates were added to the origami solution at a 10 X excess 
to the amount of sticky-ends available on each design. To verify if a 10X excess was 
sufficient to functionalise the DNA origami with high efficiency and to validate the 
sticky-end approach, DNA origami were labelled with fluorescent peptide conjugates for 
Figure 4.14. Acrydite conjugation. A. Schematic of the acrydite-thiol conjugation. B) 
HPLC analysis of successful conjugation between RGDfC and ssDNA, as evidenced by 
the decrease in the magnitude of unconjugated ssDNA relative to an increase in 
magnitude of an emerging peak. C) HPLC traces from 35B plotted relative to one 
another. Peaks have been shifted to the right for easier comparison. D) HPLC analysis 




photobleaching experiments. To achieve this, ssDNA (complimentary to sticky-ends) 
modified with Alexa-647 fluorophore were purchased from IDT and hybridised to DNA 
origami presenting 6, 12 or 18 sticky ends (Figure 12 A). To evaluate the number of 
fluorophores present on the 6, 12 and 18 designs, labelled DNA origami were cast at low 
density onto glass bottomed dishes and loaded into a confocal microscope (Zeiss Elyra) 
for photobleaching experiments using a 100X objective. The number of fluorescent 
probes on an individual origami was calculated by the total signal at the start of bleaching 
(minus the baseline) divided by the average signal drop of one bleaching event. The 
average loss of signal from 1 bleaching event was calculated from 50 observations of 
DNA origami presenting 6 fluorophores. The results found an average of 6.1 ± 1.4, 11.0 
±  2.2 and 19.0 ±  2.6 bleaching events for the 6, 12 and 18 fluorophore designs 
respectively (Figure 12). This result suggests that efficient functionalisation of DNA 




4.5.3 Verifying Functionalisation of DNA Origami with Conjugated 
Products 
4.5.3.1 Verification of cell adhesion and spreading on randomly positioned DNA 
Origami 
Prior to carrying out investigations with the EBL nanopatterning platform, it was 
necessary to validate the RGD and IKVAV functionalised DNA origami for cell adhesion 
studies.  For initial validation, readily available mouse embryonic fibroblasts (MEF) were 
used to prevent the unnecessary wastage of primary cells and EBL substrates. These cells 
express avb3 integrin subtypes which demonstrate a high affinity for the RGDfC peptides 
utilised here (Kapp et al., 2017). Initial validation studies were carried out using DNA 
origami which were cast randomly on glass coverslips; this approach was also chosen as 
randomly positioned origami arrays can be readily produced, making them suitable for 
any necessary optimisation. 
DNA origami were fabricated with 0, 6, 12 or 18 RGDfC peptides for initial studies. As 
a starting point, origami functionalised with 6xRGDfC peptides were chosen to achieve 
an inter-ligand spacing of ~ 65 nm which is known to be the minimum required for 
efficient cell spreading (Arnold et al., 2004, Cavalcanti-Adam et al., 2007). 16 mm glass 
coverslips were prepared and silanised with carboxyethylsilanetriol (CTES) (-COOH) 
and DNA origami were cast randomly onto the surface at a concentration of 2 nM, 
achieving an average density of 10 ± 3 origami per µm2, which was similar to the 
nanopattern. DNA origami were covalently cross-linked to substrates using EDC / NHS 
catalysis and the surface was blocked against non-specific adhesion using 5% bovine 
serum albumin (BSA). MEF cells were allowed to spread on the random origami 
Figure 4.15. Validation of the peptide attachment approach using photobleaching of 
DNA origami labelled with Alexa-647 fluorophores. A) DNA origami were labelled with 
6, 12 or 18 Alexa-647 fluorophores and cast onto glass bottomed dishes, loaded onto a 
confocal microscope and photobleached. B) A histogram of the number of bleaching 
events revealed an average of 6, 11 and 19 fluorophores in the 6, 12 and 18 fluorophore 
conditions. Bleaching events were counted by calculating the difference between the 
maximum signal and the background baseline by the average signal decrease from 1 
bleaching event. N = 50 DNA origami per condition. The average signal decrease from 




substrates for 90 minutes, in serum free medium. After fixation, the degree of cell 
spreading was quantified by visualising F-actin and calculating cell area.  
Initial findings revealed that cells were attaching and spreading on 0 peptide controls 
substrates, indicating a large amount of non-specific adhesion (Figure 4.16B). To improve 
background passivation and prevent non-specific adhesion,  methoxypolyethylene glycol 
amine (mPEG) was covalently cross-linked to the background using an EDC/NHS 
reaction to couple the amine group of the mPEG to the COOH silane (Figure 4.16C). 
Individual PEG molecules group together on the surface to form polymer brushes that 
effectively block against non-specific adhesion while exhibiting low cytotoxicity (Cai & 
Wind, 2016).  Surface passivation took place after covalent cross-linking of the DNA 
origami to the surface. With mPEG surface passivation, non-specific adhesion to control 
substrates was dramatically reduced (Figure 4.16). 
The experiment was then repeated, with mPEG passivation, using randomly cast origami 
presenting 6 peptides, achieving a mean ± SD density of ~60 ± 18 ligands per µm2. 
Compared to controls, Cells showed clear signs of spreading and rigidity sensing such as 
the formation of lamellipodia and the assembly of stress fibres. Furthermore, the addition 
of 12 or 18 RGDfC peptides to the origami (~120 ± 36 and 120 ± 54 ligands per µm2 
respectively) resulted in an additional, significant, increase in cell spreading compared to 
6 RGDfC (Figure 4.16). These results demonstrate that the RGDfC functionalised DNA 
origami can successfully mediate cell spreading, with low non-specific adhesion. 
Furthermore, additional increases in spreading on 12 and 18 peptides also provides further 




4.5.3.2 Verification of Peptide Functionalisation on Nanopatterned DNA Origami  
To verify the successful functionalisation of DNA origami structures with conjugated 
products, the acrydite peptide conjugation approach was extended to fluorescently 
labelled peptides. RGDfC peptides labelled with an Alexa-647 dye were purchased and 
conjugated to acrydite modified ssDNA. Alexa-647 dyes were chosen to minimise 
photobleaching from the UV light and the duration of the reaction was also minimised 
and. TCEP concentration was also reduced from 100X to 20X as this reagent been 
suggested to accelerate photobleaching (Tyagarajan et al., 2003). 647-cRGDf ssDNA 
conjugates were verified and purified using HPLC and DNA origami were then 
functionalised with 12 fluorescent peptide conjugates and cross-linked onto EBL 
Figure 4.16. Optimisation of blocking conditions using mouse embryonic fibroblasts 
cultured on random DNA origami arrays. A) mPEG was required to prevent non-specific 
adhesion to the background on DNA origami functionalised with 0, 6, 12 or 18 RGDfC. 
B) Quantification of spreading my measuring cell area, data from three independent 
repeats, One-way ANOVA with Tukey correction for multiple comparisons, ** = p<0.01, 
**** = p<0.0001. C) Schematic of mPEG passivation and covalent immobilisation of 
DNA origami. D) Representative AFM image of randomly positioned DNA origami. N = 
> 100 cells per condition. 
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nanopatterned substrates under optimised conditions. Furthermore, to further verify 
successful origami cross-linking and functionalisation with fluorescent peptides, and 
MEF cells were cultured on the substrates for 1 hour. Fluorescent signal was observed 
from the patterned areas (Figure 11 C) but the signal was very low due to photobleaching 
during peptide conjugation. However, cells attached and spread over the nanopatterned 
areas and had significantly greater cell area compared to cells that remained attached to 
the background after fixation (Figure 11 D). This confirms successful conjugation, 
origami functionalisation and nanopatterning but due to significant photobleaching, even 
under optimised conditions, we were unable to quantify the efficiency of origami 






Figure 4.17. Functionalisation of DNA origami with 12 x Alexa 647-RGDfC peptides. 
Fluorescent peptides were conjugated to acrydte modified ssDNA and DNA origami 
functionalised with fluorescent RGDfC were fabricated (A). Fluorescent 
functionalised DNA origami were cross-linked to the nanopattern and mouse 
embryonic fibroblasts were cultured on the nanopattern for 1 hour before fixation. 
Cell area was quantified with phase contrast microscopy (B) and fluoescent 
nanopatternred DNA origami were visualised with an epifluorescence microscope 
(C). Cells spread more on the 12xAlexa647-RGDfC nanopattern than on the 
background (D). Student’s t-test. Red line in B indicates the edge of the nanopattern. 
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4.5.3.3 Verification of Nanopatterned DNA Origami Arrays – Recapitulation of 
Previous Literature 
The results from the previous chapter show that by combining e-beam lithography and 
DNA origami, we can fabricate ECM mimicking substrates with precise control over the 
concentration, composition and geometry of ligands in the ECM. However, this platform 
has not yet been validated against other ligand nanopatterning platforms reported in the 
literature. 
The vast majority of the previous work on single molecule ligand nanopatterning 
platforms was carried out with cells expressing avb3 integrin subtypes (Arnold et al., 
2004, Cavalcanti-Adam et al., 2007, Huang et al., 2009). These investigations reported 
that cells will only spread on cyclic RGD peptides when individual integrins are clustered 
<60 nm apart. Furthermore, studies investigating the effect of ligand geometry also 
reported that clusters of 4 or more ligands can be spaced 200 – 300 nm apart, with 
negligible effects on cell spreading (Schvartzman et al., 2011).  In the light of this 
previous work, it was important to test the performance of the origami platform in a 
similar cell type. Mouse embryonic fibroblasts (MEFs) express avb3 integrin subtypes 
which have a high affinity for the RGDfC peptide (Kapp et al., 2017), and were therefore 
employed for initial investigations.  
Previous work has demonstrated that adequate integrin clustering facilitates spreading 
and stable adhesion formation via the ability to exert traction forces through adhesions 
(Liu et al., 2014). To investigate whether increased integrin clustering would also result 
in increased adhesion forces, RPTP𝛼(+/+) MEFs were transiently transfected with a talin 
molecular tension sensor (Talin TS). This tension sensor contains an insert between the 
talin head and tail domains, which consists of two fluorophores connected via a flexible 
linker. The fluorophores undergo Forster Resonance Energy Transfer in absence of force 
(FRET). Talin provides the mechanical link between integrin b1 tails and actin, loading 
of talin during rigidity sensing stretches the flexible linker and pulls the two fluorophores 
apart, decreasing FRET. With increasing tension, the two fluorophores are pulled further 
apart, enabling direct evaluation of the molecular tension, of up to 5 pN, across talin at 
focal adhesions, via changes in FRET efficiency (Austen et al., 2015). These cells were 
also homozygous negative for talin (talin1 and 2, talin DKO), enabling direct evaluation 
of talin tension without artefact introduced by endogenous talin. Due to equipment 
problems, however, it was not possible to carry out the appropriate data collection of the 
FRET tension sensor at this time. However, the primary aim of this experiment was to 
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validate the integrin clustering and cell spreading behaviours of fibroblasts on the DNA 
origami ligand nanopatterning platform. This could still be achieved via the quantification 
of cell area and cell spreading. Molecular tension of talin as a consequence of integrin 
clustering will be analysed and presented elsewhere in future investigations. 
The DNA origami nanopattern was evaluated against findings from other ligand 
nanopatterning platforms. Firstly, ligand spacing of <60 nm is required to initiate cell 
spreading (Cavalcanti-Adam et al., 2007) via the adequate distribution of force across an 
appropriate number of integrins, on rigid substrates (Huang et al., 2009, Oria et al., 2017). 
Secondly, efficient cell spreading is unaffected when individual clusters are spaced at 200 
or 300 nm intervals (Schvartzman et al., 2012).  Origami nanopatterns were therefore 
fabricated with 3, 6 or 12 RGDfC peptides ( ~130, ~60 and ~30 nm spacing, respectively), 
with inter cluster spacing of 200nm or 300nm, to test whether previous findings could be 
recapitulated here. All results from this experiment can be seen in Figure 4.18. 
Talin DKO MEFs transiently transfected with talin TS were seeded at a concentration of 
10,000 cells/ml on the nanopattern and cultured for 1.5 hours before fixation for analysis 
of cell attachment and spreading. On 0 peptide controls, a small number of cells adhered 
to the nanopattern (mean ± SD, 6 ± 5 % and 8 ± 5 % on 200 and 300 nm arrays), but were 
unable to spread (Cells were defined as spread if lamellipodial protrusions could be 
observed.) The cells on control substrates were rounded up and very small in size (86 ± 
54 µm2 and 129 ±42 µm2, on 200 and 300 nm arrays, respectively), demonstrating that 
the array does not mediate non-specific cell spreading in a meaningful way.  
The addition of 3, 6 or 12 peptides to the nanopattern resulted in dramatic increases in 
cell spreading. With 3 x RGDfC peptides (~130nm spacing), an increase in the number 
of spread cells (34 ± 12 % and 31 ± 12 % of cells were spread on 200 and 300nm arrays, 
respectively) and cell area (213 ± 60 µm2  and 181 ± 54 µm2 on 200 & 300 nm arrays, 
respectively) was observed (Figure 4.18). With 6 x RGDfC per origami, achieving the 60 
nm spacing threshold, a further increase in cell spreading (61 ± 9 % and 58 ± 8 % cells 
spread on 200 nm and 300 nm arrays, respectively) and cell area (428 ± 150 µm2 and 385 
± 119  µm2  for the 200 nm and 300 nm arrays, respectively) was observed (Figure 4.18). 
In this condition, cells exhibited a stronger spreading phenotype, forming larger 
lamellipodial protrusions. Further increasing the number of peptides per origami to 12 
(~30 nm spacing), did not result in a meaningful increase in the cell spreading (66.5 ± 8 
% and 66.8 ± 11 % of cells were spread on 200 & 300 nm arrays, respectively) or area 
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(462 ± 172 µm2 and 525 ± 229 µm2 on 200 & 300 nm arrays, respectively), compared to 
6 RGDfC.  
Talin DKO MEFs without the transfected talin TS are a nonadherent cell line. The degree 
of cell attachment and spreading on the nanopattern would, therefore, be dependent upon 
the efficiency the transfection and corresponding expression of the construct. To check if 
the results of this experiment were confounded by transfection efficiency, all cells used 
during this experiment were transfected in the same T25 flask. Nevertheless, the degree 
of transfection efficiency between individual cells within the same flask will vary on a 
cell to cell basis. To check whether the differences observed in spreading on 3, 6 or 12 
RGDfC peptide arrays were due to the different peptide configurations and not due to 
differences in transfection efficiency, the GFP signal intensity of the talin tension sensor 
was plotted against cell area. Figure 4.18D shows a linear relationship between talin TS 
expression (GFP Intensity) and cell area, demonstrating that the degree of cell spreading 
is dependent upon transfection efficiency, as expected. However, increasing the number 
of peptides (especially from 3 to 6, or 3 to 12) results in an additional increase in cell area, 
demonstrating an additional effect of peptide clustering on cell spreading.  
These results demonstrate that using the origami nanopattern, we can recapitulate the 60 
nm ligand threshold observed in avb3 integrin rich cells from other ligand nanopatterning 
platforms (Arnold et al., 2004, Cavalcanti-Adam et al., 2007, Huang et al., 2009, Oria et 
al., 2017). Furthermore, consistent with observations by others (Schvartzman et al., 2011) 
no significant differences in adhesion and spreading were observed between the 200 nm 











In summary, this chapter presented the fabrication and optimisation of a DNA origami, 
single molecule nanopatterning platform. By combining DNA origami with EBL, a 
powerful tool for the investigation of integrin signalling, in any cell type, has been 
presented. Millions of functional DNA origami nanostructures can be selectively 
positioned with high at a resolution of 300 nm or 200 nm. Furthermore, single molecule 
functionalisation of the origami nanoarray enables quantitative evaluation got the integrin 
clustering requirement of fibronectin an laminin integrin subtypes. This approach 
provides absolute control over the composition, concentration and geometry of integrin 
specific ligands to compare and contrast the clustering requirements, of different integrin 
subtypes, for the initiation of rigidity sensing and cell spreading. Specifically, this 
platform has been designed to investigate the integrin clustering dynamics of 
cardiomyocytes expressing fibronectin and laminin bindings integrin subtypes. The 
following chapter will present and discuss findings from the use of this platform to 
investigate the clustering and downstream signalling consequences of different integrin 
subtypes in cardiomyocytes. 
Lithographic nanopatterning of DNA origami was originally pioneered by the Rothemund 
lab, who have clearly demonstrated the ability to position individual DNA nanostructures 
in arbitrary and precise configurations (Kershner et al., 2009, Gopinath and Rothemund, 
2014, Gopinath et al., 2016). Specifically, Kershner et al. (2009) were the first to 
demonstrate that the pointed triangle design DNA origami could be selectively positioned 
Figure 4.18. Validation of the DNA origami nanopatterning platform using talin 
double knock-out MEFs, transiently expressed with a talin tension sensor. A) 
representative images of cells spread on the different nanopattern configurations. B) 
Quantitative measurement of cell area. C) Quantitative evaluation of the number of 
spread cells. Cells were deemed to be spread or spreading if stable lamellipodial 
protrusions could be observed. D) Plot of talin TS expression (quantified by GFP 
intensity) against cell area to demonstrate effects of the nanopattern, independent from 
effects of transfection efficiency. 
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on lithographically nanopatterned surfaces, with relatively precise control over the 
orientation of individual DNA origami’s. Gopinath and Rothemund (2014) took this work 
a step further by characterising the adsorption and immobilisation characteristics of the 
pointed triangle DNA origami, on lithographically nanopatterned surfaces. The 
Rothemund group has gone on to replicate their own work in subsequent publications 
(Gopinath et al., 2016) which has been replicated in this thesis. The current investigation, 
through a collaboration with the Gadegaard lab, has successfully demonstrated the ability 
fabricate lithographically nanopatterned DNA origami. However, the current 
investigation was unable to replicate previous work, under the same conditions, during 
the placement of DNA origami demonstrating the precarious nature of DNA origami 
nanopatterning. This was believed to be primarily due to differences in the surface 
silanisation used here, while others have also demonstrated vastly different origami 
placement conditions on nanopatterns of similar dimensions (Brassat et al., 2018, 
Gopinath and Rothemund, 2014, Huang et al., 2019). These contrasting reports highlight 
a potential issue with reproducibility of these nanoscale designs between laboratories and 
should be carefully considered when interpreting these findings. These considerations are 
especially important when DNA origami is being considered in the manufacturing of 
nanoscale plasmonic (Gopinath et al., 2016) or photoelectric (Huang et al., 2017) devices.  
While the Rothemund group have been pioneers in developing and expanding 
lithographic DNA origami nanopatterning methodologies, the Palma group have brought 
this approach into the ligand nanopatterning and cell receptor signalling domain by 
utilising the versatility of DNA origami with DNA-peptide conjugation strategies. 
Previous work from the lab has demonstrated the synergistic roles of integrins and 
endothelial growth factor receptors in the spreading and adhesion of cancer cells (Huang 
et al., 2019). This thesis has advanced the previous work of the Palma lab by extending 
the design of the pointed triangle DNA origami to accommodate up to 18 peptides, 
achieving an inter-peptides spacing of  <20 nm. Furthermore, the successful covalent  
nanopatterning of the 3, 6, 12 and 18 peptides designs has brought the capabilities of this 
technology in line with the capabilities of other ligand nanopatterning technologies such 
as the gold nano-island platform pioneered by Jochim Spatz (Arnold et al., 2004, 
Cavalcanti-Adam et al., 2007, Arnold et al., 2009, Huang et al., 2009, Rahmouni et al., 
2013, Liu et al., 2014, Guasch et al., 2015, Schaufler et al., 2016, Kapp et al., 2017, Zarka 
et al., 2019a). This achievement offers great potential for this DNA origami platform in 
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the investigation of adhesion receptor clustering, especially with the multi-valent 
capabilities of DNA origami, as demonstrated by the Palma lab (Huang et al., 2019).   
A significant challenge in the development of this work was the successful conjugation 
of peptides to ssDNA staples for hybridisation to the DNA origami structures. Previous 
work as demonstrated the used of thiol-maleimide reactions (Huang et al., 2019, 
Franquelim et al., 2018) for linking cysteine tagged peptides to ene-presenting ssDNA. 
The current investigation failed to replicate maleimide based conjugates for currently 
unknown reasons. However, this thesis has presented the successful fabrication and 
purification of acrydite conjugates which have the advantages of high stability prior to 
the reaction, highly efficient conjugation in aqueous solutions with neutral pH and high 
post-reaction carbon-carbon bond stability (Lutolf and Hubbell, 2003, Lowe, 2010). 
These acrydite conjugate were successfully hybridised to DNA origami structures and 
immobilised on the nanopatterned arrays, completing the platform design. However, 
others have also had success in implementing conjugate products more classically 
observed in molecular biology, such as NHS-esters (van der Velde et al., 2016), histidine 
tags (Shen et al., 2009), biotin-streptavidin (Huang et al., 2019) and antibody-antigen 
(Cremers et al., 2019). Therefore, future investigations could look to these technologies 
when seeking to improve upon the conjugation approach presented here. Furthermore, 
approaches offer tremendous opportunity when looking to design multi-valent DNA 
origami structures and future work would certainly benefit from a systematic evaluation 
of the efficacy of these approaches. 
A key strength of the current chapter is the use of the DNA origami nanopatterning 
platform to recapitulate integrin clustering dynamics previously reported by others, using 
different platform. Previous work using micellular co-block polymer arrays has 
consistently demonstrated that avb3 expressing cell lines require RGD peptide spacing 
of <60 nm for adequate integrin clustering and cell spreading (Arnold et al., 2004, 
Cavalcanti-Adam et al., 2007, Huang et al., 2009, Schvartzman et al., 2011, Schaufler et 
al., 2016, Oria et al., 2017). To validate whether the same results could be observed on 
the DNA origami nanopattern immortalised MEF cells were cultured on nanopatterned 
RGDfC ligands at 130 nm, 60 nm and 30 nm ligand spacings with 200 nm and 300 nm. 
The MEF cells were highly sensitive to inter ligand spacing and only spread consistently 
on 60 nm and 30 nm configurations, successfully demonstrating the 60 nm threshold. No 
differences were observed between 200 nm and 300 nm configurations which was also 
consistent with the work of others (Schvartzman et al., 2011), providing further 
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confirmation of successful fabrication of the DNA origami design and validation of our 
approach to use this platform to investigate integrin clustering dynamics in a different cell 
type. Asa result, this investigation was able to proceed onto culturing of neonatal rat 
















The cardiac ECM is a highly dynamic and complex structure that plays a key role in 
healthy functioning, development and disease (Buyandelger et al., 2011, Ward and 
Iskratsch, 2019). Chapter 3 presented findings that demonstrate unique spreading, traction 
forces and adhesion composition in NRCs when cultured on fibronectin compared to 
laminin. It was hypothesised that these underlying differences may initially occur at the 
level of the integrin adhesion. Indeed, investigations have shown key differences in 
activation energy (Li and Springer, 2017) and clustering (Schaufler et al., 2016) of 
different integrin subtypes, and it is important to understand the relevance of this within 
cardiomyocytes. In Chapter 4, a nanopatterning platform was developed to control the 
clustering of active, ligand bound integrins. Using this platform, the following chapter 
will present findings on the spreading and adhesion behaviours of cardiomyocytes in 
response to nanopatterning of fibronectin and laminin peptidomimetic ligands. 
5.2 Initial Validation of Cardiomyocyte spreading and adhesion 
on surfaces functionalised with random DNA Origami  
It was then necessary to validate the origami for integrin clustering investigations with 
cardiomyocytes. DNA Origami presenting 0, 6, 12 or 18 RGDfC or IKVAV peptides 
were cast randomly on glass coverslips at a concentration of 2 nM, followed by cross-
linking of origami to the surface, passivation of the surface with mPEG and additional 
blocking with 5% BSA. NRCs were isolated and cultured in serum free media on the 
random arrays for 24 hours before fixation and quantification of cell spreading by 
calculation of cell area. Previous work culturing NRCs on peptides functionalised 
substrates has reported impeded cell spreading and severe disruption to the cytoskeleton, 
with an inability to assemble sarcomeres (Boateng et al., 2005, LaNasa and Bryant, 2009). 
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Therefore, cytoskeletal maturity was also qualitatively evaluated by calculation of a-
actinin intensity and morphology, which localises to the z-line (Pandey et al., 2018). 
Three phenotypes of a-actinin localisation were used to assess cytoskeletal maturity; (1) 
localisation to stress fibre like structures (SFLS), (2) mixed localisation to SFLS and 
striated myofibrils and (3) predominant localisation to mature myofibrils which also 
demonstrate consistent alignment. All results of NRC spreading and myofibril maturity 
on random origami arrays can be seen in Figure 5.1. 
On zero peptide controls, NRCs were rounded up and unable to spread, confirming that 
non-specific adhesion was minimal. Upon presentation of 6 peptides per origami (~60 
ligands per µm2), NRCs started to spread on both RGDfC and IKVAV, with no significant 
differences observed between the two peptides (240 ± 107 and 252 ± 76 µm2 for RGDfC 
and IKVAV respectively). In general, NRCs were small on 6 RGD and IKVAV arrays 
and the increase in cell area did not constitute a strong spreading phenotype (Figure 5.1 
A & B). Evaluation of a-actinin localisation demonstrated that most NRC exhibited SFLS 
with few striations or a mixed phenotype (Figure 5.1E).  
On 12 peptide random arrays (~120 ligands per µm2), NRCs spread significantly more on 
RGDfC and IKVAV compared to 6 peptide random arrays with an average area of 313 ± 
69 µm2 and 368 ± 157 µm2, (respectively) with no significant difference between RGDfC 
and IKVAV (Figure 5.1). Localisation of a-actinin transitioned from predominantly 
SFLSs on 6 peptides to predominantly a mixed myofibril and SLFS phenotype on 12 
peptides which occurred with a corresponding increase in a-actinin density. Furthermore, 
NRCs on 12 RGDfC had significantly greater actinin density than 12 IKVAV, which is 
suggestive of subtle differences in cytoskeletal content.  
On 18 peptide random arrays (~120 ligands per µm2), further cell spreading was only 
observed on RGDfC, where cell area increased to 405 ± 135 µm2 which was significantly 
more than both 12 RGDfC and 18 IKVAV (346 ± 96 µm2). Evaluation of cytoskeletal 
maturity revealed that more NRCs exhibited a mature, or mixed phenotype. No significant 
differences were observed in a-actinin content between 18 RGDfC and 18 IKVAV, as 
measured by  a-actinin density or manual classification Figure 5.1. These findings clearly 
demonstrate that both RGDfC and IKVAV functionalised DNA origami facilitate NRC 
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spreading and cytoskeletal maturation, in a dose dependent manner. Furthermore, 
evaluation of cytoskeletal maturity has shown that the peptides utilised do not inhibit 
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myofibril assembly as reported by others (Boateng et al., 2005; LaNasa & Bryant, 2009).  
5.3 Nanoscale Integrin Clustering and Spreading Properties of 
Cardiomyocytes 
Preliminary investigations culturing NRCs on randomly positioned DNA origami 
functionalised with RGDfC or IKVAV demonstrated that this platform can mediate NRC 
spreading and adhesion. However, the random arrays can only provide information on 
integrin clustering relative to the area of a single origami structure (~85 nm2) with no 
control over the global positioning of the origami. The DNA origami nanopatterning 
platform overcomes these limitations by providing precise control of the global and local 
integrin clustering dynamics, which are key to cell adhesion and spreading (Arnold et al., 
2004, Cavalcanti-Adam et al., 2007, Oria et al., 2017). 
To compare and contrast the clustering dynamics of different integrin subtypes and their 
effect on NRC spreading and adhesion, nanopatterned DNA origami substrates were 
fabricated with 6, 12 or 18 RGDfC or IKVAV peptides in 200 nm or 300 nm arrays. Table 
5.1 summarises the local and global ligand properties of each nanopattern configuration. 
Nanopatterned DNA origami arrays with zero peptides were employed as negative 
controls. Substrates were passivated with mPEG and 5% BSA, to minimise nonspecific 
adhesion, before culturing freshly isolated neonatal cardiomyocytes for 24 hours. All 
results can be seen in Figure 5.2. The degree of cell spreading and cytoskeletal maturity 
were measured by F-actin area, intensity and circularity from two independent 
experiments. On zero peptide controls, few cells adhered to the substrates, suggesting a 
low level of non-specific adhesion. The addition of 6 RGDfC peptides (~60 nm spacing) 
resulted in an increase in cell attachment and initiated spreading only with 200 nm cluster 
spacing (150 peptides / 𝜇m2) and not with 300 nm cluster spacing (54 peptides / 𝜇m2). 
Figure 5.1. Validation of NRC spreading and sarcomere assembly on random DNA 
origami arrays. NRCs were cultured on 6, 12 or 18 RGD (A) or IKVAV (B). C & D) 
Quantification of cell area and actinin content in each condition. E) Qualitative 
evaluation of myofibril maturity. Values represent the % of cells with predominantly 
SFLS, mixed or mature phenotype. N = > 80 cells per condition from three biological 
repeats. One-way ANOVA was used to compare differences within each peptide, Tukey 
correction for post-hoc comparison, student’s t-test was used to compare differences 
between peptides, ** = p<0.01, **** = p<0.0001.  
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Cell area was significantly greater than controls at (mean ± SD) 398 ± 141 𝜇m2 with 200 
nm cluster spacing, compared to 237 ± 128 𝜇m2, with 300 nm cluster spacing. For cells 
on 6 IKVAV nanopatterns, few cells were spread on either 200 nm and 300 nm arrays 
suggesting insufficient integrin clustering to support spreading. 
Increasing the number of peptides on each DNA origami to 12 (decreasing inter ligand 
spacing to ~30 nm) resulted in a significant increase in cell area on both RGDfC and 
IKVAV peptides. Interestingly, NRCs cell area on 12 RGDfC 300 nm (108 peptides / 
𝜇m2) was comparable to cells on the 6 RGDfC 200 nm (150 peptides / 𝜇m2) nanopattern 
(398 ± 141 𝜇m2  vs 431 ± 202 𝜇m2 on 6 RGDfC 200 nm  and 12 RGDfC 300 nm, 
respectively, p > 0.05). A significant increase in cell area was only observed on 12 
RGDfC 200 nm (300 peptides / 𝜇m2) arrays where NRCs spread to 625 ± 191 µm2. On 
12 IKVAV arrays, initiation of spreading was observed on 200 nm cluster spacing 













6	 65	 300	 54	
6	 65	 200	 150	
12	 33	 300	 108	
12	 33	 200	 300	
18	 21	 300	 162	
18	 21	 200	 450	
Table 5.1. Local and global parameter of the different nanopattern configurations. Inter 
peptide distances represent the distance between modification sites on the design of the 
pointed triangle DNA origami. As the orientation of each DNA origami on the 
nanopattern was not controlled, a precise characterisation of the nanopattern 
configurations is not possible and the listed values represent the closest approximation 




of spreading on RGDfC. On 12 IKVAV 200 nm configurations, NRC cell area was 285 
± 122 𝜇m2 with 200 nm cluster spacing where a number of cells began to form stable 
protrusions, compared to 205 ± 74 𝜇m2 with 300 nm cluster spacing.  
Increasing the number of peptides on each DNA origami to 18 (decreasing inter-ligand 
distance to 20 nm) resulted in another significant change in spreading on both RGDfC 
and IKVAV. On nanopatterned RGDfC ligands, NRCs on both 200 nm (450 peptides / 
µm2) and 300 nm (162 peptides / µm2) arrays exhibited significantly less spreading (204 
± 89 and 233 ± 107, 200 nm and 300 nm arrays respectively) than cells on the 12 and 6 
peptide arrays. This result may be due to excessive ligand density and substrate stiffness 
(Engler et al., 2004). On the other hand, increasing the number of IKVAV peptides to 18 
did support further spreading in NRCs, resulting in a significant increase in spreading on 
the 200 nm array only, compared to 12 IKVAV configurations; Cell area on 18 IKVAV 
200 nm arrays increased to 410 ± 191 µm2, compared to 346 ± 152 on 18 IKVAV 300 
nm arrays. Notably, cells cultured on 18 IKVAV 300 nm arrays did not spread more than 
cells on 12 IKVAV 200 nm arrays (162 peptides / µm2 vs 300 peptides / µm2, 
respectively). 
In all experiments, NRCs spreading on RGDfC had significantly greater cell area than 
comparable conditions on IKVAV. Important differences were also observed in NRC cell 
morphology when spreading on RGDfC or IKVAV. In general, NRCs on RGDfC had a 
less circular morphology than those on IKVAV (Figure 4D) suggesting differences in 
adhesion formation and rigidity sensing (Wolfenson, Yang & Sheetz, 2019). To further 
understand these differences, F-actin content was quantified by calculating the integrated 
F-actin intensity. NRCs on RGDfC nanopatterns exhibited increases in F-actin content 
(as measured by F-actin integrated density) with increasing global ligand density, up to 
an extent. In almost all conditions, excluding 18 peptides, NRC cultured on RGDfC 
ligands had significantly greater F-actin content (Figure 4E), suggesting an important 
relationship between integrin clustering, cytoskeletal assembly and spreading. 
Interestingly, NRCs cultured on IKVAV did not exhibit the same relationship between 
cytoskeletal content, spreading and integrin clustering. On 18 IKVAV nanopatterns, 
where a stronger spreading phenotype was observed, F-actin content actually decreased 
suggesting impaired F-actin assembly. Together, these results suggest that a5b1 integrin 
adhesions are more stable and require fewer ligand to initiate spreading on NRCs 







5.4 Regulation of NRC spreading on RGDfC and IKVAV 
The ability of cells to apply local contractions through integrin clusters would be 
dependent upon stability of integrin adhesion under force. The molecular clutch model 
predicts that cell adhesions require an optimum number of integrins to adequately 
distribute forces during rigidity sensing (Elosegui-Artola et al., 2014, Elosegui-Artola et 
al.., 2016, Oria et al., 2017). The model predicts that adhesions with an insufficient 
number of integrins yield under high force while too many integrin adhesions results in 
excessive distribution of force and mechanotransduction cannot occur. The current 
investigation has demonstrated that NRCs spreading on IKVAV require more ligands per 
cluster for stable adhesion and spreading compared to cells cultured on RGDfC ligands. 
Furthermore, upon the initiation of spreading, NRCs on RGDfC exhibit a less circular 
morphology, with increased F-actin content, suggesting greater contractility. Coupled 
with findings that NRCs on RGDfC have greater traction, it was necessary to further the 
role of cytoskeletal contractility in rigidity sensing and spreading on the different ligands. 
Recent work from our lab has demonstrated that downstream of PKC activation, Src is 
activated at integrin adhesions where it regulates rigidity sensing via non-myofibrillar 
contractility (non-muscle myosin) and the actin assembly protein, FHOD1 (Pandey et al., 
2018). To investigate Src localisation on RGDfC and IKVAV, NRCs were cultured on 
nanopatterned arrays with DNA origami presenting 6, 12 or 18 RGDfC or IKVAV 
peptides at 300 nm and 200 nm intervals. Src localisation was visualised using a validated 
antibody (Figure 5.3A) targeting active (phosphorylated) Src. On 6 RGDfC 300 nm 
arrays, cells had weak Src staining with no localisation towards the cell edge or at 
adhesion like structures. When cells start to spread on 6 RGDfC 200 nm arrays, evidence 
Figure 5.2. NRCs were cultured on RGDfC or IKVAV functionalised nanopatterns for 24 
hours. A & B) Representative images of NRCs spreading on the RGDfC (A) and IKVAV 
(B) nanopatterns. Spreading and morphology was quantified by measuring cell area (C), 
circularity (D) and Integrated phalloidin density (E). Differences between peptide 
numbers and DNA origami spacing were evaluated with a Two-way ANOVA with Tukey 
corrections for multiple comparisons, ** = p<0.01, *** = p<0.001, **** = p<0.0001. 
Data from 2 independent experiments. N = >50 cells per condition from 2 biological 
repeats. Modified from Hawkes et al. 2019. 
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of Src clustering at the cell edge was observed, which also showed partial co-localisation 
with a-actinin and F-actin (Figure 5.3C), consistent with its role in integrin adhesion 
signalling. On IKVAV nanopatterned arrays however, there was little evidence of Src 
clustering or localisation at the cell edge, on 12 IKVAV 200 nm (where cells begin to 
spread) or on 18 IKVAV 200 configurations Figure 5.3D. This could indicate differential 
integrin signalling mechanisms when spreading on different integrin isoforms. The data 
at this point is purely qualitative and future investigations will investigate the 
nanoclustering activity of pSrc using super resolution microscopy. 
To further investigate the role of Src in NRC rigidity sensing, we returned to experiments 
on random DNA origami arrays. While these arrays do not provide control over inter-
cluster spacing, NRCs on 18 RGDfC or IKVAV still exhibit significant differences in 
spreading under comparable conditions. Furthermore, unlike the nanopattern, NRCs 
spreading on random 18 RGCfC and IKVAV have a more mature cytoskeletal structure,  
and Src may be playing a stronger role in contractility. Thus, NRCs spreading on random 
18 RGDfC or 18 IKVAV arrays were treated with 10 µm of the Src inhibitor PP2 for 3 
hours and the corresponding change in cell area was calculated. After PP2 treatment, 
subtle differences were observed in spreading where cells on RGDfC had a slight 
significant decrease in cell area and cells on IKVAV had a slight, but significant increase. 
Previous work has demonstrated that contractility inhibition can promote or inhibit 
spreading depending on the stability of integrin-ECM bonds (Oria et al., 2017). To further 
test if the differential response to Src inhibition was specific for Src inhibition or due to 
differences in the inter-ligand bonds, NRCs on random 18 RGDfC and IKVAV arrays 
were treated with a range of drugs to inhibit or promote cytoskeletal contractility. To 
inhibit contractility, NRCs were treated with the myosin II inhibitor blebbistatin, the 
muscle myosin inhibitor verapamil, PP2 and the ROCK inhibitor Y-27632. To compare 
whether promotion of cytoskeletal contractility has the opposite effect to inhibition, cells 
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were also treated with the cardiac myosin activator omecamtiv mercabil (OM) and the 
myosin activator calyculin A. Finally, to investigate the role of formins in NRCs 
spreading on cRGDfC and IKVAV, cells were also treated with the pan formin inhibitor, 
smiFH2. On 18 IKVAV, inhibiting contractility resulted in a slight but significant 
increase in cell area in all cases, suggesting that reduced contractility may act to stabilise 
adhesion and facilitate spreading. On 18 RGDfC, only PP2 resulted in a significant 
change in cell area, suggesting that Src plays a key role in spreading and rigidity sensing. 
Drugs promoting contractility resulted in a significant decrease in cell area for 18 IKVAV 
with OM treatment only and on RGDfC, cells exhibited a significant decrease in cell area 
with OM and calyculin-A treatment. Upon treatment with any drug, all cells exhibited a 
Figure 5.3. Active Src localisation on RGDfC and IKVAV Nanopatterns. A) pSrc 
antibody validation showing co-localisation between transfected GFP-Src and pSrc 
antibody. NRCs were cultured on 6 x RGDfC 300nm (B), 6 x RGDfC 200nm (C) and 
18 IKVAV 200nm (D) arrays and immunostained for pSrc, a-actinin and phalloidin.  
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more circular morphology, consistent with a decrease in cytoskeletal tension. These 
results suggest that on RGDfC, Src plays a key role in NRC spreading and that 
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cytoskeletal contractility may play different roles in cell spreading depending on the 
integrin subtype. 
5.5 Discussion 
This chapter has presented investigations on the nanoscale integrin clustering and cell 
spreading properties of a5b1 and a7b1 integrin subtypes in NRCs. The results 
demonstrate that fibronectin binding integrins require fewer integrin adhesions to initiate 
spreading than laminin binding integrins in NRCs. In comparable conditions, NRCs 
spreading on fibronectin mimetic peptides exhibited a more active spreading phenotype, 
with significantly greater cell area and cytoskeletal content after 24 hours in culture. Thus, 
Figure 5.5. Quantification of NRC cell area and a-actinin intensity after contractility 
inhibition or enhancement and formin inhibition.  One-way ANOVA with Dunnets 
correction for multiple comparison, * = p<0.05, *=p<0.01, ***=p<0.001, 
****=p<0.0001. N= 3 biological repeats. 
 
Figure 5.4. Representative images of NRCs spreading on random DNA origami 
presenting 18 RGD or 18 IKVAV peptides. NRCs were treated with drugs to inhibit 
(Blebbistatin, PP2, Y-27632 or Verapamil) or enhance Calyculin-A, OM) 
contractility. Cells were also treated with the formin inhibitor smiFH2. The 
cytoskeleton was visualised by immunostaining for a-actinin (green) or F-actin 
(red). Cells were spread for 19 hours after plating before being treated with drugs 
for 3 hours followed by fixation. 
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these findings show that fibronectin and laminin binding integrins differ in their clustering 
dynamics for cellular adhesion and integrin signalling. Furthermore, this investigation has 
also observed important effects of inter-cluster spacing or global ligand density 
suggesting that, unlike other cell types (Schvartzman et al., 2009, Schvartzman et al., 
2011), NRCs are highly sensitive to the nanoscale organisation of their ECM. 
This investigation has been the first to quantitatively compare the clustering dynamics of 
a5b1 and a7b1 integrins in cardiomyocytes and analyse the resulting effect on cell 
spreading and morphology. On RGDfC, spreading was initiated in NRCs when individual 
integrins where spaced ~60 nm apart but only when clusters were also spaced 200 nm 
apart, whereas spreading wasn’t initiated on IKVAV until integrins were ~30 nm apart at 
200 nm cluster spacings. On both RGDfC and IKVAV, NRCs were sensitive to the inter 
cluster spacing and the overall global ligand density, requiring 108 – 150 and 162 – 300 
ligands per µm2 on RGDfC and IKVAV nanopatterns, respectively. While the functional 
implications of these clustering differences remain unclear, these results highlight the 
importance of understanding the importance of ECM regulation of integrin signalling. 
Others have previously observed that cells utilise different integrin subtypes to enact 
specific behavioural phenotypes, such as migration, rigidity sensing, spreading and 
integrin signalling (Elosegui-Artola et al., 2014, Bharadwaj et al., 2017, Schaufler et al., 
2016, Lerche et al., Preprint). The differences in integrin clustering and cell spreading 
between RGDfC and IKVAV binding integrins may also suggest that cardiomyocytes 
modulate integrin expression to regulate integrin signalling. This would be in line with 
the changing integrin expression observe during key developmental and pathological 
situations (Brancaccio et al., 1998, Nawata et al., 1999, Maitra et al., 2000, Burgess et al., 
2001). Further investigation is therefore required to understand the functional impact of 
differential integrin expression in cardiomyocytes. The rapidly developing molecular 
clutch model may offer some useful insights to understand the functional importance of 
the results observed in the current investigation. 
An important consideration from the literature is the complementary role of integrin 
subtypes that bind to the same ECM ligand. As demonstrated by Schaufler et al. (2016) 
and Bharadwaj et al. (2017), a5b1 and avb3 integrin subtypes exhibit functionally 
distinct roles at the focal adhesion, even though they both bind to the RGD motif of 
fibronectin. The current investigation has demonstrated that under various micro and  
nanopatterning configurations, RGD binding integrins appear to stimulate a stronger 
spreading phenotype than IKVAV binding subtypes. However, it is likely that different 
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RGD and IKVAV binding subtypes are present in neonatal rat cardiomyocytes, as 
demonstrated by micro RNA data in chapter 1. Indeed, various papers have also 
demonstrated a highly diverse integrin expression profile in cardiomyocytes during 
development and disease (Brancaccio et al., 1998, Maitra et al., 2000, Burgess et al., 2001, 
Willey, 2003) Therefore, future work should attempt to characterise the contribution of 
different integrin subtypes to adhesion, spreading and mechanotransduction in 
cardiomyocytes. This could be achieved via siRNA mediated knock down of integrin 
subtypes or through the use of integrin specific antibodies to block subtype activity during 
spreading. Combining this approach with the nanopatterning platform presented here 
would provide key information subtype specific nano-clustering and help elucidate their 
roles in specific cardiomyocyte behaviours, such as the hypertrophic response. 
Furthermore, as discussed previously, the regulation of integrin subtype activity may be 
dependent upon substrate rigidity (Lerche et al., Preprint, Elosegui-Artola et al., 2014, 
Oria et al., 2017). Therefore, future work could combine integrin subtype 
knockdown/blocking techniques with ligand nanopatterning on different substrate 
rigidities to investigate integrin subtype behaviours at functionally relevant stiffnesses. 
Recent work has provided strong evidence that a molecular clutch mechanism determines 
the 60 nm requirement for adequate integrin clustering (Oria et al., 2017). An optimum 
integrin cluster density is required to withstand traction forces and engage mechanically 
sensitive integrin adaptor proteins during rigidity sensing; insufficient or excessive 
clustering results in over- or under-loading of the adhesion, respectively. Results from the 
nanopatterning of RGDfC and IKVAV, in addition to the work of others (Schaufler et al., 
2016, Lerche et al., Preprint), suggests that different integrin subtypes have unique 
clustering requirements to engage the molecular clutch and initiate spreading. One 
possible explanation for this could be that different integrin subtypes have different bond 
dynamics under force. The molecular clutch model demonstrates that rigidity sensing 
occurs via the application of forces through integrins and their adaptor proteins and thus, 
stability of the integrin-ECM bond is central for efficient mechanotransduction (Elosegui-
Artola et al., 2016). Integrin bond stability is highly dependent upon substrate rigidity and 
recent insights have identified that different subtypes are most stable at specific substrate 
rigidities, with collagen binding integrins (a11b1) being most stable on soft rigidities and 
fibronectin binding subtypes (a5b1 and avb6) being most stable at higher rigidities 
(Elosegui-Artola et al., 2014, Oria et al., 2017, Lerche et al., Preprint). Therefore, the 
requirement for increased integrin clustering in NRCs cultured on IKVAV nanopatterns 
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suggests that a7b1 integrins are less stable under force on highly rigid glass substrates. 
Because integrin clustering is dependent upon substrate rigidity, it is of great interest to 
further development this DNA origami nanopatterning platform to substrates with 
tuneable stiffness to evaluate integrin clustering within more physiological contexts. 
A central component of the molecular clutch model is the application of force upon 
integrin adhesions to engage mechanosensitive proteins involved in rigidity sensing. 
Actin flow and the contractile action of myosin machinery act as the primary force 
producers within the model. Within cardiomyocytes, rigidity sensing occurs through a 
unique combination of myofibrillar and non-myofibrillar contractility, with actin flow 
taking a less important role (Pandey et al., 2018). Inhibition of cytoskeletal contractility 
resulted in different effects on NRC spreading depending on whether cells were cultured 
on RGDfC or IKVAV peptides. NRCs spreading on RGDfC demonstrated a significant 
decrease in cell area and a-actinin content under Src inhibition which is consistent with 
previous work (Pandey et al., 2018). Furthermore, this result is also consistent with 
observation of Src clustering at the cell edge upon the initiation of spreading on 
nanopatterned RGDfC, providing further evidence of an important role for Src in 
fibronectin mediated spreading. However, other contractility inhibitors (blebbistatin, Y-
27632 & Verapamil) did not result in significant changes in cell area or a-actinin content 
(with the exception of blebbistatin) on RGDfC. However, NRCs spreading on IKVAV 
demonstrated a general increase in cell area under all treatments for contractility 
inhibition. These results suggest that adhesion stability and spreading is enhanced under 
lower force conditions on IKVAV but not on RGDfC. On the other hand, NRCs on 
RGDfC and IKVAV exhibited a general decrease in cell area and disruption to a-actinin 
content upon stimulation of cytoskeletal contractility, suggesting that adhesion stability 
can be equally compromised under higher force conditions.  
The nanopatterning platform presented here represents a quantitative way to compare the 
clustering activity of different integrin subtypes. However, this oversimplified model of 
the ECM ignores any cooperative effect of different integrin subtypes (Miao et al., 2002, 
Schiller et al., 2013, Bharadwaj et al., 2017)  or that of other receptors such as the 
dystroglycan complex which has recently been demonstrated to possess 
mechanosignalling properties (Allikian et al., 2004, Morikawa et al., 2017). Furthermore, 
full length fibronectin contains a synergistic domain that greatly enhances integrin 
binding and adhesion (Benito-Jardon et al., 2017) and may play an important role in 
integrin signalling. An example of the effect of the simplified ECM is demonstrated by 
 
 132 
the small cell size observed after 24 hours spreading. At 300 – 500 µm2, these cells spread 
about half as much as they do on full length fibronectin and laminin. Another potential 
reason for this could, in part, be due to the RGDfC and IKVAV peptides chosen. The 
affinity of integrins for peptide ligands can be highly affected by confirmation (cyclic or 
linear) and sequence (RGD vs GRGDS), especially in the case of a5b1 subtypes (Kapp 
et al., 2017). Furthermore, IKVAV peptides are found on laminin a1 chains which 
primarily recruit a7X2b1 integrins and within this study, the roles of other  a7Xb1 and 
a3b1 integrins, which bind laminin a5chains, remains unclear.  Future investigations 
should test the effect of different RGD and laminin peptides to further understand and 
validate the current results. Furthermore, the ability of DNA origami to present different 
peptides on the same structures also provides the opportunity to investigate the 
complementary role of different integrin subtypes in NRC spreading and adhesion. 
The use of peptides for culturing cardiomyocytes and the investigation of their integrin 
signalling properties has remained limited to date. Numerous studies have reported that 
peptides such as RGD and YIGSR severely disrupt cell spreading, integrin signalling and 
cytoskeletal maturation (Boateng et al., 2005, LaNasa and Bryant, 2009). Our results also 
demonstrated that NRCs have reduced spreading and sarcomeric assembly when cultured 
on RGDfC and IKVAV nanopatterns. However, culturing of NRCs on disorganised 
random DNA origami arrays clearly demonstrated that, under currently unknown 
conditions, cells are able to assemble mature sarcomeric like structures. These findings, 
again, demonstrate the sensitivity of NRCs to the properties of the ECM and also suggest 
an important relationship between integrin clustering and cytoskeletal/sarcomeric 
assembly, as hypothesised by others (Sparrow and Schöck, 2009). 
An unexpected result from this investigation was the inability of NRCs to spread on the 
18 RGDfC nanopattern arrays. This result was observed in 4 independent repeats and was 
always carried out in parallel with 18 RGDfC random DNA origami arrays, which 
invariably enabled spreading. To the best of our knowledge, nobody has investigated the 
effect of integrin cluster spacing at 20 nm intervals and so, it is difficult to make 
comparisons within the literature. Previous work has investigated 36 nm ligand spacing 
in a5b1 subtypes (Schaufler et al., 2016) and 30 nm spacing in avb3 subtypes (Oria et 
al., 2017), which facilitated greater spreading than 60 nm arrays, as seen in the present 
study. However, these investigations immobilise individual ligands across entire surfaces 
and achieve a higher ligand density of ~400 ligands per µm2 at 60 nm spacing, compared 
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to 150 ligands per µm2 on the 6 peptide, 200 nm configuration used here, making 
comparison difficult. Furthermore, in contrast to what others have reported in adherent 
cells expressing avb3 integrins (Schvartzman et al., 2009), DNA origami nanopatterning 
has demonstrated that on both RGDfC and IKVAV, the spacing between clusters is very 
important for NRC spreading. These results again demonstrate that findings from 
different cell and integrin subtypes are not universally applicable and more work is 
required in NRCs to understand the observations made here. On a final note, it is possible 
that on 18 RGDfC arrays, NRC exceed their maximum ligand density on such stiff 
substrates. Previous work with smooth muscle cells on collagen substrates demonstrates 
a decline in cell area with excessive substrate stiffness and ligand density (Engler et al., 
2004), providing a possible explanation for the resulted presented here. 
In summary, this chapter has presented the first investigation to quantitatively evaluate 
and compare the integrin clustering dynamics of a5b1 and a7b1 integrin subtypes in 
NRCs. We observed that on RGDfC ligands, fewer ligands were required to initiate 
spreading compared to IKVAV and in all conditions, cells on RGDfC had greater cell 
area, more cytoskeletal enrichment and were less circular in morphology. This suggests 
that RGDfC and IKVAV integrin receptors differ dramatically in their clustering 
requirements to initiate spreading and rigidity sensing. Furthermore, manipulation of 
cytoskeletal contractility revealed an essential role of Src in NRC spreading on RGDfC 
ligands (in agreement with previous work (Pandey et al., 2018)) and also suggested that 
RGDfC adhesions are more mechanically stable that IKVAV adhesions. In other cell 
types, differential clustering of integrin subtypes has been found to reflect functional 
differences in their roles during spreading and adhesion (Elosegui-Artola et al., 2014, 
Schaufler et al., 2016, Lerche et al., Preprint). Therefore, future work should aim to 
investigate the differential cardiomyocyte integrin signalling dynamics occurring 
downstream of a5b1 and a7b1 integrin adhesion. Furthermore, understanding how a5b1 
and a7b1 integrin-ECM bond kinetics differ will likely elucidate the underlying 





CONCLUSIONS & FUTURE 
DIRECTIONS 
During development and disease, cardiomyocyte integrin expression favours fibronectin 
binding subtypes, while laminin binding integrins are the dominant subtypes in healthy 
adult cardiomyocytes (Brancaccio et al., 1998, Maitra et al., 2000). Previous work has 
clearly demonstrated that different integrin subtypes have unique rigidity sensing 
properties, but the consequences of dynamic integrin expression in cardiomyocytes is not 
well understood (Kong et al., 2009, Chen et al., 2017, Elosegui-Artola et al., 2014, 
Bharadwaj et al., 2017, Schaufler et al., 2016, Ward and Iskratsch, 2019). The current 
investigation has taken a highly interdisciplinary approach to conduct a comparative 
analysis of cardiomyocyte spreading and integrin clustering on fibronectin and laminin 
functionalised substrates. Early results demonstrated that cardiomyocytes cultured on 
fibronectin exhibit stronger spreading, contractility and vinculin enrichment compared to 
cells cultured on laminin. It was hypothesised that these differences could arise due to 
differential integrin clustering. Particular focus has been given to the development and 
implementation of a single molecule ligand nanopatterning platform to perform a 
quantitative analysis of integrin clustering on fibronectin and laminin receptors. The 
results suggest that cardiomyocytes spreading on a7b1 integrins require more 
concentrated integrin clusters to initiate spreading compared to a5b1 integrins. Follow 
up investigations suggested that these differences could be driven by the ability of either 
subtype to respond to cytoskeletal contractility. Together these results suggest that the 
switch in cardiomyocyte integrin expression has important implications for integrin 
signalling and mechanotransduction. Furthermore, this work clearly identifies a need for 
further investigation into subtype specific integrin signalling in cardiomyocytes. 
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6.1 The Cardiac ECM – The Functional Role of Cues from The 
Basement Membrane 
The cardiac ECM contains a diverse mixture of matrix proteins and sugars which can be 
classified into glycoproteins, glycosaminoglycans and proteoglycans (Rienks et al., 
2014). The glycoproteins collagen, fibronectin and laminin are core elements of the 
basement membrane (the inner most layer) within the cardiac ECM, that provide 
structural rigidity and cell-receptor binding domains for the adhesion receptors, integrins. 
As a result, cardiomyocytes express a range of integrin subtypes, with specific affinity 
for collagen, fibronectin and laminin. Cardiomyocyte integrin expression is highly 
regulated, and specific expression profiles are activated during developmental, neonatal, 
healthy adult and diseased states  (Belkin et al., 1997, Brancaccio et al., 1998, Nawata et 
al., 1999, Maitra et al., 2000, Burgess et al., 2001). Specifically, the fibronectin binding 
a5b1 integrins are the predominant subtype during developmental and diseased states 
(Brancaccio et al., 1998, Nawata et al., 1999). The laminin binding a7b1 integrin subtype 
becomes the primary receptor after downregulation of a5b1 receptors in neonates, which 
remains steady into adulthood (Brancaccio et al., 1998, Maitra et al., 2000). Importantly, 
the expression of integrin subtypes closely matches the presence of glycoproteins within 
the ECM. For example, a5b1 expression is strongly upregulated after MI, as cardiac 
fibroblasts rapidly deposit fibronectin around the infarcted area, in a process called 
fibrosis (Burgess et al., 2001, Valiente-Alandi et al., 2018). Furthermore, a7b1 
expression also matches the increased deposition of laminin during neonatal development 
(Burgess et al., 2001, Yang et al., 2015). Thus, cardiomyocytes actively utilise integrins 
to detect dynamic cues from the ECM. 
Changes in integrin expression are strongly related to specific behaviours observed in 
cardiomyocytes. This has been demonstrated most convincingly in models of 
hypertrophy, where a5b1 integrins are upregulated to detect both chemical and 
mechanical signals to activate compensatory hypertrophic signalling pathways such as 
ERK, AKT1, JNK or NFkB (Ogawa et al., 2000, Balasubramanian and Kuppuswamy, 
2003, Israeli-Rosenberg et al., 2014, Pandey et al., 2018). In contrast, the neonatal 
increase in a7b1 integrin expression also coincides with an important developmental 
period where cardiomyocytes lose their ability to proliferate and continued heart growth 
must occur via hypertrophy. However, the role a7b1 integrin signalling in post-natal 
development is not well understood, even though laminin ligands have been reported to 
stimulate hypertrophic markers to a similar extent (Ogawa et al., 2000). Importantly, the 
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physiological hypertrophy observed in neonatal development differs dramatically to 
pathological hypertrophy, which results in excessive heart wall thickness and a decrease 
in chamber volume (Nakamura and Sadoshima, 2018). Therefore, a7b1 and a5b1 
integrins may engage differential signalling regimes that contribute toward physiological 
and pathological hypertrophy. Thus, the lack of knowledge on the independent roles of 
fibronectin and laminin integrins in cardiomyocyte mechanotransduction represents a 
significant gap in the literature that warrants further investigation.  
Chapter 3 of this thesis presented preliminary investigations into the differential 
behaviours of cardiomyocytes cultured on fibronectin and laminin coated substrates. The 
results consistently demonstrated that NRCs on fibronectin have enhanced spreading than 
cells cultured on laminin, at physiological and fibrotic stiffness. Cell spreading is closely 
regulated by the assembly of a contractile cytoskeleton, which associates with integrin 
adhesions to apply traction forces onto the ECM (Schwarz and Gardel, 2012, Iskratsch et 
al., 2014). Therefore, nanopillar arrays were employed to analyse the tractions forces in 
NRCs cultured on fibronectin or laminin. The results demonstrated that NRCs cultured 
on fibronectin exhibit greater traction forces than cells cultured on nanopillars coated with 
laminin. Propagation of traction forces through adhesions acts to stabilise 
mechanosensitive proteins such as talin, which reveal cryptic binding sites for proteins 
such as vinculin to reinforce actin association with the adhesion(del Rio et al., 2009). 
Micropatterning arrays revealed greater vinculin enrichment to fibronectin adhesions, 
suggesting altered rigidity sensing and mechanotransduction. Importantly, differences in 
cell spreading and vinculin enrichment to fibronectin adhesions were more pronounced 
at fibrotic stiffnesses (130 kPa), with laminin adhesions playing a more significant role at 
physiological stiffness (20 kPa). However, at both stiffnesses, fibronectin adhesions 
remained dominant with greater spreading and vinculin enrichment. These results suggest 
that fibronectin and laminin adhesions possess unique integrin signalling and 
mechanotransduction properties at fibronectin and laminin adhesions. Indeed, fibronectin 
adhesions have been suggested to play an enhanced role in hypertrophic signalling 
(Balasubramanian and Kuppuswamy, 2003, Johnston et al., 2009), but the differential 
role of fibronectin and laminin integrins remains poorly understood. 
While the functional implications of differential integrin expression in cardiomyocytes 
are poorly understood, we can look towards work in other cell types that modulate integrin 
expression for functional purposes. Fibroblasts and other migratory cell types (e.g. U2OS) 
express a5b1 and avb3 integrin subtypes, which both bind to fibronectin. Recent 
 
 137 
developments have established that these two subtypes possess functionally distinct roles. 
Owing to greater adhesion force and turnover, avb3 outcompete a5b1 subtypes for 
available adaptor proteins and initially activate rigidity sensing via RhoA/ROCK and 
Arp2/3 pathways. The initiation of rigidity sensing and traction forces then signals the 
clustering of a5b1 subtypes to further strengthen the adhesion (Bharadwaj et al., 2017, 
Schaufler et al., 2016). In line with their role as mechanosensors, other cell types have 
also been shown to exploit the enhanced adhesion kinetics of different integrin subtypes, 
which possess unique properties at different substrate rigidities (e.g. a5b1 vs avb6, 
(Elosegui-Artola et al., 2014)). For example, mammary gland fibroblasts assemble larger, 
more stable adhesions via the collagen binding a11b1 integrin subtype at low substrate 
rigidity (2 kPa) while fibronectin integrins become dominant at higher rigidities (Lerche 
et al., Preprint). Furthermore, in breast myoepithelial cells, a5b1 integrins are able to 
generate greater traction forces at lower tissue stiffnesses (1-10 kPa) whereas avb6 
integrins are more suitable at higher rigidities (Elosegui-Artola et al., 2014). Within these 
experiments, cells were utilising differential integrin expression to perform specific 
behaviours (e.g. migration, adhesion formation) at specific substrate rigidities (Elosegui-
Artola et al., 2018). This is hypothesised to be due to unique integrin-ECM bond 
dynamics (e.g. binding/unbinding rates & catch/slip bond behaviour) which are highly 
sensitive to force, contractility and substrate rigidity (Elosegui-Artola et al., 2018). 
Therefore, cardiomyocyte integrin expression may also reflect a similar requirement, as 
cardiac tissue stiffness changes during development and disease. The upregulation of 
fibronectin binding integrin subtypes may specifically promote enhanced integrin 
signalling through greater cytoskeletal contractility which may, in turn, favour 
hypertrophy during development or pathology. However, it is unclear whether the 
differences between fibronectin and laminin occur according to substrate rigidity. At 6 
kPa (embryonic/neonatal stiffness), we observe similar spreading and a-actinin content 
on fibronectin and laminin adhesions but at 10 kPa, traction forces are greater in cells 
cultured on fibronectin. Further investigation is required to understand whether 
differences in rigidity sensing determine the functional role of dynamic integrin 
expression in cardiomyocyte or whether changes occur as a result of other factors, such 




6.2 The Nanoscale Cytoarchitecture of Fibronectin and Laminin 
Adhesions in Cardiomyocytes. 
A recent study has demonstrated that key differences in the functional roles in different 
integrin subtypes could be underpinned by their clustering properties (Schaufler et al., 
2016). Work in migratory cell lines has demonstrated that on stiff (1 GPa) substrates, 
individual a5b1 integrin-ligand adhesions are required to be spaced < 60 nm apart to 
initiate stable adhesion formation (Schaufler et al., 2016, Oria et al., 2017), which is the 
same recorded in avb3 expressing cells (Arnold et al., 2004, Cavalcanti-Adam et al., 
2007, Huang et al., 2009). This 60 nm clustering threshold appears to be consistent in cell 
types that specialise in migratory phenotypes which require strong adhesion kinetics, such 
as myoepithelial cells, platelets, carcinoma cells and fibroblasts (Oria et al., 2017, Huang 
et al., 2019, Zarka et al., 2019b). However, under comparable clustering conditions, cells 
cultured on a5b1 adhesions spread far more rapidly and to a greater extent than cells 
cultured on avb3 adhesions(Schaufler et al., 2016). Currently, little is known about the 
clustering behaviours of fibronectin and laminin integrin subtypes in cardiomyocytes. 
This investigation has focussed on the role of a5b1 and a7b1 subtypes which have a high 
affinity for fibronectin and laminin, respectively (Nishiuchi et al., 2006, Kapp et al., 
2017). The current investigation has also observed the same 60 nm threshold for a5b1 
subtypes within cardiomyocytes. However, unlike observations in fibroblasts on avb3 
integrin subtypes in the current investigation (Chapter 5.3) and in previous work by others 
(Schvartzman et al., 2011), cardiomyocytes spreading on a5b1 subtypes were unable to 
spread on 60 nm configurations when individual clusters were spaced at 300 nm intervals. 
This result suggests that observations in others cell types on different integrin subtypes 
are not universally applicable. Furthermore, this finding provides further evidence that 
integrin subtypes do not play redundant roles in integrin signalling, consistent with 
previous work (Schaufler et al., 2016, Bharadwaj et al., 2017).   
Another novel observation from this study is that the laminin binding a7b1 integrins 
require much closer clustering of ~30 nm to initiate spreading (12 peptides per cluster) 
than fibronectin binding a5b1 integrins (6 peptides per cluster). This is the first 
investigation to analyse the clustering dynamics of a7b1 in cardiomyocytes and previous 
work on developing the molecular clutch model can help to explain the differences in 
integrin clustering observed between a7b1 and a5b1 subtypes. The model predicts that 
integrin clustering directly modulates the forces experienced by components of the FA; a 
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greater number of actively engaged integrins enables distribution of traction forces among 
more proteins, resulting in less force being sensed by individual integrins and adaptors 
(Elosegui-Artola et al., 2018). Integrin clustering is an active part of maintaining protein 
turnover by modulating molecular tension to extend (in the case of catch bonds) or reduce 
(in the case of slip bonds) bond lifetime. Therefore, the increased clustering requirement 
for a7b1 ligands suggest that more adhesions are required for stable adhesion formation. 
Pharmacological inhibition of cytoskeletal contractility resulted in an increase in NRC 
spreading on a7b1 integrins, further suggesting that a7b1 integrin adhesions may be less 
stable under high forces. This would also agree with observations of decreased 
cytoskeletal content, traction forces and spreading in cells cultured on laminin in Chapter 
3. Together, these results suggest that fibronectin adhesions mediate stronger spreading, 
contractility and integrin adaptor enrichment phenotypes via and enhanced stability of 
individual adhesions. Furthermore, this finding suggests that a transition in integrin 
expression to favour fibronectin binding subtypes may also favour the activation of 
integrin signalling and mechanotransduction pathways, as is observed during hypertrophy 
(Balasubramanian and Kuppuswamy, 2003, Johnston et al., 2009, Valiente-Alandi et al., 
2018). 
6.3 Potential Physiological Relevance of the Results Presented 
this Thesis 
This investigation has consistently observed enhanced cardiomyocyte spreading, traction 
forces and adhesion enrichment when spreading over fibronectin or RGD. These 
behaviours were particularly prominent at higher substrate stiffness. Fibronectin binding 
integrins have been shown to play a key role in key behaviours observed in the failing 
heart, especially in cases of cardiac fibrosis or hypertension where physiological changes 
are observed in the myocardium (Nawata et al., 1999, Ogawa et al., 2000, 
Balasubramanian and Kuppuswamy, 2003, Johnston et al., 2009). Fibronectin integrins 
exhibit a sharp increase in expression after cardiac injury and beta 3 integrins (which bind 
strongly to fibronectin) have been found to have a key role in hypertrophic signalling 
(Ogawa et al., 2000). Indeed, recent work from the Iskratsch lab has begun to elucidate 
some of the molecular pathways involved in mediating such as responses and has 
identified Src as a key player in the mechanosensitive hypertrophic response (Pandey et 
al., 2018). The current investigation has presented preliminary results that suggest Src 
localisation to nanopatterned adhesions is greater on RGD than IKVAV. Future work 
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could investigate Src localisation and enrichment at fibronectin and laminin adhesion to 
evaluate if this hypothesis holds any water. 
Another phenomenon particularly relevant to the results in this thesis is the 
downregulation of fibronectin binding integrin subtypes during post-natal development 
and the consequent upregulation of laminin binding subtypes (Brancaccio et al., 1998, 
Maitra et al., 2000, Burgess et al., 2001). Little is known about the signalling 
consequences of this behaviour. The results in this thesis suggest that this switch in 
integrin expression may result in a less mechanosensitive costamere. It could be 
hypothesised that this may help stimulate a transition to signalling from the ICD, but 
evidence of this does not currently exist. Another intriguing hypothesis could be that the 
switch to laminin binding subtypes may result in a different hypertrophic response. 
Fibronectin binding integrins are well documented to play key roles in pathological 
hypertrophy. However, there is a clear distinction between pathological and physiological 
hypertrophy, which result in different morphological and signalling phenotypes 
(Nakamura and Sadoshima, 2018). Indeed, many of the classic markers of cardiomyocyte 
hypertrophy, which are commonly investigated in-vitro on fibronectin coated substrates, 
such as JNK and p38 are considered parts of the pathological hypertrophy pathway 
(Nakamura and Sadoshima, 2018). On the other hand, to observe this at the level of 
integrins is too narrow when considering different types of hypertrophy. The DNA 
origami platform presented in this thesis offers a unique opportunity to investigate the 
role of integrin signalling alongside other important signalling receptors such as 
angiotensin and natriuretic peptides receptors. This could be achieved  by functionalising 
DNA nanostructures with integrin, angiotensin and/or natriuretic peptide ligands which 
could subsequently be combined with nanopatterning or magnetic tweezers to investigate 
the corresponding signalling pathways in the presence of hypertrophic stimuli. 
6.4 Summary and Conclusions 
 
This investigation has adopted a highly interdisciplinary approach to investigate the 
integrin signalling behaviours of cardiomyocytes cultured on fibronectin and laminin 
ligands. The results have consistently demonstrated that at the level of the single cell, 
down to the level of integrin-ligand clusters, cardiomyocytes behave differently 
depending on the predominant integrin subtype. These findings are in line with work 
reporting differential signalling behaviours of integrin subtypes (Elosegui-Artola et al., 
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2014, Schaufler et al., 2016, Bharadwaj et al., 2017, Lerche et al., Preprint). 
Cardiomyocyte integrin adhesions to RGDfC peptides required fewer integrins per cluster 
for stable adhesion which, according to the molecular clutch model (Elosegui-Artola et 
al., 2018), suggests that adaptor proteins may be under greater stress resulting in the 
activation of signalling pathways. This observation appears to be consistent with results 
from Chapter 3 where cardiomyocytes spreading on full length fibronectin which 
demonstrated greater spreading and contractility, compared to laminin. Furthermore, 
cardiomyocytes exhibited preferential alignment and stronger vinculin enrichment to 
fibronectin adhesions. Together these results suggest that differential integrin signalling 
regimes may be activated through fibronectin and laminin adhesions and that changes in 
integrin expression has important implications for cardiomyocyte behaviour. 
The finding that fibronectin adhesions facilitate greater contractility and spreading via 
greater adhesion stability under force is a surprising one. From embryonic and neonatal 
development through to adulthood, laminin integrins become the dominant subtype as the 
myocardium stiffens from 1 – 10 kPa to 10 – 20 kPa, respectively (Ward and Iskratsch, 
2019). It is not currently clear why cardiomyocytes would preferentially change integrin 
expression to favour subtypes which are less mechanically stable under force. It could be 
that cardiomyocytes utilise a range of fibronectin (a5b1, avb3 and a8b1) or laminin 
(a7b1, a3b1 and a6b1) binding integrin subtypes, all of which may have unique 
characteristics that contribute towards costameric integrin signalling. On the other hand, 
transition of the predominant integrin to a subtype with less mechanical stability may 
facilitate the redirection of forces from cell-ECM to cell-cell contacts. Thus, further 
investigation is required to understand the cross-talk between integrin subtypes, which 
has been demonstrated to play a key role in cell spreading and integrin signalling 
(Rahmouni et al., 2013, Schaufler et al., 2016, Bharadwaj et al., 2017), and to understand 
their specific role in cardiomyocyte development or disease. Furthermore, other 
components of the costamere such as the desmin cytoskeleton and DGC may also 
contribute towards mechanosignaling (Morikawa et al., 2017, Ward and Iskratsch, 2019). 
As discussed in the future directions section, the DNA origami platform presented in this 
thesis provides a powerful platform to investigate the roles of different components of the 
costamere and cell membrane receptors, including different integrin subtypes. Therefore, 
the work presented in this thesis offers several opportunities to provide further clarity on 
the results presented. 
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This investigation has conducted a comparative analysis of cardiomyocyte adhesion, 
spreading and integrin clustering on fibronectin and laminin receptors. The results have 
demonstrated that NRCs cultured on fibronectin exhibit behaviours that suggest a 
stronger spreading and contractile phenotype, when compared to cells cultured on 
laminin. These differences are likely to occur due to the underlying differences in the 
integrin adhesion properties of a7b1 and a5b1 integrin subtypes, as evidenced by 
differences in integrin clustering and differential responses to cytoskeletal contractility. 
Thus, these results provide novel insights into the molecular underpinnings of 
cardiomyocyte integrin signalling and further our understanding of their roles in 
development and disease. 
This thesis has also presented the optimisation and implementation of a DNA origami 
nanopatterning platform for the investigations of integrin adhesion and clustering 
behaviours in cardiomyocytes. This platform offers a highly versatile setup for the 
investigation of numerous additional properties of cardiomyocyte integrin signalling such 
as ECM composition, geometry and stoichiometry. Therefore, this platform provides 
many opportunities for future investigations to further understand the integrin signalling 
regimes of fibronectin and laminin binding integrin subtypes.  
6.5 Future Directions 
Recent work from the Iskratsch lab had reported that NRCs sense the rigidity of their 
environment through a combination of muscle and non-muscle myosin contractions. The 
non-receptor tyrosine kinase Src was found to play a key role in coordinating non-
myofibrillar rigidity sensing through recruitment and activation of FHOD1 and non-
muscle myosin. Results from nanopillars and ligand micropatterning suggest that 
fibronectin and laminin receptors respond differently at physiological and fibrotic 
stiffnesses. This may suggest the activation of a different signalling regime and that 
results from previous work using fibronectin substrates may not be applicable to laminin 
substrates. Therefore, future work could aim to evaluate whether the observed differences 
occur through a different pathways or due to lower Src activity.  
This investigation has also presented the development of a platform to quantitatively 
evaluate the integrin clustering behaviours of different integrin subtypes and adhesion 
receptors. This platform offers the ability to evaluate the downstream signalling 
consequences of different integrin/ligand cluster interactions. As a result, the work carried 
 
 143 
out here could be extended to other techniques to provide further data on the differential 
integrin signalling activity of fibronectin and laminin subtypes. 
The observation that laminin adhesions require more ligands per cluster for stable 
adhesion and spreading, may suggest that they are less stable under force (Elosegui-Artola 
et al., 2014, Oria et al., 2017). This would be a surprising result as cardiomyocytes 
preferentially express laminin integrin subtypes in the adult heart, where they are required 
to resist higher forces, compared to developmental and neonatal stages. To further 
understand fibronectin vs laminin adhesion stability, magnetic tweezers could be 
employed to evaluate the bond strength of integrin subtypes under various force regimes. 
Importantly, the DNA origami platform could be extended to magnetic bead studies, by 
covalent attachment of peptide functionalised DNA origami to the beads themselves. This 
would enable the evaluation of integrin bond characteristics relative to integrin cluster 
size (6 – 18 peptides) and force loading regime, which dictates bond association 
dissociation rates (Elosegui-Artola et al., 2018). Uncovering the adhesion kinetics of 
fibronectin and laminin integrins in cardiomyocytes would help to provide stronger 
evidence of functionally distinct roles of either subtype. Furthermore, this data would also 
compliment the work presented in this thesis. 
To further understand how fibronectin and laminin integrins alter rigidity sensing, the 
nanopatterned DNA origami arrays could be utilised to evaluate protein turnover (using 
fluorescence recovery after photobleaching) and molecular tension across 
mechanosensitive proteins such as talin (using FRET tension sensors). This would 
provide further clarity of the relationship between integrin clustering for adhesion 
reinforcement and the corresponding activity of key mechanotransduction proteins such 
as talin in response to the differential clustering regimes. This data would also 
compliment previous work which has demonstrated that integrin clustering enables force 
transmission through adhesions (Liu et al., 2014), and may provide further clarification 
on the integrin clustering results obtained here. 
Another promising line of investigation with the DNA origami platform, is the 
opportunity for multivalent investigations. Recent work from the Palma lab (Huang et al., 
2019) has demonstrated the power of DNA origami for the nanopatterning of more than 
one ligand of interest, to look at the cooperative effect of different receptors. In-vivo, 
cardiomyocytes express a combination of integrin receptors, which likely cooperate for 
various functions. Multivalent investigations offer the ability to quantitatively analyse the 
cooperative effects of fibronectin and laminin adhesions within the same clusters. Indeed, 
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previous work has demonstrated functionally distinct roles of different integrin subtypes 
within the same adhesions (Schaufler et al., 2016, Bharadwaj et al., 2017). Multivalent 
investigations also open up the possibilities to investigate the effect of integrin cluster 
composition on the turnover and lifetime of various proteins to evaluate how integrin 
expression can be modulated to fine tune the composition and corresponding 
mechanosignalling at the costamere. Thus, the DNA origami platform developed here 
provides a highly dynamic and effective platform to understand the role of different 
integrin subtypes in costameric signalling. 
A recent study has demonstrated that the requirement for integrin clustering in FAs is 
dependent upon substrate stiffness (Oria et al., 2017). The results show that at 
physiological stiffnesses of 20 – 30 kPa, integrin clusters are required to be dramatically 
less dense (100-200 nm integrin spacing) than at fibrotic stiffnesses (30-60 nm integrin 
spacing). Therefore, the 30-60 nm clustering requirements observed are likely to 
overestimate the integrin clustering dynamics at physiologically relevant stiffnesses. 
Future investigations should aim to combine the nanopatterning capabilities of DNA 
DNA origami with PDMS or acrylamide substrates, to evaluate how integrin clustering 
dynamics change with substrate rigidity. This would further help to uncover the 
functional roles of fibronectin and laminin binding integrins in embryonic, healthy and 
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STUDIES USED IN INTEGRIN EXPRESSION MINI META-ANALYSIS 
Neonatal Ventricular Cardiomyocytes 
Study 1: Geo Page , PubMed, Anand et al., 2013 Doi 10.1016/j.cell.2013.07.013 
Genevestigator Experiment ID: RN-00210  
 
Title : BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure 
[NRVM Expression] 
 
Method: Cells were harvested from 2 day old Sprague-Dawley Rats and maintained in 
serum free medium for 48 hours. For cellular samples, total RNA from NRVM was 
isolated using the High Pure RNA isolation kit (Roche #11828665001) with on-column 
DNAase treatment according to manufacturer’s directions. Purified RNA was reverse 
transcribed to complementary DNA using the iScriptTM RT Supermix (Biorad #170-
8841) following manufacturer's protocol. 
 
Data taken from three independent repeats of control samples treated with DMSO for 90 
minutes 
Log2 Values for ITGa5: 9.26, 9.21, 9.23  
Log2 Values for ITGa7: 13.9, 13.79, 13.87 
Log2 Values for ITGa6: 12.86, 12.82, 12.68 
Log2 Values for ITGa3: 12.78, 12.72, 12.72 
Log2 Values for ITGb1: 16.37, 16.28, 16.33 
Log2 Values for ITGa8: 11.41, 11.42, 11.4 
Log2 Values for ITGav: 12.31, 12.25, 12.14 
Log2 Values for ITGb3: 10.62, 10.66, 10.69 
 
Study 2 : Array Express Page, PubMed , Marshall et al., 2010 Doi: 
10.1371/journal.pone.0010027 




Title: ERK1/2 Signaling Dominates Over RhoA Signaling in Regulating Early Changes 
in RNA Expression Induced by Endothelin-1 in Neonatal Rat Cardiomyocytes 
 
 Method: Neonatal ventricular cardiomyocytes derived from Sprague Dawley rats. 
Cardiomyocytes were isolated from ventricles of 2-day-old neonatal Sprague Dawley 
rats, and propagated in 80% DMEM/20% MEM. RNA from three individual experiments 
was pooled and analyzed as a single sample set. Total RNA was taken from cells after 
42-48 hours in culture. 
 
Log2 Values for ITGa5:  11.79, 11.75, 11.42, 11.38, 11.69, 11.39, 11.48, 11.47 
Log2 Values for ITGa7: 12.87, 12.99, 12.92, 12.87, 12.73, 12.92, 12.90, 12.91 
Log2 Values for ITGa6: 11.69, 11.55, 11.55, 11.36, 11.54, 11.30, 11.72, 11.60 
Log2 Values for ITGa3: 12.00, 11.95, 12.02, 11.86, 11.95, 11.95, 11.91, 11.95 
Log2 Values for ITGb1: 15.55, 15.23, 15.20, 15.31, 15.53, 15.05, 15.21, 15.38 
Log2 Values for ITGa8: 11.15, 11.31, 11.42, 11.09, 11.11, 11.37, 11.45, 11.14 
Log2 Values for ITGav: 10.86, 10.99, 11.11, 11.11, 10.91, 11.04, 11.5, 11.16 
Log2 Values for ITGb3: 10.96, 11.48, 11.82, 11.86, 11.06, 11.53, 12.05, 12.1 
 
Study 3: Array Express, Pubmed, Markou et al., 2010 DOI: 10.1186/1471-2164-11-343 
Genevestigator Experiment ID: RN-00297 
 
Title: Regulation of the cardiomyocyte transcriptome vs translatome by endothelin-1 and 
insulin: translational regulation of 5' terminal oligopyrimidine tract (TOP) mRNAs by 
insulin. 
 
Method: Neonatal ventricular cardiomyocytes isolated from ventricles of 1-3-day-old 
Sprague Dawley rats. Cardiomyocytes were cultured in 68% Dulbecco's modified 
Eagele's medium, 17% M199, 15% fetal calf serum, and 100 units/ml penicillin and 
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streptomycin for 18 h. Serum was withdrawn and cells cultured in 80% 
DMEM/20%MEM for 24 h. Total RNA was used for the analysis.  
 
Log2 Values for ITGa5:  11.86, 12.27, 12.19, 11.69 
Log2 Values for ITGa7: 13.08, 13.11, 13.32, 13.20 
Log2 Values for ITGa6: 11.70, 11.97, 11.70, 11.79 
Log2 Values for ITGa3: 12.46, 12.27, 12.42, 12.26 
Log2 Values for ITGb1: 15.50, 15.30, 15.42, 15.57 
Log2 Values for ITGa8: 11.64, 11.63, 11.31, 11.72 
Log2 Values for ITGav: 11.32, 11.35, 11.18, 11.11 
Log2 Values for ITGb3: 11.34, 11.6, 11.74, 11.41 
 
 
Study 4: GEO, PubMed, Yoshikawa et al., 2009 Doi: 10.1152/ajpendo.90767.2008. 
Genevestigator Experiment ID: RN-00298  
 
Title: Ligand-based gene expression profiling reveals novel roles of glucocorticoid 
receptor in cardiac metabolism. 
 
Method: Neonatal ventricular cardiomyocytes derived from Wistar rats treated with 
vehicle (ethanol) for 3h. Cardiomyocytes were isolated from ventricles of 1-day-old 
neonatal Wistar rats. Primary cultures of cardiomyocytes were grown in OPTI-MEM for 
24 h, and then treated with ethanol for 3h. Pooled RNA samples were used from three 
independent experiments.  
 
Log2 Values for ITGa5:  10.77, 11.64 
Log2 Values for ITGa7: 13.00, 12.86 
Log2 Values for ITGa6: 12.48, 11.77 
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Log2 Values for ITGa3: 12.79, 13.13 
Log2 Values for ITGb1:15.32, 15.06 
Log2 Values for ITGa8: 11.07, 10.10 
Log2 Values for ITGav: 10.58, 9.62 




ANTIBODIES TESTED BUT FOUND TO BE OF INSUFFICIENT QUALITY 
 
Daam1 (Rabbit) –   Protientec – 20466 – used at 1:200 
mDia1 (Rabbit) – Abcam – Ab11173 – used at 1:200 
FMNL1 (Rabbit) – Abcam – Ab97456 – used at 1:200 
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